<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">100653</article-id><article-id pub-id-type="doi">10.7554/eLife.100653</article-id><article-id pub-id-type="doi" specific-use="version">10.7554/eLife.100653.3</article-id><article-version article-version-type="publication-state">version of record</article-version><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>Prosapip1 (encoded by the <italic>Lzts3</italic> gene) in the dorsal hippocampus mediates synaptic protein composition, long-term potentiation, and spatial memory</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Hoisington</surname><given-names>Zachary W</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Gangal</surname><given-names>Himanshu</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Phamluong</surname><given-names>Khanhky</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Shukla</surname><given-names>Chhavi</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Moffat</surname><given-names>Jeffrey J</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Salvi</surname><given-names>Alexandra</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-0148-2406</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Homanics</surname><given-names>Gregg</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Jun</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-0085-4722</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Ehinger</surname><given-names>Yann</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-9314-6575</contrib-id><email>yann.ehinger@gmail.com</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Ron</surname><given-names>Dorit</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-5161-967X</contrib-id><email>dorit.ron@ucsf.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/043mz5j54</institution-id><institution>Alcohol and Addiction Research Group, Department of Neurology, University of California, San Francisco</institution></institution-wrap><addr-line><named-content content-type="city">San Francisco</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01tx6pn92</institution-id><institution>Department of Neuroscience and Experimental Therapeutics, School of Medicine, Texas A&amp;M University Health Science Center</institution></institution-wrap><addr-line><named-content content-type="city">College Station</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01an3r305</institution-id><institution>Department of Anesthesiology and Perioperative Medicine, University of Pittsburgh</institution></institution-wrap><addr-line><named-content content-type="city">Pittsburgh</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>McElligott</surname><given-names>Zoe A</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0130frc33</institution-id><institution>University of North Carolina at Chapel Hill</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Chen</surname><given-names>Lu</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00f54p054</institution-id><institution>Stanford University</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>26</day><month>11</month><year>2025</year></pub-date><volume>13</volume><elocation-id>RP100653</elocation-id><history><date date-type="sent-for-review" iso-8601-date="2024-06-20"><day>20</day><month>06</month><year>2024</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint.</event-desc><date date-type="preprint" iso-8601-date="2024-06-13"><day>13</day><month>06</month><year>2024</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2024.06.13.597459"/></event><event><event-desc>This manuscript was published as a reviewed preprint.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2024-10-03"><day>03</day><month>10</month><year>2024</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.100653.1"/></event><event><event-desc>The reviewed preprint was revised.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2025-03-26"><day>26</day><month>03</month><year>2025</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.100653.2"/></event></pub-history><permissions><copyright-statement>© 2024, Hoisington et al</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>Hoisington et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-100653-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-100653-figures-v1.pdf"/><abstract><p> Prosapip1 is a brain-specific protein, encoded by <italic>Lzts3</italic>, localized to the postsynaptic density, where it promotes dendritic spine maturation in primary hippocampal neurons. However, nothing is known about the role of Prosapip1 in vivo. To examine this, we utilized the Cre-loxP system to develop a Prosapip1 neuronal knockout mouse. We found that Prosapip1 controls the synaptic localization of its binding partner SPAR, along with PSD-95 and the GluN2B subunit of the NMDA receptor (NMDAR) in the dorsal hippocampus (dHP). We next sought to identify the potential contribution of Prosapip1 to the activity and function of the NMDAR and found that Prosapip1 plays an important role in NMDAR-mediated transmission and long-term potentiation (LTP) in the CA1 region of the dHP. As LTP is the cellular hallmark of learning and memory, we examined the consequences of neuronal knockout of Prosapip1 on dHP-dependent memory. We found that global or dHP-specific neuronal knockout of Prosapip1 caused a deficit in learning and memor,y whereas developmental, locomotor, and anxiety phenotypes were normal. Taken together, Prosapip1 in the dHP promotes the proper localization of synaptic proteins which, in turn, facilitates LTP driving recognition, social, and spatial learning and memory.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>memory</kwd><kwd>prosapip</kwd><kwd>hippocampus</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02jzrsm59</institution-id><institution>National Institute on Alcohol Abuse and Alcoholism</institution></institution-wrap></funding-source><award-id>AA020889</award-id><principal-award-recipient><name><surname>Homanics</surname><given-names>Gregg</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02jzrsm59</institution-id><institution>National Institute on Alcohol Abuse and Alcoholism</institution></institution-wrap></funding-source><award-id>AA027474</award-id><principal-award-recipient><name><surname>Ron</surname><given-names>Dorit</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02jzrsm59</institution-id><institution>National Institute on Alcohol Abuse and Alcoholism</institution></institution-wrap></funding-source><award-id>AA027682</award-id><principal-award-recipient><name><surname>Ron</surname><given-names>Dorit</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04q48ey07</institution-id><institution>National Institute of General Medical Sciences</institution></institution-wrap></funding-source><award-id>GM007175</award-id><principal-award-recipient><name><surname>Hoisington</surname><given-names>Zachary W</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Novel function of Prosapip1, a scaffolding protein highly expressed in the hippocampus, in maintaining postsynaptic density integrity and plays a vital role in synaptic plasticity, learning, and memory.</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>publishing-route</meta-name><meta-value>prc</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>The brain-specific protein ProSAP-interacting protein 1 (Prosapip1), encoded by the gene <italic>Lzts3,</italic> shows particularly high expression in the cortex, cerebellum, and hippocampus (<xref ref-type="bibr" rid="bib80">Wendholt et al., 2006</xref>; <xref ref-type="bibr" rid="bib42">Laguesse et al., 2017</xref>). Prosapip1 is highly enriched in the PSD of excitatory synapses and plays an important role in dendritic spine maturation in primary hippocampal neurons (<xref ref-type="bibr" rid="bib80">Wendholt et al., 2006</xref>; <xref ref-type="bibr" rid="bib26">Dolnik et al., 2016</xref>). The PSD is a complex protein network located at the postsynaptic membrane of neurons, namely excitatory neurons (<xref ref-type="bibr" rid="bib10">Boeckers et al., 2002</xref>; <xref ref-type="bibr" rid="bib38">Kaizuka and Takumi, 2018</xref>). The PSD is crucial for synaptic transmission and plasticity (<xref ref-type="bibr" rid="bib10">Boeckers et al., 2002</xref>; <xref ref-type="bibr" rid="bib38">Kaizuka and Takumi, 2018</xref>), and abnormalities in the PSD network are linked to various neuropsychiatric and neurodegenerative disorders (<xref ref-type="bibr" rid="bib38">Kaizuka and Takumi, 2018</xref>), such as schizophrenia, autism spectrum disorder (ASD), depression, and Alzheimer’s disease (<xref ref-type="bibr" rid="bib38">Kaizuka and Takumi, 2018</xref>). The PSD contains scaffolding proteins such as PSD-95, Shank, and Homer (<xref ref-type="bibr" rid="bib39">Kennedy, 2018</xref>). The major scaffold in the PSD is actin (<xref ref-type="bibr" rid="bib60">Qualmann et al., 2004</xref>), which recycles between globular (G-actin) and filamentous (F-actin) actin and is crucial in reorganizing and stabilizing the PSD (<xref ref-type="bibr" rid="bib60">Qualmann et al., 2004</xref>; <xref ref-type="bibr" rid="bib40">Kuriu et al., 2006</xref>).</p><p>Prosapip1 has a C-terminal Fez1 domain that it shares with the other members of the Fezzin family (LAPSER1, PSD-Zip70, N4BP3) (<xref ref-type="bibr" rid="bib80">Wendholt et al., 2006</xref>). Fezzins interact with the PDZ (PSD-95/Dlg1/ZO-1) domain of SH3 and multiple ankyrin repeat domains (Shank) family proteins. Shanks are also known as proline-rich synapse-associated proteins (ProSAPs) and were originally identified as proteins primarily localizing in the PSD of excitatory synapses (<xref ref-type="bibr" rid="bib9">Boeckers et al., 1999</xref>; <xref ref-type="bibr" rid="bib68">Sheng and Kim, 2000</xref>; <xref ref-type="bibr" rid="bib10">Boeckers et al., 2002</xref>). Prosapip1 specifically interacts with the PSD protein, Shank3 (<xref ref-type="bibr" rid="bib80">Wendholt et al., 2006</xref>). Prosapip1 also interacts with the spine-associated Rap GTPase-activating protein (SPAR) (<xref ref-type="bibr" rid="bib80">Wendholt et al., 2006</xref>; <xref ref-type="bibr" rid="bib61">Reim et al., 2016</xref>). SPAR catalyzes the conversion of the small G-protein Rap from its active, GTP-bound form to its inactive GDP-bound form, thereby inhibiting Rap activity. SPAR is an essential modulator of spine morphology through its interaction with actin (<xref ref-type="bibr" rid="bib57">Pak et al., 2001</xref>; <xref ref-type="bibr" rid="bib63">Richter et al., 2007</xref>). In hippocampal neurons, it is localized to dendritic spines and leads to spine head enlargement (<xref ref-type="bibr" rid="bib57">Pak et al., 2001</xref>). SPAR also associates with PSD-95/NMDAR-complex components (<xref ref-type="bibr" rid="bib51">Matsuura et al., 2022</xref>). Wendholt et al. reported that in primary hippocampal neurons Prosapip1 regulates the synaptic levels of SPAR by scaffolding it to Shank3 (<xref ref-type="bibr" rid="bib80">Wendholt et al., 2006</xref>; <xref ref-type="bibr" rid="bib26">Dolnik et al., 2016</xref>; <xref ref-type="bibr" rid="bib61">Reim et al., 2016</xref>).</p><p>We previously found that mRNA to protein translation of Prosapip1 is controlled by the mechanistic target of rapamycin complex 1 (mTORC1) in the nucleus accumbens (NAc) of mice consuming large quantities of alcohol (<xref ref-type="bibr" rid="bib42">Laguesse et al., 2017</xref>). We further showed that Prosapip1 interacts with SPAR in the NAc and leads to alcohol-dependent synaptic and structural plasticity (<xref ref-type="bibr" rid="bib42">Laguesse et al., 2017</xref>). Specifically, we found that knockdown of Prosapip1 in the NAc led to a reduction in F-actin, while overexpression of Prosapip1 led to an increase in F-actin (<xref ref-type="bibr" rid="bib42">Laguesse et al., 2017</xref>). Knockdown of Prosapip1 caused a reduction of mature, mushroom-type spines and an increase in immature, thin spines (<xref ref-type="bibr" rid="bib42">Laguesse et al., 2017</xref>). Finally, we found that Prosapip1 in the NAc contributes to alcohol self-administration and reward (<xref ref-type="bibr" rid="bib42">Laguesse et al., 2017</xref>). However, nothing is known about the normal in vivo role of Prosapip1 in the central nervous system (CNS). Here, we report that Prosapip1 in the dHP controls the localization of synaptic proteins at the PSD and contributes to LTP as well as recognition, social, and spatial learning and memory.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Generation and characterization of <italic>Prosapip1</italic>(fl/fl) mice</title><p>To elucidate the role of Prosapip1 in the CNS, we generated a mouse line with flox sites flanking the Prosapip1 encoding gene, <italic>Lzts3</italic>. Guide RNA binding sites were identified in intron 2 and in the 3’ UTR of exon 5 of <italic>Lzts3</italic> (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). PAGE-purified Ultramer single-stranded DNA oligos that were homologous to the target loci in intron 2 and exon 5 (<xref ref-type="fig" rid="fig1">Figure 1B</xref>) were used as repair templates.</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Generation and characterization of Prosapip1 cKO mice.</title><p>(<bold>A</bold>) Identification of guide RNA binding sites in intron 2 and the 3’ UTR of exon 5 of <italic>Lzts3</italic>. (<bold>B</bold>) PAGE-purified Ultramer single-stranded DNA oligos that were homologous to the target loci in intron 2 and exon 5 were used as repair templates. (<bold>C</bold>) Genetic crossing scheme of the <italic>Lzts3</italic><sup>fl/fl</sup>;Syn1-Cre mice. Male <italic>Lzts3</italic><sup>fl/fl</sup>;Syn1-Cre(-) mice were mated with female <italic>Lzts3</italic><sup>fl/fl</sup>;Syn1-Cre(+) (Prosapip1 cKO) mice, leading to litters of control (<italic>Lzts3</italic><sup>fl/fl</sup>;Syn1-Cre(-)) or Prosapip1 cKO (<italic>Lzts3</italic><sup>fl/fl</sup>;Syn1-Cre(+)) mice. (<bold>D</bold>) The dHP of C57BL/6, control and Prosapip1 cKO mice was dissected. Prosapip1 was detected using anti-Prosapip1 antibodies. GAPDH was used as a loading control. (<bold>E</bold>) Histogram of litter size from <italic>Lzts3</italic><sup>fl/fl</sup> × Syn1-Cre mating pairs. X-axis depicts number of pups per litter, while Y-axis depicts numbers of litters at that size. (<bold>F</bold>) Proportion of male and female offspring from <italic>Lzts3</italic><sup>fl/fl</sup> × Syn1-Cre matings. (<bold>G</bold>) Proportion of Cre(-) and Cre(+) offspring from <italic>Lzts3</italic><sup>fl/fl</sup> × Syn1-Cre matings. (<bold>H</bold>) Body weight of male and female Prosapip1 cKO and control mice was measured biweekly from birth to assess overt developmental deficits. Data are represented as mean ± SEM and analyzed using three-way ANOVA (<xref ref-type="table" rid="table1">Table 1</xref>). n=10 (control male), 5 (control female), 11 (Prosapip1 cKO male), 11 (Prosapip1 cKO female). (<bold>I–J</bold>) Mice were placed in an open field and locomotion was recorded for 20 min. Total distance traveled during the open field test (<bold>I</bold>) and time spent in the center of the open field (<bold>J</bold>). Data represented as mean ± SEM and analyzed using an unpaired t-test (<xref ref-type="table" rid="table1">Table 1</xref>). ns, non-significant. n=22 (control), 21 (Prosapip1 cKO).</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>File containing raw data for <xref ref-type="fig" rid="fig1">Figure 1</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-100653-fig1-data1-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig1sdata2"><label>Figure 1—source data 2.</label><caption><title>Original files for western blot analysis displayed in <xref ref-type="fig" rid="fig1">Figure 1D</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-100653-fig1-data2-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100653-fig1-v1.tif"/></fig><p>To generate a neuron-specific conditional knockout of Prosapip1, we crossed homozygous <italic>Lzts3</italic> floxed (<italic>Lzts3</italic><sup>fl/fl</sup>) mice with a Synapsin I promoter–driven Cre recombinase line (Syn1-Cre). Specifically, male <italic>Lzts3</italic><sup>fl/fl</sup>;Syn1-Cre(–) mice were bred with female <italic>Lzts3</italic><sup>fl/fl</sup>;Syn1-Cre(+) mice (<xref ref-type="fig" rid="fig1">Figure 1C</xref>), producing <italic>Lzts3</italic><sup>fl/fl</sup>;Syn1-Cre(+) offspring (Prosapip1 cKO) and <italic>Lzts3</italic><sup>fl/fl</sup>;Syn1-Cre(–) littermates, which served as controls. The neuronal knockout was confirmed by estern blot analysis using an anti-Prosapip1 antibody. As shown in <xref ref-type="fig" rid="fig1">Figure 1D</xref>, control mice have Prosapip1 protein levels comparable to those of a C57BL/6 mouse, while Prosapip1 cKO mice show a complete knockout of Prosapip1 protein in the dHP.</p><p>We examined the breeding history of the newly developed line to identify any abnormalities. The litter sizes of <italic>Lzts3</italic><sup>fl/fl</sup>;Syn1-Cre matings followed a normal distribution with an average litter size between 5 and 6 pups (<xref ref-type="fig" rid="fig1">Figure 1E</xref>, <xref ref-type="table" rid="table1">Table 1</xref>). The proportion of male and female pups were near expectations, with 52% of pups being male and 48% female (<xref ref-type="fig" rid="fig1">Figure 1F</xref>). Inheritance of Syn1-Cre(+) was also split evenly, with 53% of pups from the line being born with the transgene (<xref ref-type="fig" rid="fig1">Figure 1G</xref>). Body weight of male and female mice was monitored every 2 weeks from birth to assess potential developmental effects. While males were significantly heavier than females throughout development, there was no significant effect of the genotype on weight over time (<xref ref-type="fig" rid="fig1">Figure 1H</xref>, <xref ref-type="table" rid="table1">Table 1</xref>).</p><table-wrap id="table1" position="float"><label>Table 1.</label><caption><title>Statistics.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Figure</th><th align="left" valign="bottom">n</th><th align="left" valign="bottom">Sex <bold>d</bold>ifference</th><th align="left" valign="bottom">Statistical <bold>t</bold>est</th><th align="left" valign="bottom">Effect</th><th align="left" valign="bottom">Result</th><th align="left" valign="bottom">p-value</th><th align="left" valign="bottom">Post-hoc</th><th align="left" valign="bottom">Post-hoc comparison</th><th align="left" valign="bottom">p-value</th></tr></thead><tbody><tr><td align="char" char="." valign="middle"><xref ref-type="fig" rid="fig1">Figure 1E</xref></td><td align="char" char="." valign="middle">77</td><td align="left" valign="middle"/><td align="left" valign="middle">D'Agostino &amp; Pearson test</td><td align="left" valign="middle">Normality</td><td align="left" valign="middle">K2=5.480</td><td align="char" char="." valign="middle">0.0646</td><td align="left" valign="middle"/><td align="left" valign="middle"/><td align="left" valign="middle"/></tr><tr><td align="char" char="." valign="middle" rowspan="7"><xref ref-type="fig" rid="fig1">Figure 1H</xref></td><td align="left" valign="middle" rowspan="7">10 (Cre- Male), 5 (Cre- Female), 11 (Cre +Male), 11 (Cre +Female)</td><td align="left" valign="middle" rowspan="7">Yes</td><td align="left" valign="middle" rowspan="7">Three-way ANOVA</td><td align="left" valign="middle">Genotype</td><td align="left" valign="middle">F<sub>(1,33)</sub>=0.7842</td><td align="char" char="." valign="middle">0.3823</td><td align="left" valign="middle"/><td align="left" valign="middle"/><td align="left" valign="middle"/></tr><tr><td align="left" valign="middle">Sex</td><td align="left" valign="middle">F<sub>(1,33)</sub>=23.94</td><td align="char" char="." valign="middle">&lt;0.0001</td><td align="left" valign="middle"/><td align="left" valign="middle"/><td align="left" valign="middle"/></tr><tr><td align="left" valign="middle">Time</td><td align="left" valign="middle">F<sub>(5,158)</sub>=588.4</td><td align="char" char="." valign="middle">&lt;0.0001</td><td align="left" valign="middle"/><td align="left" valign="middle"/><td align="left" valign="middle"/></tr><tr><td align="left" valign="middle">Genotype x Sex</td><td align="left" valign="middle">F<sub>(1,33)</sub>=1.345</td><td align="char" char="." valign="middle">0.2545</td><td align="left" valign="middle"/><td align="left" valign="middle"/><td align="left" valign="middle"/></tr><tr><td align="left" valign="middle">Genotype x Time</td><td align="left" valign="middle">F<sub>(5,158)</sub>=0.1476</td><td align="char" char="." valign="middle">0.9805</td><td align="left" valign="middle"/><td align="left" valign="middle"/><td align="left" valign="middle"/></tr><tr><td align="left" valign="middle">Sex x Time</td><td align="left" valign="middle">F<sub>(5,158)</sub>=2.345</td><td align="char" char="." valign="middle">0.0437</td><td align="left" valign="middle"/><td align="left" valign="middle"/><td align="left" valign="middle"/></tr><tr><td align="left" valign="middle">Genotype x Sex x Time</td><td align="left" valign="middle">F<sub>(5,158)</sub>=0.3764</td><td align="char" char="." valign="middle">0.8643</td><td align="left" valign="middle"/><td align="left" valign="middle"/><td align="left" valign="middle"/></tr><tr><td align="char" char="." valign="middle"><xref ref-type="fig" rid="fig1">Figure 1I</xref></td><td align="left" valign="middle">22 (Cre-), 21 (Cre+)</td><td align="left" valign="middle">No</td><td align="left" valign="middle">Unpaired t-test</td><td align="left" valign="middle">Genotype</td><td align="left" valign="middle">t<sub>(41)</sub>=1.460</td><td align="char" char="." valign="middle">0.1518</td><td align="left" valign="middle"/><td align="left" valign="middle"/><td align="left" valign="middle"/></tr><tr><td align="char" char="." valign="middle"><xref ref-type="fig" rid="fig1">Figure 1J</xref></td><td align="left" valign="middle">22 (Cre-), 21 (Cre+)</td><td align="left" valign="middle">No</td><td align="left" valign="middle">Mann-Whitney Test</td><td align="left" valign="middle">Genotype</td><td align="left" valign="middle">U=220</td><td align="char" char="." valign="middle">0.8007</td><td align="left" valign="middle"/><td align="left" valign="middle"/><td align="left" valign="middle"/></tr><tr><td align="char" char="." valign="middle"><xref ref-type="fig" rid="fig2">Figure 2B</xref></td><td align="left" valign="middle">5 (Cre-), 5 (Cre+)</td><td align="left" valign="middle"/><td align="left" valign="middle">Unpaired t-test</td><td align="left" valign="middle">Genotype</td><td align="left" valign="middle">t<sub>(6.963)</sub>=1.427</td><td align="char" char="." valign="middle">0.1968</td><td align="left" valign="middle"/><td align="left" valign="middle"/><td align="left" valign="middle"/></tr><tr><td align="char" char="." valign="middle"><xref ref-type="fig" rid="fig2">Figure 2C</xref></td><td align="left" valign="middle">5 (Cre-), 5 (Cre+)</td><td align="left" valign="middle"/><td align="left" valign="middle">Unpaired t-test</td><td align="left" valign="middle">Genotype</td><td align="left" valign="middle">t<sub>(5.880)</sub>=5.183</td><td align="char" char="." valign="middle">0.0022</td><td align="left" valign="middle"/><td align="left" valign="middle"/><td align="left" valign="middle"/></tr><tr><td align="char" char="." valign="middle"><xref ref-type="fig" rid="fig2">Figure 2F</xref></td><td align="left" valign="middle">5 (Cre-), 5 (Cre+)</td><td align="left" valign="middle"/><td align="left" valign="middle">Unpaired t-test</td><td align="left" valign="middle">Genotype</td><td align="left" valign="middle">t<sub>(6.932)</sub>=1.345</td><td align="char" char="." valign="middle">0.221</td><td align="left" valign="middle"/><td align="left" valign="middle"/><td align="left" valign="middle"/></tr><tr><td align="char" char="." valign="middle"><xref ref-type="fig" rid="fig2">Figure 2G</xref></td><td align="left" valign="middle">5 (Cre-), 5 (Cre+)</td><td align="left" valign="middle"/><td align="left" valign="middle">Unpaired t-test</td><td align="left" valign="middle">Genotype</td><td align="left" valign="middle">t<sub>(6.720)</sub>=0.1306</td><td align="char" char="." valign="middle">0.8999</td><td align="left" valign="middle"/><td align="left" valign="middle"/><td align="left" valign="middle"/></tr><tr><td align="char" char="." valign="middle"><xref ref-type="fig" rid="fig2">Figure 2H</xref></td><td align="left" valign="middle">9 (Cre-), 10 (Cre+)</td><td align="left" valign="middle"/><td align="left" valign="middle">Unpaired t-test</td><td align="left" valign="middle">Genotype</td><td align="left" valign="middle">t<sub>(16.38)</sub>=0.5588</td><td align="char" char="." valign="middle">0.5839</td><td align="left" valign="middle"/><td align="left" valign="middle"/><td align="left" valign="middle"/></tr><tr><td align="char" char="." valign="middle"><xref ref-type="fig" rid="fig2">Figure 2I</xref></td><td align="left" valign="middle">9 (Cre-), 10 (Cre+)</td><td align="left" valign="middle"/><td align="left" valign="middle">Unpaired t-test</td><td align="left" valign="middle">Genotype</td><td align="left" valign="middle">t<sub>(16.44)</sub>=6.095</td><td align="char" char="." valign="middle">&lt;0.0001</td><td align="left" valign="middle"/><td align="left" valign="middle"/><td align="left" valign="middle"/></tr><tr><td align="char" char="." valign="middle"><xref ref-type="fig" rid="fig2">Figure 2L</xref></td><td align="left" valign="middle">4 (Cre-), 5 (Cre+)</td><td align="left" valign="middle"/><td align="left" valign="middle">Unpaired t-test</td><td align="left" valign="middle">Genotype</td><td align="left" valign="middle">t<sub>(4.429)</sub>=0.1050</td><td align="char" char="." valign="middle">0.921</td><td align="left" valign="middle"/><td align="left" valign="middle"/><td align="left" valign="middle"/></tr><tr><td align="char" char="." valign="middle"><xref ref-type="fig" rid="fig2">Figure 2M</xref></td><td align="left" valign="middle">4 (Cre-), 5 (Cre+)</td><td align="left" valign="middle"/><td align="left" valign="middle">Unpaired t-test</td><td align="left" valign="middle">Genotype</td><td align="left" valign="middle">t<sub>(6.689)</sub>=0.1758</td><td align="char" char="." valign="middle">0.8656</td><td align="left" valign="middle"/><td align="left" valign="middle"/><td align="left" valign="middle"/></tr><tr><td align="char" char="." valign="middle"><xref ref-type="fig" rid="fig2">Figure 2N</xref></td><td align="left" valign="middle">4 (Cre-), 5 (Cre+)</td><td align="left" valign="middle"/><td align="left" valign="middle">Unpaired t-test</td><td align="left" valign="middle">Genotype</td><td align="left" valign="middle">t<sub>(6.700)</sub>=1.675</td><td align="char" char="." valign="middle">0.1398</td><td align="left" valign="middle"/><td align="left" valign="middle"/><td align="left" valign="middle"/></tr><tr><td align="char" char="." valign="middle"><xref ref-type="fig" rid="fig2">Figure 2O</xref></td><td align="left" valign="middle">4 (Cre-), 5 (Cre+)</td><td align="left" valign="middle"/><td align="left" valign="middle">Unpaired t-test</td><td align="left" valign="middle">Genotype</td><td align="left" valign="middle">t<sub>(6.332)</sub>=5.524</td><td align="char" char="." valign="middle">0.0012</td><td align="left" valign="middle"/><td align="left" valign="middle"/><td align="left" valign="middle"/></tr><tr><td align="char" char="." valign="middle"><xref ref-type="fig" rid="fig2">Figure 2P</xref></td><td align="left" valign="middle">4 (Cre-), 5 (Cre+)</td><td align="left" valign="middle"/><td align="left" valign="middle">Unpaired t-test</td><td align="left" valign="middle">Genotype</td><td align="left" valign="middle">t<sub>(6.956)</sub>=0.1831</td><td align="char" char="." valign="middle">0.8599</td><td align="left" valign="middle"/><td align="left" valign="middle"/><td align="left" valign="middle"/></tr><tr><td align="char" char="." valign="middle"><xref ref-type="fig" rid="fig2">Figure 2Q</xref></td><td align="left" valign="middle">4 (Cre-), 5 (Cre+)</td><td align="left" valign="middle"/><td align="left" valign="middle">Unpaired t-test</td><td align="left" valign="middle">Genotype</td><td align="left" valign="middle">t<sub>(6.060)</sub>=0.8548</td><td align="char" char="." valign="middle">0.4252</td><td align="left" valign="middle"/><td align="left" valign="middle"/><td align="left" valign="middle"/></tr><tr><td align="char" char="." valign="middle"><xref ref-type="fig" rid="fig3">Figure 3D</xref></td><td align="left" valign="middle">10/6 (Cre-), 9/5 (Cre+)</td><td align="left" valign="middle"/><td align="left" valign="middle">Unpaired t-test</td><td align="left" valign="middle">Genotype</td><td align="left" valign="middle">t<sub>(17)</sub>=3.933</td><td align="char" char="." valign="middle">0.0011</td><td align="left" valign="middle"/><td align="left" valign="middle"/><td align="left" valign="middle"/></tr><tr><td align="char" char="." valign="middle" rowspan="4"><xref ref-type="fig" rid="fig3">Figure 3E</xref></td><td align="left" valign="middle" rowspan="4">14/4 (Cre-), 11/4 (Cre+)</td><td align="left" valign="middle" rowspan="4"/><td align="left" valign="middle" rowspan="4">Two-way ANOVA</td><td align="left" valign="middle">Genotype</td><td align="left" valign="middle">F<sub>(1,3)</sub>=9.441</td><td align="char" char="." valign="middle">0.044</td><td align="left" valign="middle" rowspan="4">Tukey</td><td align="left" valign="middle"><bold>0.2 (Cre- vs. Cre+)</bold></td><td align="char" char="." valign="middle">0.345</td></tr><tr><td align="left" valign="middle">Intensity</td><td align="left" valign="middle">F<sub>(1,3)</sub>=9.441</td><td align="char" char="." valign="middle">&lt;0.001</td><td align="left" valign="middle"><bold>0.4 (Cre- vs. Cre+)</bold></td><td align="char" char="." valign="middle">0.025</td></tr><tr><td align="left" valign="middle">Genotype x Intensity</td><td align="left" valign="middle">F<sub>(1,3)</sub>=1.376</td><td align="char" char="." valign="middle">0.258</td><td align="left" valign="middle"><bold>0.6 (Cre- vs. Cre+)</bold></td><td align="char" char="." valign="middle">0.034</td></tr><tr><td align="left" valign="middle"/><td align="left" valign="middle"/><td align="left" valign="middle"/><td align="left" valign="middle"><bold>0.9 (Cre- vs. Cre+)</bold></td><td align="char" char="." valign="middle">0.046</td></tr><tr><td align="char" char="." valign="middle"><xref ref-type="fig" rid="fig3">Figure 3F</xref></td><td align="left" valign="middle">3/4 (Cre-), 11/4 (Cre+)</td><td align="left" valign="middle"/><td align="left" valign="middle">Unpaired t-test</td><td align="left" valign="middle">Genotype</td><td align="left" valign="middle">t<sub>(22)</sub>=3.094</td><td align="char" char="." valign="middle">0.00529</td><td align="left" valign="middle"/><td align="left" valign="middle"/><td align="left" valign="middle"/></tr><tr><td align="char" char="." valign="middle"><xref ref-type="fig" rid="fig3">Figure 3G</xref></td><td align="left" valign="middle">11/3 (Cre-), 13/4 (Cre+)</td><td align="left" valign="middle"/><td align="left" valign="middle">Unpaired t-test</td><td align="left" valign="middle">Genotype</td><td align="left" valign="middle">t<sub>(22)</sub>=2.099</td><td align="char" char="." valign="middle">0.0475</td><td align="left" valign="middle"/><td align="left" valign="middle"/><td align="left" valign="middle"/></tr><tr><td align="char" char="." valign="middle" rowspan="3"><xref ref-type="fig" rid="fig4">Figure 4A</xref></td><td align="left" valign="middle" rowspan="3">22 (Cre-), 20 (Cre+)</td><td align="left" valign="middle" rowspan="3">No</td><td align="left" valign="middle" rowspan="3">Two-way ANOVA</td><td align="left" valign="middle">Genotype</td><td align="left" valign="middle">F<sub>(1,40)</sub>=0.3079</td><td align="left" valign="middle"><italic>P</italic>=0.5821</td><td align="left" valign="middle" rowspan="3">Šidák</td><td align="left" valign="middle">Familiar vs. Novel (Cre-)</td><td align="char" char="." valign="middle">&lt;0.0001</td></tr><tr><td align="left" valign="middle">Object</td><td align="left" valign="middle">F<sub>(1,40)</sub>=34.32</td><td align="char" char="." valign="middle">&lt;0.0001</td><td align="left" valign="middle">Familiar vs. Novel (Cre+)</td><td align="char" char="." valign="middle">0.4871</td></tr><tr><td align="left" valign="middle">Genotype x Object</td><td align="left" valign="middle">F<sub>(1,40)</sub>=18.37</td><td align="char" char="." valign="middle">0.0001</td><td align="left" valign="middle"/><td align="left" valign="middle"/></tr><tr><td align="char" char="." valign="middle"><xref ref-type="fig" rid="fig4">Figure 4B</xref></td><td align="left" valign="middle">22 (Cre-), 19 (Cre+)</td><td align="left" valign="middle">No</td><td align="left" valign="middle">Unpaired t-test</td><td align="left" valign="middle">Genotype</td><td align="left" valign="middle">t<sub>(26.08)</sub>=5.434</td><td align="char" char="." valign="middle">&lt;0.0001</td><td align="left" valign="middle"/><td align="left" valign="middle"/><td align="left" valign="middle"/></tr><tr><td align="char" char="." valign="middle" rowspan="3"><xref ref-type="fig" rid="fig4">Figure 4D</xref></td><td align="left" valign="middle" rowspan="3">14 (Cre-), 17 (Cre+)</td><td align="left" valign="middle" rowspan="3">No</td><td align="left" valign="middle" rowspan="3">Two-way ANOVA</td><td align="left" valign="middle">Genotype</td><td align="left" valign="middle">F<sub>(1,29)</sub>=5.419</td><td align="char" char="." valign="middle">0.0271</td><td align="left" valign="middle" rowspan="3">Šidák</td><td align="left" valign="middle">Empty vs. Social (Cre-)</td><td align="char" char="." valign="middle">0.0006</td></tr><tr><td align="left" valign="middle">Social</td><td align="left" valign="middle">F<sub>(1,29)</sub>=34.30</td><td align="char" char="." valign="middle">&lt;0.0001</td><td align="left" valign="middle">Empty vs. Social (Cre+)</td><td align="char" char="." valign="middle">0.0005</td></tr><tr><td align="left" valign="middle">Genotype x Social</td><td align="left" valign="middle">F<sub>(1,29)</sub>=0.05655</td><td align="char" char="." valign="middle">0.8137</td><td align="left" valign="middle"/><td align="left" valign="middle"/></tr><tr><td align="char" char="." valign="middle" rowspan="3"><xref ref-type="fig" rid="fig4">Figure 4E</xref></td><td align="left" valign="middle" rowspan="3">14 (Cre-), 17 (Cre+)</td><td align="left" valign="middle" rowspan="3">No</td><td align="left" valign="middle" rowspan="3">Two-way ANOVA</td><td align="left" valign="middle">Genotype</td><td align="left" valign="middle">F<sub>(1,29)</sub>=1.463</td><td align="char" char="." valign="middle">0.2362</td><td align="left" valign="middle" rowspan="3">Šidák</td><td align="left" valign="middle">Familiar vs. Novel (Cre-)</td><td align="char" char="." valign="middle">0.0008</td></tr><tr><td align="left" valign="middle">Social Novelty</td><td align="left" valign="middle">F<sub>(1,29)</sub>=17.60</td><td align="char" char="." valign="middle">0.0002</td><td align="left" valign="middle">Familiar vs. Novel (Cre+)</td><td align="char" char="." valign="middle">0.1451</td></tr><tr><td align="left" valign="middle">Genotype x Social Novelty</td><td align="left" valign="middle">F<sub>(1,29)</sub>=2.947</td><td align="char" char="." valign="middle">0.0967</td><td align="left" valign="middle"/><td align="left" valign="middle"/></tr><tr><td align="left" valign="middle">Ext. <xref ref-type="fig" rid="fig4">Figure 4A</xref></td><td align="left" valign="middle">6 (Cre-), 12 (Cre+)</td><td align="left" valign="middle">No</td><td align="left" valign="middle">Unpaired t-test</td><td align="left" valign="middle">Genotype</td><td align="left" valign="middle">t<sub>(16)</sub>=0.2635</td><td align="char" char="." valign="middle">0.7955</td><td align="left" valign="middle"/><td align="left" valign="middle"/><td align="left" valign="middle"/></tr><tr><td align="char" char="." valign="middle" rowspan="12"><xref ref-type="fig" rid="fig4">Figure 4F</xref></td><td align="left" valign="middle" rowspan="12">9 (Cre-), 12 (Cre+)</td><td align="left" valign="middle" rowspan="12">No</td><td align="left" valign="middle" rowspan="12">Two-way ANOVA</td><td align="left" valign="middle">Genotype</td><td align="left" valign="middle">F<sub>(1,19)</sub>=102.0</td><td align="char" char="." valign="middle">&lt;0.0001</td><td align="left" valign="middle" rowspan="12">Šidák</td><td align="left" valign="middle">Trial 2 (Cre- vs. Cre+)</td><td align="char" char="." valign="middle">&lt;0.0001</td></tr><tr><td align="left" valign="middle">Trial</td><td align="left" valign="middle">F<sub>(15,285)</sub>=7.899</td><td align="char" char="." valign="middle">&lt;0.0001</td><td align="left" valign="middle">Trial 3 (Cre- vs. Cre+)</td><td align="char" char="." valign="middle">0.0067</td></tr><tr><td align="left" valign="middle">Genotype x Trial</td><td align="left" valign="middle">F<sub>(15,285)</sub>=1.401</td><td align="char" char="." valign="middle">0.1454</td><td align="left" valign="middle">Trial 4 (Cre- vs. Cre+)</td><td align="char" char="." valign="middle">0.0018</td></tr><tr><td align="left" valign="middle"/><td align="left" valign="middle"/><td align="left" valign="middle"/><td align="left" valign="middle">Trial 5 (Cre- vs. Cre+)</td><td align="char" char="." valign="middle">0.0002</td></tr><tr><td align="left" valign="middle"/><td align="left" valign="middle"/><td align="left" valign="middle"/><td align="left" valign="middle">Trial 6 (Cre- vs. Cre+)</td><td align="char" char="." valign="middle">0.002</td></tr><tr><td align="left" valign="middle"/><td align="left" valign="middle"/><td align="left" valign="middle"/><td align="left" valign="middle">Trial 7 (Cre- vs. Cre+)</td><td align="char" char="." valign="middle">0.0002</td></tr><tr><td align="left" valign="middle"/><td align="left" valign="middle"/><td align="left" valign="middle"/><td align="left" valign="middle">Trial 8 (Cre- vs. Cre+)</td><td align="char" char="." valign="middle">0.0016</td></tr><tr><td align="left" valign="middle"/><td align="left" valign="middle"/><td align="left" valign="middle"/><td align="left" valign="middle">Trial 9 (Cre- vs. Cre+)</td><td align="char" char="." valign="middle">&lt;0.0001</td></tr><tr><td align="left" valign="middle"/><td align="left" valign="middle"/><td align="left" valign="middle"/><td align="left" valign="middle">Trial 10 (Cre- vs. Cre+)</td><td align="char" char="." valign="middle">0.0006</td></tr><tr><td align="left" valign="middle"/><td align="left" valign="middle"/><td align="left" valign="middle"/><td align="left" valign="middle">Trial 11 (Cre- vs. Cre+)</td><td align="char" char="." valign="middle">0.0049</td></tr><tr><td align="left" valign="middle"/><td align="left" valign="middle"/><td align="left" valign="middle"/><td align="left" valign="middle">Trial 12 (Cre- vs. Cre+)</td><td align="char" char="." valign="middle">0.0169</td></tr><tr><td align="left" valign="middle"/><td align="left" valign="middle"/><td align="left" valign="middle"/><td align="left" valign="middle">Trial 13 (Cre- vs. Cre+)</td><td align="char" char="." valign="middle">0.0098</td></tr><tr><td align="char" char="." valign="middle" rowspan="7"><xref ref-type="fig" rid="fig4">Figure 4G</xref></td><td align="left" valign="middle" rowspan="7">9 (Cre-), 12 (Cre+)</td><td align="left" valign="middle" rowspan="7">No</td><td align="left" valign="middle" rowspan="7">Three-way ANOVA</td><td align="left" valign="middle">Genotype</td><td align="left" valign="middle">F<sub>(1,19)</sub>=100.7</td><td align="char" char="." valign="middle">&lt;0.0001</td><td align="left" valign="middle"/><td align="left" valign="middle"/><td align="left" valign="middle"/></tr><tr><td align="left" valign="middle">Trial</td><td align="left" valign="middle">F<sub>(15,289)</sub>=7.289</td><td align="char" char="." valign="middle">&lt;0.0001</td><td align="left" valign="middle"/><td align="left" valign="middle"/><td align="left" valign="middle"/></tr><tr><td align="left" valign="middle">Error Type</td><td align="left" valign="middle">F<sub>(0.4468, 8.489)</sub>=4.554</td><td align="char" char="." valign="middle">0.0772</td><td align="left" valign="middle"/><td align="left" valign="middle"/><td align="left" valign="middle"/></tr><tr><td align="left" valign="middle">Genotype x Trial</td><td align="left" valign="middle">F<sub>(15,289)</sub>=1.529</td><td align="char" char="." valign="middle">0.094</td><td align="left" valign="middle"/><td align="left" valign="middle"/><td align="left" valign="middle"/></tr><tr><td align="left" valign="middle">Genotype x Error Type</td><td align="left" valign="middle">F<sub>(1,19)</sub>=15.09</td><td align="char" char="." valign="middle">0.001</td><td align="left" valign="middle"/><td align="left" valign="middle"/><td align="left" valign="middle"/></tr><tr><td align="left" valign="middle">Trial x Error Type</td><td align="left" valign="middle">F<sub>(6.157, 117)</sub>=2.865</td><td align="char" char="." valign="middle">0.0115</td><td align="left" valign="middle"/><td align="left" valign="middle"/><td align="left" valign="middle"/></tr><tr><td align="left" valign="middle">Genotype x Trial x Error Type</td><td align="left" valign="middle">F<sub>(15,285)</sub>=1.831</td><td align="char" char="." valign="middle">0.0303</td><td align="left" valign="middle"/><td align="left" valign="middle"/><td align="left" valign="middle"/></tr><tr><td align="char" char="." valign="middle"><xref ref-type="fig" rid="fig4">Figure 4K</xref></td><td align="left" valign="middle">9 (Cre-), 12 (Cre+)</td><td align="left" valign="middle">No</td><td align="left" valign="middle">Mann-Whitney Test</td><td align="left" valign="middle">Genotype</td><td align="left" valign="middle">U=8</td><td align="char" char="." valign="middle">0.0004</td><td align="left" valign="middle"/><td align="left" valign="middle"/><td align="left" valign="middle"/></tr><tr><td align="left" valign="middle" rowspan="3">Ext. <xref ref-type="fig" rid="fig4">Figure 4B</xref></td><td align="left" valign="middle" rowspan="3">15 (Cre-), 16 (Cre+)</td><td align="left" valign="middle" rowspan="3">No</td><td align="left" valign="middle" rowspan="3">Two-way ANOVA</td><td align="left" valign="middle">Chamber</td><td align="left" valign="middle">F<sub>(1,29)</sub>=92.69</td><td align="char" char="." valign="middle">&lt;0.0001</td><td align="left" valign="middle" rowspan="3">Šidák</td><td align="left" valign="middle">Light vs. Dark (Cre-)</td><td align="char" char="." valign="middle">&lt;0.0001</td></tr><tr><td align="left" valign="middle">Genotype</td><td align="left" valign="middle">F<sub>(1,29)</sub>=0.9504</td><td align="char" char="." valign="middle">0.3377</td><td align="left" valign="middle">Light vs. Dark (Cre+)</td><td align="char" char="." valign="middle">&lt;0.0001</td></tr><tr><td align="left" valign="middle">Genotype x Chamber</td><td align="left" valign="middle">F<sub>(1,29)</sub>=0.09645</td><td align="char" char="." valign="middle">0.7584</td><td align="left" valign="middle"/><td align="left" valign="middle"/></tr><tr><td align="left" valign="middle">Ext. <xref ref-type="fig" rid="fig4">Figure 4C</xref></td><td align="left" valign="middle">7 (Cre-), 17 (Cre+)</td><td align="left" valign="middle">No</td><td align="left" valign="middle">Mann-Whitney Test</td><td align="left" valign="middle">Genotype</td><td align="left" valign="middle">U=42</td><td align="char" char="." valign="middle">0.2878</td><td align="left" valign="middle"/><td align="left" valign="middle"/><td align="left" valign="middle"/></tr><tr><td align="char" char="." valign="middle"><xref ref-type="fig" rid="fig5">Figure 5C</xref></td><td align="left" valign="middle">19 (AAV-GFP), 15 (AAV-Cre)</td><td align="left" valign="middle">No</td><td align="left" valign="middle">Unpaired t-test</td><td align="left" valign="middle">Treatment</td><td align="left" valign="middle">t<sub>(29.59)</sub>=1.961</td><td align="char" char="." valign="middle">0.0594</td><td align="left" valign="middle"/><td align="left" valign="middle"/><td align="left" valign="middle"/></tr><tr><td align="char" char="." valign="middle"><xref ref-type="fig" rid="fig5">Figure 5D</xref></td><td align="left" valign="middle">19 (AAV-GFP), 15 (AAV-Cre)</td><td align="left" valign="middle">No</td><td align="left" valign="middle">Unpaired t-test</td><td align="left" valign="middle">Treatment</td><td align="left" valign="middle">t<sub>(29.72)</sub>=1.066</td><td align="char" char="." valign="middle">0.2951</td><td align="left" valign="middle"/><td align="left" valign="middle"/><td align="left" valign="middle"/></tr><tr><td align="char" char="." valign="middle" rowspan="3"><xref ref-type="fig" rid="fig5">Figure 5E</xref></td><td align="left" valign="middle" rowspan="3">19 (AAV-GFP), 15 (AAV-Cre)</td><td align="left" valign="middle" rowspan="3">No</td><td align="left" valign="middle" rowspan="3">Two-way ANOVA</td><td align="left" valign="middle">Treatment</td><td align="left" valign="middle">F<sub>(1,32)</sub>=2.361</td><td align="char" char="." valign="middle">0.1342</td><td align="left" valign="middle" rowspan="3">Šidák</td><td align="left" valign="middle">Light vs. Dark (AAV-GFP)</td><td align="char" char="." valign="middle">&lt;0.0001</td></tr><tr><td align="left" valign="middle">Chamber</td><td align="left" valign="middle">F<sub>(1,32)</sub>=46.74</td><td align="char" char="." valign="middle">&lt;0.0001</td><td align="left" valign="middle">Light vs. Dark (AAV-Cre)</td><td align="char" char="." valign="middle">0.0003</td></tr><tr><td align="left" valign="middle">Treatment x Chamber</td><td align="left" valign="middle">F<sub>(1,32)</sub>=0.1588</td><td align="char" char="." valign="middle">0.6929</td><td align="left" valign="middle"/><td align="left" valign="middle"/></tr><tr><td align="char" char="." valign="middle" rowspan="3"><xref ref-type="fig" rid="fig5">Figure 5F</xref></td><td align="left" valign="middle" rowspan="3">16 (AAV-GFP), 17 (AAV-Cre)</td><td align="left" valign="middle" rowspan="3">No</td><td align="left" valign="middle" rowspan="3">Two-way ANOVA</td><td align="left" valign="middle">Treatment</td><td align="left" valign="middle">F<sub>(1,31)</sub>=3.069</td><td align="char" char="." valign="middle">0.0897</td><td align="left" valign="middle" rowspan="3">Šidák</td><td align="left" valign="middle">Familiar vs. Novel (AAV-GFP)</td><td align="char" char="." valign="middle">&lt;0.0001</td></tr><tr><td align="left" valign="middle">Object</td><td align="left" valign="middle">F<sub>(1,31)</sub>=36.30</td><td align="char" char="." valign="middle">&lt;0.0001</td><td align="left" valign="middle">Familiar vs. Novel (AAV-Cre)</td><td align="char" char="." valign="middle">0.9965</td></tr><tr><td align="left" valign="middle">Treatment x Object</td><td align="left" valign="middle">F<sub>(1,31)</sub>=35.05</td><td align="char" char="." valign="middle">&lt;0.0001</td><td align="left" valign="middle"/><td align="left" valign="middle"/></tr><tr><td align="char" char="." valign="middle"><xref ref-type="fig" rid="fig5">Figure 5G</xref></td><td align="left" valign="middle">18 (AAV-GFP), 15 (AAV-Cre)</td><td align="left" valign="middle">No</td><td align="left" valign="middle">Unpaired t-test</td><td align="left" valign="middle">Treatment</td><td align="left" valign="middle">t<sub>(26.04)</sub>=3.777</td><td align="char" char="." valign="middle">0.0008</td><td align="left" valign="middle"/><td align="left" valign="middle"/><td align="left" valign="middle"/></tr><tr><td align="char" char="." valign="middle" rowspan="3"><xref ref-type="fig" rid="fig5">Figure 5H</xref></td><td align="left" valign="middle" rowspan="3">18 (AAV-GFP), 15 (AAV-Cre)</td><td align="left" valign="middle" rowspan="3">No</td><td align="left" valign="middle" rowspan="3">Two-way ANOVA</td><td align="left" valign="middle">Treatment</td><td align="left" valign="middle">F<sub>(1,31)</sub>=0.0003957</td><td align="char" char="." valign="middle">0.9843</td><td align="left" valign="middle" rowspan="3">Šidák</td><td align="left" valign="middle">Empty vs. Social (AAV-GFP)</td><td align="char" char="." valign="middle">&lt;0.0001</td></tr><tr><td align="left" valign="middle">Social</td><td align="left" valign="middle">F<sub>(1,31)</sub>=31.60</td><td align="char" char="." valign="middle">&lt;0.0001</td><td align="left" valign="middle">Empty vs. Social (AAV-Cre)</td><td align="char" char="." valign="middle">0.0062</td></tr><tr><td align="left" valign="middle">Treatment x Social</td><td align="left" valign="middle">F<sub>(1,31)</sub>=0.7781</td><td align="char" char="." valign="middle">0.3845</td><td align="left" valign="middle"/><td align="left" valign="middle"/></tr><tr><td align="char" char="." valign="middle" rowspan="3"><xref ref-type="fig" rid="fig5">Figure 5I</xref></td><td align="left" valign="middle" rowspan="3">18 (AAV-GFP), 15 (AAV-Cre)</td><td align="left" valign="middle" rowspan="3">No</td><td align="left" valign="middle" rowspan="3">Two-way ANOVA</td><td align="left" valign="middle">Treatment</td><td align="left" valign="middle">F<sub>(1,31)</sub>=0.2045</td><td align="char" char="." valign="middle">0.6543</td><td align="left" valign="middle" rowspan="3">Šidák</td><td align="left" valign="middle">Familiar vs. Novel (AAV-GFP)</td><td align="char" char="." valign="middle">0.0303</td></tr><tr><td align="left" valign="middle">Social Novelty</td><td align="left" valign="middle">F<sub>(1,31)</sub>=9.777</td><td align="char" char="." valign="middle">0.0038</td><td align="left" valign="middle">Familiar vs. Novel (AAV-Cre)</td><td align="char" char="." valign="middle">0.1319</td></tr><tr><td align="left" valign="middle">Treatment x Social Novelty</td><td align="left" valign="middle">F<sub>(1,31)</sub>=0.1131</td><td align="char" char="." valign="middle">0.7389</td><td align="left" valign="middle"/><td align="left" valign="middle"/></tr><tr><td align="char" char="." valign="middle" rowspan="4"><xref ref-type="fig" rid="fig5">Figure 5J</xref></td><td align="left" valign="middle" rowspan="4">8 (AAV-GFP), 6 (AAV-Cre)</td><td align="left" valign="middle" rowspan="4">No</td><td align="left" valign="middle" rowspan="4">Two-way ANOVA</td><td align="left" valign="middle">Treatment</td><td align="left" valign="middle">F<sub>(1,12)</sub>=22.95</td><td align="char" char="." valign="middle">0.0004</td><td align="left" valign="middle" rowspan="4">Šidák</td><td align="left" valign="middle">Trial 5 (AAV-GFP vs. AAV-Cre)</td><td align="char" char="." valign="middle">&lt;0.0001</td></tr><tr><td align="left" valign="middle">Trial</td><td align="left" valign="middle">F<sub>(15,180)</sub>=6.246</td><td align="char" char="." valign="middle">&lt;0.0001</td><td align="left" valign="middle">Trial 9 (AAV-GFP vs. AAV-Cre)</td><td align="char" char="." valign="middle">0.0026</td></tr><tr><td align="left" valign="middle">Treatment x Trial</td><td align="left" valign="middle">F<sub>(15,180)</sub>=2.033</td><td align="char" char="." valign="middle">0.0153</td><td align="left" valign="middle">Trial 10 (AAV-GFP vs. AAV-Cre)</td><td align="char" char="." valign="middle">&lt;0.0001</td></tr><tr><td align="left" valign="middle"/><td align="left" valign="middle"/><td align="left" valign="middle"/><td align="left" valign="middle">Trial 14 (AAV-GFP vs. AAV-Cre)</td><td align="char" char="." valign="middle">0.0475</td></tr><tr><td align="char" char="." valign="middle"><xref ref-type="fig" rid="fig5">Figure 5K</xref></td><td align="left" valign="middle">8 (AAV-GFP), 6 (AAV-Cre)</td><td align="left" valign="middle">No</td><td align="left" valign="middle">Mann-Whitney Test</td><td align="left" valign="middle">Treatment</td><td align="left" valign="middle">U=3</td><td align="char" char="." valign="middle">0.0047</td><td align="left" valign="middle"/><td align="left" valign="middle"/><td align="left" valign="middle"/></tr></tbody></table></table-wrap><p>We next assessed baseline locomotor and exploratory behavior of these mice. Upon reaching adulthood, mice were placed in an open field and allowed to explore for 20 min, and total distance traveled and time spent in the center of the open field were measured. Deletion of neuronal Prosapip1 did not alter locomotor activity (<xref ref-type="fig" rid="fig1">Figure 1I</xref>, <xref ref-type="table" rid="table1">Table 1</xref>). Furthermore, there were no differences between genotypes when assessing the time spent in the center of the open field (<xref ref-type="fig" rid="fig1">Figure 1J</xref>, <xref ref-type="table" rid="table1">Table 1</xref>).</p></sec><sec id="s2-2"><title>Prosapip1 is required for synaptic localization of PSD proteins</title><p>Prosapip1 is a scaffolding protein that recruits SPAR to the PSD and interconnects it with Shank3 in primary hippocampal neurons (<xref ref-type="bibr" rid="bib80">Wendholt et al., 2006</xref>; <xref ref-type="bibr" rid="bib61">Reim et al., 2016</xref>). First, we examined if the synaptic localization of SPAR was affected by Prosapip1 neuronal knockout. To do this, we isolated the synaptic fraction from the total homogenate. We confirmed the efficacy of the crude synaptosomal fraction isolation by measuring enrichment of synapsin, a protein found at the synapse, and lack of cAMP response element-binding protein (CREB), a transcription factor located in the nucleus (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). We analyzed the total (<xref ref-type="fig" rid="fig2">Figure 2B</xref>) and synaptic (<xref ref-type="fig" rid="fig2">Figure 2C</xref>) levels of SPAR in the dHP of control and Prosapip1 cKO male and female mice. Total levels of SPAR were similar between the groups (<xref ref-type="fig" rid="fig2">Figure 2B</xref>, <xref ref-type="table" rid="table1">Table 1</xref>). However, we detected a significant reduction in synaptic SPAR in Prosapip1 cKO mice as compared to the control group (<xref ref-type="fig" rid="fig2">Figure 2C</xref>, <xref ref-type="table" rid="table1">Table 1</xref>).</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Prosapip1 is required for synaptic localization of PSD proteins.</title><p>(<bold>A</bold>) The levels of Prosapip1 (top), Synapsin (middle), and cAMP response element-binding protein (CREB) (bottom) in the dorsal hippocampus of control (<italic>Lzts3</italic><sup>fl/fl</sup>;Syn1-Cre(-)) mice were measured in the total and crude synaptosomal fraction. (<bold>B–I</bold>) Total levels of SPAR (<bold>B</bold>), Shank3 (<bold>D, F</bold>), and PSD-95 (<bold>D, H</bold>) alongside the synaptic levels of SPAR (<bold>C</bold>), Shank3 (<bold>E, G</bold>), and PSD-95 (<bold>E, I</bold>) were measured in the dHP of Prosapip1 cKO and control mice using western blot analysis. Protein levels were normalized to GAPDH and presented as a percentage of the average of the control mice values. Data are represented as mean ± SEM and analyzed using an unpaired two-tailed t-test with Welch’s correction (<xref ref-type="table" rid="table1">Table 1</xref>). **p&lt;0.01, ****p&lt;0.0001; ns, non-significant. n=5 per group (<bold>B–G</bold>), 9 (control) and 10 (Prosapip1 cKO) (<bold>H–I</bold>). (<bold>J–Q</bold>) The total levels of GluN2A (<bold>J, L</bold>), GluN2B (<bold>J, N</bold>), and GluA1 (<bold>J, P</bold>) and the synaptic levels of GluN2A (<bold>K, M</bold>), GluN2B (<bold>K, O</bold>), and GluA1 (<bold>K, Q</bold>) were measured in the dHP of Prosapip1 cKO and control mice using western blot analysis. Protein levels were normalized to GAPDH and presented as a percentage of the average of the control mice values. Data are represented as mean ± SEM and analyzed using an unpaired two-tailed t-test with Welch’s correction (<xref ref-type="table" rid="table1">Table 1</xref>). **p&lt;0.01; ns, non-significant. n=4 (control), 5 (Prosapip1 cKO).</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>File containing raw data for <xref ref-type="fig" rid="fig2">Figure 2</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-100653-fig2-data1-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig2sdata2"><label>Figure 2—source data 2.</label><caption><title>Original files for western blot analysis displayed in <xref ref-type="fig" rid="fig2">Figure 2A–E, J and K</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-100653-fig2-data2-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100653-fig2-v1.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Verification of the crude synaptic preparation.</title><p>(<bold>A</bold>) Tissue was first homogenized in Krebs buffer. A portion of the homogenate was saved as total homogenate, and the remaining homogenate was diluted and centrifuged. The supernatant (<bold>S1</bold>) was collected, and the pellet (<bold>P1</bold>) was saved. The process was repeated, and the S2 supernatant was saved, while the pellet (<bold>P2</bold>) was kept on ice. The resulting pellet contained the synaptosomal fraction. (<bold>B</bold>) The levels of PSD-95, Synapsin, CREB, GAPDH, Actin, GluN2B, GluN2A, and GluA1 were measured via western blot analysis in the total homogenate (<bold>T</bold>), the nuclei and large debris fraction (<bold>P1</bold>), the non-synaptic fraction (<bold>S2</bold>), and the crude synaptosomal fraction (<bold>P2</bold>).</p><p><supplementary-material id="fig2s1sdata1"><label>Figure 2—figure supplement 1—source data 1.</label><caption><title>File containing raw data for <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-100653-fig2-figsupp1-data1-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig2s1sdata2"><label>Figure 2—figure supplement 1—source data 2.</label><caption><title>Original files for western blot analysis displayed in <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-100653-fig2-figsupp1-data2-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100653-fig2-figsupp1-v1.tif"/></fig></fig-group><p> Prosapip1 interconnects SPAR to Shank3, and SPAR forms a complex with PSD-95 (<xref ref-type="bibr" rid="bib80">Wendholt et al., 2006</xref>; <xref ref-type="bibr" rid="bib61">Reim et al., 2016</xref>; <xref ref-type="bibr" rid="bib51">Matsuura et al., 2022</xref>). Therefore, we next examined the total and synaptic levels of Shank3 and PSD-95. Prosapip1 deletion did not affect the total or synaptic levels of Shank3 (<xref ref-type="fig" rid="fig2">Figure 2D–G</xref>, <xref ref-type="table" rid="table1">Table 1</xref>). We also found that Prosapip1 cKO mice have similar levels of total PSD-95 (<xref ref-type="fig" rid="fig2">Figure 2D and H</xref>, <xref ref-type="table" rid="table1">Table 1</xref>) compared to controls. However, when examining synaptic PSD-95, Prosapip1 cKO mice displayed drastically reduced levels compared to controls (<xref ref-type="fig" rid="fig2">Figure 2E and I</xref>, <xref ref-type="table" rid="table1">Table 1</xref>). Collectively, these results imply that Prosapip1 in the dHP is necessary for synaptic localization of SPAR and PSD-95, but not Shank3. It is important to note that our method of synaptic fractionation does not distinguish between pre- and post-synaptic compartments. Consequently, we cannot determine whether Prosapip1 is involved in the assembly of axonal proteins.</p><p> SPAR and Shank3 are both known to interact with the NMDAR and AMPAR, and PSD-95 stabilizes NMDAR surface localization (<xref ref-type="bibr" rid="bib55">Naisbitt et al., 1999</xref>; <xref ref-type="bibr" rid="bib74">Tu et al., 1999</xref>; <xref ref-type="bibr" rid="bib57">Pak et al., 2001</xref>; <xref ref-type="bibr" rid="bib10">Boeckers et al., 2002</xref>; <xref ref-type="bibr" rid="bib3">Arons et al., 2012</xref>; <xref ref-type="bibr" rid="bib81">Won et al., 2016</xref>; <xref ref-type="bibr" rid="bib18">Coley and Gao, 2019</xref>; <xref ref-type="bibr" rid="bib51">Matsuura et al., 2022</xref>). As the synaptic localization of SPAR and PSD-95 is disrupted in the absence of Prosapip1, we next tested the synaptic levels of NMDAR subunits GluN2A and GluN2B, along with AMPAR subunit GluA1. There was no change in the overall levels of NMDAR subunits GluN2A and GluN2B or the AMPAR subunit GluA1 (<xref ref-type="fig" rid="fig2">Figure 2J, L, N and P</xref>, <xref ref-type="table" rid="table1">Table 1</xref>). The synaptic levels of GluN2A and GluA1 were also unaltered in the dHP of Prosapip1 cKO mice compared to controls (<xref ref-type="fig" rid="fig2">Figure 2K, M and Q</xref>, <xref ref-type="table" rid="table1">Table 1</xref>). In contrast, the synaptic levels of the NMDAR subunit GluN2B were significantly reduced in Prosapip1 cKO mice (<xref ref-type="fig" rid="fig2">Figure 2K and Q</xref>, <xref ref-type="table" rid="table1">Table 1</xref>). Together, these data suggest that Prosapip1 controls the synaptic localization of NMDAR subunit GluN2B, but not GluN2A or GluA1, in the dHP.</p><p> Further studies are needed to determine the mechanism by which Prosapip1 controls the localization of PSD95,GluN2BB, and potentially others. It is plausible that post-translational modifications are responsible for Prosapip1 function. For example, the Prosapip1 sequence contains a potential glycosylation site (Ser622) and several potential phosphorylation sites. These post-translational modifications can contribute to the stabilization of the synaptic localization of GluN2B and PSD95. Therefore, proteomic studies are required for a comprehensive study of the role of Prosapip1 in the PSD.</p></sec><sec id="s2-3"><title>Prosapip1 in the dorsal hippocampus plays a role in NMDA receptor-mediated transmission and long-term potentiation</title><p>The GluN2B subunit of the NMDAR is critically involved in learning and memory, a process reliant on LTP (<xref ref-type="bibr" rid="bib54">Nachtigall et al., 2024</xref>). Therefore, we examined the contribution of Prosapip1 to GluN2B-mediated LTP. To examine this, hippocampal slices from male and female Prosapip1 cKO and control mice were prepared for electrophysiology recordings. Bipolar stimulating electrodes were positioned in the CA1 region of the dHP. Simultaneously, the recording electrode was placed approximately 100–150 µm away from the stimulating electrode (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). The administration of a single electrical pulse (2ms) elicited a fiber volley, followed by a field excitatory postsynaptic potential response (fEPSPs) (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). Before inducing LTP, a stable baseline of fEPSPs was established for 10 min (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). Upon establishing a baseline of fEPSPs, high-frequency stimulation (HFS) was applied at 100 Hz for 1 s, repeated four times at 20 s intervals, to trigger LTP. In the control mice, there was a significant increase in the fEPSP amplitude following HFS, indicating a successful LTP induction (<xref ref-type="fig" rid="fig3">Figure 3C</xref>), which persisted for at least 30 min (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). However, LTP was absent in the Prosapip1 cKO mice (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). A comparative analysis of the normalized fEPSPs, conducted 20–30 min post-HFS, revealed a significantly reduced fEPSP amplitude in the Prosapip1 cKO group compared to controls (<xref ref-type="fig" rid="fig3">Figure 3D</xref>, <xref ref-type="table" rid="table1">Table 1</xref>). Together, these findings strongly suggest Prosapip1 plays an important role in dHP LTP.</p><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Prosapip1 in the dHP plays a role in NMDA receptor-mediated transmission and long-term potentiation.</title><p>(<bold>A</bold>) Location of stimulating and recording electrodes within the hippocampal CA1 region. (<bold>B</bold>) Sample of field excitatory postsynaptic potential (fEPSP) traces recorded before (pre) and after (post) administering high-frequency stimulation (HFS) (100 Hz, 100 pulses every 20 s) in Prosapip1 cKO (Cre(+)) and control (Cre(-)) mice. (<bold>C</bold>) A stable baseline of fEPSPs was established for 10 min before application of HFS and fEPSPs were recorded for 30 min after HFS. Time course of fEPSPs before and after HFS. (<bold>D</bold>) Quantification of average fEPSP amplitudes measured between 30–40 min. Data are represented as mean ± SEM and analyzed using unpaired two-tailed t-test (<xref ref-type="table" rid="table1">Table 1</xref>). **p&lt;0.01. n=10 slices from 6 mice (10/6) (Cre(-)) and (9/5) (Cre(+)). (<bold>E</bold>) Cells were clamped at –65 mV and the bath contained both DNQX and PTX to block AMPA and GABA-mediated responses. Voltage clamp whole cell recordings and representative electrically evoked NMDA currents in control (Cre(-)) and Prosapip1 cKO (Cre(+)) mice at four stimulation intensities (left). Summarized responses of control (Cre(-)) and Prosapip1 cKO (Cre(+)) CA1 neurons quantified by average at each stimulating intensity; #p&lt;0.05 by two-way repeated measures ANOVA followed by post-hoc Tukey test (Cre(-) vs. Cre(+)) at the same stimulating intensities, *p&lt;0.05. n=14/4 (Cre(-)) and 11/4 (Cre(+)). (<bold>F</bold>) Representative currents evoked in the CA1 neurons after NMDA bath application (20 μM, 30 s) in control <italic>(</italic>Cre(-)) and Prosapip1 cKO (Cre(+)) mice (left). Average of the peak current elicited by each mouse (right). Data are represented as mean ± SEM and analyzed using unpaired two-tailed t-test (<xref ref-type="table" rid="table1">Table 1</xref>). **p&lt;0.01. n=13/4 (Cre(-)) and 11/4 (Cre(+)). (<bold>G</bold>) In voltage clamp recordings, two electrical stimulations (100 ms separation) were provided to elicit two responses in the CA1 neurons. Paired-pulse ratio (PPR) was calculated as the amplitude of peak 2/amplitude of peak 1. Representative paired-pulse ratio in control (Cre(-)) and Prosapip1 cKO (Cre(+)) mice (left). Average PPR for control (Cre(-)) and Prosapip1 cKO (Cre(+)) (right). Data are represented as mean ± SEM and analyzed using unpaired two-tailed t-test (<xref ref-type="table" rid="table1">Table 1</xref>). *p&lt;0.05. n=11/3 (Cre(-)) and 13/4 (Cre(+)).</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>File containing raw data for <xref ref-type="fig" rid="fig3">Figure 3</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-100653-fig3-data1-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100653-fig3-v1.tif"/></fig><p>LTP induction in the hippocampus is known to rely on the functioning of postsynaptic NMDARs. Therefore, we aimed to discern if there were any differences between Prosapip1 cKO and control mice in terms of NMDAR-mediated excitatory postsynaptic currents (EPSCs) in dHP CA1 pyramidal neurons. A whole-cell voltage-clamp recording technique was employed for this purpose. First, a low concentration of external Mg<sup>2+</sup> (0.05 mM) was used to facilitate the removal of the magnesium block from the NMDAR channel. Concurrently, AMPARs and GABA<sub>A</sub> receptors (GABA<sub>A</sub>Rs) were pharmacologically inhibited. NMDAR-EPSCs were recorded in response to an escalating series of stimulus intensities. The amplitude of NMDAR-EPSCs was significantly reduced in the Prosapip1 cKO mice compared to the controls (<xref ref-type="fig" rid="fig3">Figure 3E</xref>, <xref ref-type="table" rid="table1">Table 1</xref>). Next, we investigated whether LTP inhibition because of Prosapip1 deletion is due to post and/or presynaptic changes. First, we investigated postsynaptic changes by measuring NMDA-induced currents. NMDA (20 µM) was bath applied for 30 s and peak current was measured. We observed that the peak current in the Prosapip1 cKO mice was markedly lower than that in their control counterparts (<xref ref-type="fig" rid="fig3">Figure 3F</xref>, <xref ref-type="table" rid="table1">Table 1</xref>). These data suggest that postsynaptic NMDAR responsiveness was decreased in the dHP of Prosapip1 cKO mice as compared to control mice. Finally, to examine the presence of any presynaptic alterations in glutamatergic transmission in CA1 neurons upon Prosapip1 deletion, we measured the paired-pulse ratio (PPR, 100 millisecond interval) of electrically evoked EPSCs in CA1 dHP neurons. Surprisingly, we found that PPR was significantly higher in the Prosapip1 cKO group as compared to control mice (<xref ref-type="fig" rid="fig3">Figure 3G</xref>, <xref ref-type="table" rid="table1">Table 1</xref>), indicating a probable reduction in presynaptic glutamate release onto CA1 neurons in the Prosapip1 cKO mice (<xref ref-type="bibr" rid="bib84">Zucker and Regehr, 2002</xref>). Together, the data imply that the Prosapip1 is crucial for the induction of hippocampal LTP, which is likely attributed to the downregulation of NMDAR function.</p></sec><sec id="s2-4"><title>Prosapip1 contributes to spatial memory</title><p>Prosapip1 was originally identified in hippocampal neurons (<xref ref-type="bibr" rid="bib80">Wendholt et al., 2006</xref>; <xref ref-type="bibr" rid="bib61">Reim et al., 2016</xref>). The hippocampus is a brain region associated with memory (<xref ref-type="bibr" rid="bib12">Broadbent et al., 2004</xref>). Given the altered PSD composition and subsequent loss of LTP in this region after Prosapip1 knockout, we hypothesized that Prosapip1 contributes to memory-dependent behavior. First, we tested whether Prosapip1 contributes to long-term recognition memory in male and female mice using the novel object recognition (NOR) test with an inter-trial interval of 24 hr (<xref ref-type="bibr" rid="bib44">Leger et al., 2013</xref>; <xref ref-type="bibr" rid="bib48">Lueptow, 2017</xref>). Control animals showed a significant preference for the novel object, indicating long-term memory of the familiar object and its spatial location (<xref ref-type="fig" rid="fig4">Figure 4A</xref>, <xref ref-type="table" rid="table1">Table 1</xref>). Contrarily, male and female Prosapip1 cKO mice spent a similar amount of time exploring both objects, performing at chance levels (<xref ref-type="fig" rid="fig4">Figure 4A</xref>, <xref ref-type="table" rid="table1">Table 1</xref>). The lack of novel object recognition in Prosapip1 knockout mice implies a loss of object characteristic acquisition or long-term recognition memory.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Prosapip1 contributes to recognition, social, and spatial memory.</title><p>(<bold>A</bold>) Mice underwent the novel object recognition test, where they were first allowed to explore two similar objects. After 24 hr, one of the familiar objects was replaced by a novel object, and mice were again allowed to explore and interact with the objects. Time spent interacting with the familiar and novel objects. n=22 (control), 20 (Prosapip1 cKO). (<bold>B–C</bold>) In the novelty T-maze test, mice were allowed to explore two arms of a three-armed, T-shaped maze. There were five training trials separated by a 1 min inter-trial interval. During testing, the third ‘novel’ arm was unblocked and allowed to be explored. (<bold>B</bold>) Difference score (time exploring novel arm – time exploring familiar arm) performance during the novelty T-maze test. A positive difference score indicates preference for the novel arm of the maze. n=22 (control), 19 (Prosapip1 cKO). (<bold>C</bold>) Heat map of group average time spent in each arm of the T-maze during the test trial. (<bold>D–E</bold>) Mice performed the 3-chamber social interaction test. Specifically, they were placed in the center chamber of a 3-chamber apparatus and allowed to freely explore for 15 min for two trials. During the first trial, one chamber was paired with a juvenile interaction partner (social), while the other chamber contained only the empty interaction cage (empty). During the second trial, one chamber was paired with the familiar mouse from the first trial (familiar), and the other chamber contained a novel juvenile interaction partner (novel). (<bold>D</bold>) Time spent in the empty and social-paired chamber, respectively, in the first portion of the 3-chamber social interaction test. n=14 (control), 17 (Prosapip1 cKO). (<bold>E</bold>) Time spent in the familiar and novel chamber during the second portion of the 3-chamber social interaction test. n=14 (control), 17 (Prosapip1 cKO). (<bold>F–K</bold>) Mice performed the Barnes maze test, where they were placed in the center of a white plastic platform with 40 uniformly distributed holes around the perimeter, one of which had an exit compartment placed underneath. The goal of the trial was to escape into the exit compartment. There were four training trials a day over the course of 4 days, separated by an inter-trial interval of 30 min. 24 hr after the last training trial, mice were placed back onto the platform but with the exit compartment removed (probe trial) and allowed to explore for 5 min. (<bold>F</bold>) Average distance traveled from start point to exit during the Barnes maze training trials. n=9 (control), 12 (Prosapip1 cKO). (<bold>G</bold>) Primary (filled circles) and secondary (hollow circles) errors committed during Barnes maze training. Primary errors are an incorrect hole visit and secondary errors are an incorrect hole revisit. n=9 (control), 12 (Prosapip1 cKO). (<bold>H</bold>) The method of searching utilized by each mouse for each training trial was qualified. Example path to exit from mice exhibiting random, serial, and spatial search strategies. (<bold>I–J</bold>) Ratio of search strategy utilization by control (<bold>I</bold>) and Prosapip1 cKO (<bold>J</bold>) mice during Barnes maze training. (<bold>K–L</bold>) Time spent in exit-associated quartile during the probe trial and associated heatmaps (<bold>L</bold>). n=9 (control), 12 (Prosapip1 cKO). Data are represented as mean ± SEM and analyzed using two-way ANOVA (<bold>A, C, D, E</bold>), Welch’s t-test (<bold>B</bold>), three-way ANOVA (<bold>F</bold>), or Mann-Whitney test (<bold>J</bold>) (<xref ref-type="table" rid="table1">Table 1</xref>). *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, ****p&lt;0.0001.</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>File containing raw data for <xref ref-type="fig" rid="fig4">Figure 4</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-100653-fig4-data1-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100653-fig4-v1.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Prosapip1 knockout did not affect Barnes maze exploratory behavior or baseline anxiety.</title><p>(<bold>A</bold>) Before the Barnes maze training trials began, mice were placed on the platform to assess baseline exploratory behavior and locomotion in the environment. The exit compartment was in a different location than training trials. Distance traveled during the Barnes maze habituation trial. Data represented as mean ± SEM and analyzed using unpaired t-test (<xref ref-type="table" rid="table1">Table 1</xref>). ns, non-significant. n=6 (control), 12 Prosapip1 cKO. (<bold>B</bold>) To assess anxiety, mice were placed on the light side of a light/dark box apparatus and allowed to explore for 10 min. Time spent in the light and dark chambers during the test. Data represented as mean ± SEM and analyzed using a two-way ANOVA (<xref ref-type="table" rid="table1">Table 1</xref>). ****p&lt;0.0001. n=15 (control), 16 (Prosapip1 cKO). (<bold>C</bold>) Mice were placed in the center of a plus-shaped maze and allowed to explore two closed and two open arms for 5 min to assess anxiety and exploratory behavior. Time spent in the open arm of the elevated plus maze. Open-arm time was measured and analyzed using an unpaired two-tailed t-test (<xref ref-type="table" rid="table1">Table 1</xref>). ns, non-significant. n=7 (control), 17 (Prosapip1 cKO).</p><p><supplementary-material id="fig4s1sdata1"><label>Figure 4—figure supplement 1—source data 1.</label><caption><title>File containing raw data for <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-100653-fig4-figsupp1-data1-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100653-fig4-figsupp1-v1.tif"/></fig></fig-group><p> To determine whether Prosapip1 contributes to spatial learning or working memory, male and female mice performed a novelty T-maze test (d'<xref ref-type="bibr" rid="bib25">d’Isa et al., 2021</xref>). Mice were allowed to explore two arms of a ‘T’-shaped maze during training trials while the third arm was blocked. All three arms were available during the test. The experiment utilized a 1 min inter-trial interval, performance of which is reliant on hippocampal LTP (<xref ref-type="bibr" rid="bib66">Sanderson et al., 2009</xref>). During the test trial, control mice primarily explored the novel arm of the T-maze, indicated by a positive difference score (time spent in novel arm – time spent in familiar arm) (<xref ref-type="fig" rid="fig4">Figure 4B</xref>, <xref ref-type="table" rid="table1">Table 1</xref>). Prosapip1 cKO mice explored the arms at comparable levels, performing significantly worse than control animals, and indicating a lack of spatial learning for the familiar arm of the maze (<xref ref-type="fig" rid="fig4">Figure 4B</xref>, <xref ref-type="table" rid="table1">Table 1</xref>). This difference can be seen visually in the heatmap (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). Taken together, these data suggest that Prosapip1 is required for spatial learning and working memory.</p><p>We next utilized the 3-chamber social interaction (3CSI) test. The 3CSI test has two stages. The first part measures the preference for social interaction with a juvenile interaction partner. We found that male and female Prosapip1 cKO and control mice behave similarly, with both significantly preferring the interaction partner over the empty chamber (<xref ref-type="fig" rid="fig4">Figure 4D</xref>, <xref ref-type="table" rid="table1">Table 1</xref>). In the second stage of the 3CSI, the mouse has the choice between interacting with a familiar partner (partner from part 1) or a novel interaction partner. This assesses the social novelty recognition of the subject. Control mice displayed a preference for the novel interaction partner, exhibited by the increase in time spent in close proximity to the novel partner (<xref ref-type="fig" rid="fig4">Figure 4E</xref>, <xref ref-type="table" rid="table1">Table 1</xref>). Prosapip1 cKO mice spent a similar amount of time with the familiar and novel interaction partners (<xref ref-type="fig" rid="fig4">Figure 4E</xref>, <xref ref-type="table" rid="table1">Table 1</xref>). The lack of discrimination from Prosapip1 cKO mice implies a loss of recognition of social novelty or loss of social memory.</p><p> While the Prosapip1 cKO mice show impaired performance in the NOR and novelty T-maze tests, these results may be attributed to the learning/acquisition process or storage of memory. To confirm that Prosapip1 is important for processes underlying spatial learning and memory, we employed the Barnes maze (<xref ref-type="bibr" rid="bib59">Pitts, 2018</xref>). The Barnes maze is a white plastic circle with holes evenly drilled around the perimeter. Underneath one of these holes is an exit tunnel. The protocol has a training and testing phase, where spatial learning and memory, respectively, are separately examined. First, mice were habituated to the platform. There were no differences in baseline exploratory profile between Prosapip1 cKO and control mice (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A</xref>, <xref ref-type="table" rid="table1">Table 1</xref>). The primary variable examined during training trials was the path to escape, which tracked the distance traveled from the starting point to the exit compartment. A shorter path to escape is more efficient and indicates learning of the paradigm objective and exit location. Control mice immediately improve performance, with a significant decrease in path to escape observed as soon as the third trial (<xref ref-type="fig" rid="fig4">Figure 4F</xref>, <xref ref-type="table" rid="table1">Table 1</xref>). Prosapip1 cKO mice improved performance over time but more gradually and performed significantly worse than control mice over the entirety of training (<xref ref-type="fig" rid="fig4">Figure 4F</xref>, <xref ref-type="table" rid="table1">Table 1</xref>). Control mice showed a significantly reduced path to escape by the second trial (<xref ref-type="fig" rid="fig4">Figure 4F</xref>, <xref ref-type="table" rid="table1">Table 1</xref>). In addition, Prosapip1 cKO mice committed significantly more primary (incorrect hole visit) and secondary (incorrect hole revisit) errors throughout training (<xref ref-type="fig" rid="fig4">Figure 4G</xref>, <xref ref-type="table" rid="table1">Table 1</xref>).</p><p>Differences in training performance can be explained by examining the search strategy of each mouse. There are three defined search strategies: random, serial, and spatial, which correspond to an increase in task efficiency (<xref ref-type="fig" rid="fig4">Figure 4H</xref>; <xref ref-type="bibr" rid="bib64">Rosenfeld and Ferguson, 2014</xref>). Mice searching serially methodically inspected holes with minimal directional changes (<xref ref-type="bibr" rid="bib64">Rosenfeld and Ferguson, 2014</xref>). Spatial searchers used environmental cues to navigate efficiently to the exit with less than 10 primary errors (<xref ref-type="bibr" rid="bib64">Rosenfeld and Ferguson, 2014</xref>). In contrast, random search strategies involved frequent direction changes and errors, with mice often skipping between holes (<xref ref-type="bibr" rid="bib64">Rosenfeld and Ferguson, 2014</xref>). Control mice mainly searched randomly during the first trial, but 66% of mice utilized a serial search strategy by the second trial (<xref ref-type="fig" rid="fig4">Figure 4I</xref>). Spatial searching appeared as early as trial 3, and its ratio increased until it had become a majority on the last day of training, with 77% of mice spatially searching on the final trial (<xref ref-type="fig" rid="fig4">Figure 4I</xref>). In the Prosapip1 cKO mice, randomly searching was a prevalent strategy throughout training, with 39% of all trials being classified as random (<xref ref-type="fig" rid="fig4">Figure 4J</xref>, <xref ref-type="table" rid="table1">Table 1</xref>). More than 50% of Prosapip1 cKO mice switched to serial search strategy by the third day of training, which also explains the gradual decrease in path to escape (<xref ref-type="fig" rid="fig4">Figure 4J</xref>, <xref ref-type="table" rid="table1">Table 1</xref>). Interestingly, less than 2% of all trials completed by Prosapip1 cKO mice utilized the spatial search strategy (<xref ref-type="fig" rid="fig4">Figure 4J</xref>, <xref ref-type="table" rid="table1">Table 1</xref>). Both groups remember the context of the Barnes maze and the objective to escape, but Prosapip1 cKO mice fail to remember the spatial location of the exit. These results confirm the conclusion that Prosapip1 is required for spatial learning.</p><p> The probe trial of the Barnes maze specifically assesses the spatial memory of the mouse. During the probe trial, the exit was removed, and the mouse was allowed to explore the platform for 5 min. If the mouse retained spatial memory of the exit, it spent significantly more time exploring the quartile associated with the exit compartment compared to chance (25% of the time). Control mice performed above chance value, spending an average of 116.84 s in the exit quartile (<xref ref-type="fig" rid="fig4">Figure 4K</xref>, <xref ref-type="table" rid="table1">Table 1</xref>). Prosapip1 cKO mice, conversely, performed around chance, spending an average of 68.52 s in the exit quartile (<xref ref-type="fig" rid="fig4">Figure 4K</xref>, <xref ref-type="table" rid="table1">Table 1</xref>). This was significantly less than control mice and can be observed in the probe trial heat map (<xref ref-type="fig" rid="fig4">Figure 4L</xref>). Thus, Prosapip1 is required for spatial memory in the Barnes maze.</p><p> To exclude the possibility that Prosapip1 cKO mice preferred familiar situations compared to novel situations due to an increase in anxiety, we used the light/dark box and elevated plus maze paradigms to assess the baseline anxiety of these mice. The light/dark box consists of two chambers where the subject may choose to explore the well-lit (‘light’) or visible-light-blocked (‘dark’) side of a chamber (<xref ref-type="bibr" rid="bib11">Bourin and Hascoët, 2003</xref>). Spending less time in the light side of the chamber implies an increase in anxiety (<xref ref-type="bibr" rid="bib11">Bourin and Hascoët, 2003</xref>). Both Prosapip1 cKO and control mice spent significantly more time in the dark side compared to the light side, but there was no significant difference between the genotypes (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B</xref>, <xref ref-type="table" rid="table1">Table 1</xref>). Mice also underwent the elevated plus maze test. In this case, the maze is elevated above the floor and consists of two ‘closed’ arms with opaque walls and two ‘open’ arms with no railing. Time exploring the open arm is used to assess anxiety (<xref ref-type="bibr" rid="bib76">Walf and Frye, 2007</xref>). Prosapip1 cKO and control mice spent a similar amount of time exploring the open arm (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1C</xref>, <xref ref-type="table" rid="table1">Table 1</xref>). Taken together, our data suggest that Prosapip1 is not involved in anxiety-related behaviors.</p></sec><sec id="s2-5"><title>Prosapip1 in the dorsal hippocampus contributes to recognition, social, and spatial memory</title><p>Memory is often associated with the dHP (<xref ref-type="bibr" rid="bib58">Pilly and Grossberg, 2012</xref>). As our data suggest that Prosapip1 contributes to recognition, social, and spatial memory, we next determined whether the dHP is the loci of Prosapip1’s contribution to learning and memory processes. To do so, the dHP of <italic>Lzts3</italic><sup>fl/fl</sup> mice was infected with an adeno-associated virus (AAV) expressing Cre to knockout Prospaip1 specifically in this region. Stereotaxic surgery was performed when mice were between 5 and 6 weeks of age, to ensure full viral expression by the 8–9 weeks of age. An AAV expressing solely GFP was used as a control (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). Western blot analysis of the AAV-Cre-infected dHP shows efficient deletion of Prosapip1 protein (<xref ref-type="fig" rid="fig5">Figure 5B</xref>).</p><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Prosapip1 in the dHP contributes to recognition, social, and spatial memory.</title><p>(<bold>A</bold>) Images of adeno-associated virus (AAV)-GFP (green) and AAV-Cre (red) overexpression in the dHP of <italic>Lzts3</italic><sup>fl/fl</sup> mice. (<bold>B</bold>) Western blot analysis of Prosapip1 protein level in the dHP in non-infected mice compared to mice infected with AAV-Cre. (<bold>C–D</bold>) Mice infected with AAV-GFP or AAV-Cre in the dHP were placed in an open field, and their behavior was recorded for 20 min. The total distance traveled (<bold>C</bold>) and the time spent in the center of the field (<bold>D</bold>) were measured during the test. n=19 (AAV-GFP), 15 (AAV-Cre). (<bold>E</bold>) Mice infected with AAV-GFP or AAV-Cre in the dHP were placed on the light side of a light/dark box apparatus and allowed to explore for 10 min. Time spent in the dark and light chambers during the light/dark box test. n=19 (AAV-GFP), 15 (AAV-Cre). (<bold>F</bold>) Mice infected with AAV-GFP or AAV-Cre in the dHP underwent the novel object recognition test. Briefly, they were familiarized with two similar objects before one was switched for a novel object after 24 hr. Cumulative time spent exploring the familiar and novel object during the novel object recognition test. n=16 (AAV-GFP), 17 (AAV-Cre). (<bold>G</bold>) Mice infected with AAV-GFP or AAV-Cre in the dHP underwent the novelty T-maze test, where they were first allowed to explore two arms of a three-armed, T-shaped maze. During the testing phase, the third ‘novel’ arm was unblocked and made available for exploration. Difference score (time exploring novel arm – time exploring familiar arm) of time spent exploring the novel arm of the T-maze. A heatmap of each average group performance during the test is also presented. n=18 (AAV-GFP), 15 (AAV-Cre). (<bold>H–I</bold>) Mice infected with AAV-GFP or AAV-Cre in the dHP performed the 3-chamber social interaction test. Briefly, they were placed in the center chamber and allowed to freely explore for 15 min during two trials. In the first trial, one chamber had a juvenile interaction partner, and the other was empty. In the second trial, one chamber had the familiar mouse from the first trial, and the other had a new juvenile interaction partner. (<bold>H</bold>) Cumulative time spent in the empty and social chamber of the 3-chamber social interaction test. n=18 (AAV-GFP), 15 (AAV-Cre). (<bold>I</bold>) Cumulative time spent in the familiar and novel chambers in the 3-chamber social interaction test. n=18 (AAV-GFP), 15 (AAV-Cre). (<bold>J–K</bold>) Mice infected with AAV-GFP or AAV-Cre in the dHP underwent the Barnes maze experiment. They were placed in the center of a platform with 40 evenly spaced holes around the perimeter, one of which led to an exit compartment. Mice underwent four training trials per day for 4 days, with 30 min intervals between trials. Twenty-four hours after the last training trial, they were placed back on the platform without the exit compartment (probe trial) and allowed to explore for 5 min. (<bold>J</bold>) Average distance traveled from start point to exit during the Barnes maze training trials. n=8 (AAV-GFP), 6 (AAV-Cre). (<bold>K</bold>) Time spent in the exit quartile during the probe trial. n=8 (AAV-GFP), 6 (AAV-Cre). Data are represented as mean ± SEM and analyzed using two-way ANOVA (<bold>E, F, H, I, J</bold>), Welch’s t-test (<bold>C, D, G</bold>), or Mann-Whitney test (<bold>K</bold>) (<xref ref-type="table" rid="table1">Table 1</xref>). *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, ****p&lt;0.0001.</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>File containing raw data for <xref ref-type="fig" rid="fig5">Figure 5</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-100653-fig5-data1-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig5sdata2"><label>Figure 5—source data 2.</label><caption><title>Original files for western blot analysis displayed in <xref ref-type="fig" rid="fig5">Figure 5</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-100653-fig5-data2-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100653-fig5-v1.tif"/></fig><p>We repeated the experimental battery performed on the genetically manipulated mice on the mice infused with AAV-GFP or AAV-Cre in the dHP. In the open field, AAV-GFP- and AAV-Cre-infected mice exhibited similar levels of locomotion (<xref ref-type="fig" rid="fig5">Figure 5C</xref>, <xref ref-type="table" rid="table1">Table 1</xref>) and spent a similar amount of time in the center of the field (<xref ref-type="fig" rid="fig5">Figure 5D</xref>, <xref ref-type="table" rid="table1">Table 1</xref>). The region-specific knockout of Prosapip1 did not affect exploratory behavior. We also directly assessed anxiety-like behavior using the light/dark box. Mice infected with AAV-GFP or AAV-Cre both spent comparable amounts of time in the light and dark chambers, preferring the dark (<xref ref-type="fig" rid="fig5">Figure 5E</xref>, <xref ref-type="table" rid="table1">Table 1</xref>). Therefore, Prosapip1 in the dHP does not control locomotion or anxiety-like behavior.</p><p>Next, we examined the role of Prosapip1 in the dHP on memory. We first assessed recognition memory using the novel object recognition test. The AAV-GFP-infected mice showed a significant preference for the novel object, indicating functioning long-term recognition memory (<xref ref-type="fig" rid="fig5">Figure 5F</xref>, <xref ref-type="table" rid="table1">Table 1</xref>). Mice infected with AAV-Cre, however, showed no significant preference for either object (<xref ref-type="fig" rid="fig5">Figure 5F</xref>, <xref ref-type="table" rid="table1">Table 1</xref>). Similarly, in the novelty T-maze test, AAV-GFP-infected mice spent much of the test exploring the novel arm of the maze, indicated by a positive difference score (<xref ref-type="fig" rid="fig5">Figure 5G</xref>, <xref ref-type="table" rid="table1">Table 1</xref>). AAV-Cre-infected mice spent significantly less time exploring the novel arm of the maze, performing at chance levels (<xref ref-type="fig" rid="fig5">Figure 5G</xref>, <xref ref-type="table" rid="table1">Table 1</xref>). Together, these results suggest that Prosapip1 in the dHP specifically contributes to recognition and spatial working memory.</p><p>We also assessed the effects of region-specific Prosapip1 knockout on sociability and social memory using the 3-chamber social interaction test. Both AAV-GFP- and AAV-Cre-infected mice showed a significant preference for interacting with a social partner over the empty cage (<xref ref-type="fig" rid="fig5">Figure 5H</xref>, <xref ref-type="table" rid="table1">Table 1</xref>). When a novel interaction partner was introduced, AAV-GFP mice significantly preferred interacting with the novel partner (<xref ref-type="fig" rid="fig5">Figure 5I</xref>, <xref ref-type="table" rid="table1">Table 1</xref>). AAV-Cre-infected mice did not show a significant preference (<xref ref-type="fig" rid="fig5">Figure 5I</xref>, <xref ref-type="table" rid="table1">Table 1</xref>).</p><p>Finally, AAV-GFP- and AAV-Cre-infected mice underwent the Barnes maze procedure to separately assess spatial learning and memory. During training trials, AAV-Cre-infected mice performed significantly worse when examining path to escape (<xref ref-type="fig" rid="fig5">Figure 5J</xref>, <xref ref-type="table" rid="table1">Table 1</xref>). While AAV-GFP-infected mice quickly improved exit strategy, AAV-Cre-infected mice were more variable and took a longer path, on average (<xref ref-type="fig" rid="fig5">Figure 5J</xref>, <xref ref-type="table" rid="table1">Table 1</xref>). After training, during the probe trial, AAV-GFP-infected mice spent significantly more time in the exit quartile compared to AAV-Cre-infected mice (<xref ref-type="fig" rid="fig5">Figure 5K</xref>, <xref ref-type="table" rid="table1">Table 1</xref>). Together, our data suggest that Prosapip1 in the dHP is specifically involved in the formation of spatial memory.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Our findings suggest that Prosapip1 in the dHP is responsible for the synaptic localization of SPAR and PSD-95, and consequently, for the membrane localization of GluN2B. Furthermore, our data suggest that Prosapip1 in the dHP plays an important role in LTP as well as learning and memory.</p><sec id="s3-1"><title>Prosapip1 is a key protein in the PSD</title><p>Prosapip1 is highly enriched in the PSD of primary hippocampal neurons (<xref ref-type="bibr" rid="bib80">Wendholt et al., 2006</xref>; <xref ref-type="bibr" rid="bib61">Reim et al., 2016</xref>), and our results suggest that Prosapip1 could be crucial to the formation and stability of PSD complexes. Prosapip1 scaffolds SPAR to Shank3 in the PSD (<xref ref-type="bibr" rid="bib80">Wendholt et al., 2006</xref>; <xref ref-type="bibr" rid="bib26">Dolnik et al., 2016</xref>; <xref ref-type="bibr" rid="bib61">Reim et al., 2016</xref>). We found that knockout of Prosapip1 reduced the synaptic localization of SPAR but not Shank3. Reim et al. reported that Prosapip1 is directly regulating SPAR levels in the PSD in primary hippocampal neurons (<xref ref-type="bibr" rid="bib61">Reim et al., 2016</xref>). Our data supports this study, as Prosapip1 knockout in vivo led to a reduction of synaptic SPAR. SPAR plays a role in the formation of F-actin, which is important for dendritic spine maturation (<xref ref-type="bibr" rid="bib57">Pak et al., 2001</xref>). We previously showed Prosapip1 interacts with SPAR in the NAc of mice (<xref ref-type="bibr" rid="bib42">Laguesse et al., 2017</xref>), and Prosapip1 knockdown reduces F-actin content while overexpression of Prosapip1 increases F-actin content in the NAc (<xref ref-type="bibr" rid="bib42">Laguesse et al., 2017</xref>). Furthermore, we showed that Prosapip1 plays a role in spine maturation in the NAc (<xref ref-type="bibr" rid="bib42">Laguesse et al., 2017</xref>). Our results suggest that the recruitment of SPAR to the PSD via Prosapip1 in the dHP promotes F-actin formation and lead to dendritic spine maturation, however, these possibilities merit further examined.</p><p>Both SPAR and Shank3 interact with PSD-95 (<xref ref-type="bibr" rid="bib55">Naisbitt et al., 1999</xref>; <xref ref-type="bibr" rid="bib74">Tu et al., 1999</xref>; <xref ref-type="bibr" rid="bib57">Pak et al., 2001</xref>). SPAR binds PSD-95 directly (<xref ref-type="bibr" rid="bib57">Pak et al., 2001</xref>), and Shank3 associates with Guanylate kinase-associated protein (GKAP), which binds PSD-95 (<xref ref-type="bibr" rid="bib55">Naisbitt et al., 1999</xref>; <xref ref-type="bibr" rid="bib74">Tu et al., 1999</xref>). PSD-95 binds to NMDAR subunits GluN2A and GluN2B and stabilizes NMDAR surface localization (<xref ref-type="bibr" rid="bib81">Won et al., 2016</xref>; <xref ref-type="bibr" rid="bib18">Coley and Gao, 2019</xref>). Studies have shown that PSD-95 deficiency causes an imbalance of NMDAR and AMPAR synaptic presence, altering glutamatergic transmission (<xref ref-type="bibr" rid="bib46">Lin et al., 2004</xref>; <xref ref-type="bibr" rid="bib29">Elias et al., 2006</xref>; <xref ref-type="bibr" rid="bib83">Zhang et al., 2013</xref>; <xref ref-type="bibr" rid="bib16">Chen et al., 2015</xref>). Surprisingly, we discovered that loss of Prosapip1 resulted in a marked reduction of synaptic PSD-95, and a correlated reduction in the synaptic compartmentalization of the NMDAR subunit GluN2B, raising the possibility that the interaction between Prosapip1 and PSD-95 is required for synaptic membrane localization of GluN2B. However, we did not observe a change in the synaptic level of GluN2A. In addition, we did not find that the localization of the AMPAR subunit GluA1 was altered as a result of Prosapip1 knockout. In line with our findings, <xref ref-type="bibr" rid="bib57">Pak et al., 2001</xref> showed that SPAR binds PSD-95 and GluN2B, but not GluA1. Based on our results and these studies, the complex controlling AMPAR synaptic localization is different, and likely independent of Prosapip1 in the dHP. Together, our data suggest that Prosapip1 is necessary for the formation and/or maintenance of the NMDAR-associated PSD network.</p><p>We previously discovered that Prosapip1’s translation depends on mTORC1 in the NAc of mice consuming excessive levels of alcohol, which in turn promotes F-actin formation, dendritic spine maturation, and alcohol-reward memory and the reinforcement of alcohol consumption (<xref ref-type="bibr" rid="bib42">Laguesse et al., 2017</xref>). mTORC1 activation by alcohol also induces the translation of the scaffolding protein Homer and PSD-95 in the NAc of mice (<xref ref-type="bibr" rid="bib7">Beckley et al., 2016</xref>; <xref ref-type="bibr" rid="bib47">Liu et al., 2017</xref>). mTORC1 plays an essential role in the translation of a subset of mRNAs to proteins and in the CNS, mTORC1 promotes the translation of synaptic proteins at dendrites (<xref ref-type="bibr" rid="bib14">Buffington et al., 2014</xref>), and plays an important role in LTP, learning, and memory (<xref ref-type="bibr" rid="bib34">Hoeffer and Klann, 2010</xref>; <xref ref-type="bibr" rid="bib32">Graber et al., 2013</xref>). Therefore, it would be of great interest to test the hypothesis that learning-dependent activation of mTORC1 in the dHP activates the translational machinery at synapses and, therefore, increases the translation of Prosapip1, which in turn recruits proteins such as PSD-95 to stabilize the PSD-95 complex.</p></sec><sec id="s3-2"><title>Prosapip1 is required for LTP in the dHP</title><p>In our study, we discovered that mice lacking Prosapip1 exhibited markedly diminished NMDAR-mediated synaptic transmission, which is in line with the fact that the synaptic GluN2B levels are reduced. We also found that Prosapip1 knockout led to a significant reduction in the formation of LTP. LTP is a persistent increase in synaptic strength between neurons that can last for months in vivo (<xref ref-type="bibr" rid="bib1">Abraham et al., 2002</xref>; <xref ref-type="bibr" rid="bib21">Cooke and Bliss, 2006</xref>) and is the cellular hallmark of learning and memory. It is often induced by HFS, which causes extensive glutamate release and significant AMPAR activity, resulting in large membrane depolarization (<xref ref-type="bibr" rid="bib49">Ma et al., 2018</xref>). This depolarization facilitates the removal of Mg<sup>2+</sup> blockage in NMDARs, thereby activating them and leading to calcium influx (<xref ref-type="bibr" rid="bib49">Ma et al., 2018</xref>). This influx triggers the calmodulin/CaMKII pathway, initiating a series of cascades that enhance AMPAR phosphorylation and trafficking, culminating in sustained synaptic strengthening (<xref ref-type="bibr" rid="bib36">Huganir and Nicoll, 2013</xref>; <xref ref-type="bibr" rid="bib33">Herring and Nicoll, 2016</xref>). Therefore, the induction of hippocampal LTP heavily relies on NMDAR activation, with alterations in NMDAR function significantly affecting the establishment of hippocampal LTP and its associated learning and memory processes. In Prosapip1 knockout mice, the reduction in NMDAR functionality likely results in decreased calcium influx during high-frequency stimulation and diminished activation of the calmodulin/CaMKII pathway, leading to weaker synaptic strengthening.</p></sec><sec id="s3-3"><title>Prosapip1 is required for learning and memory</title><p>As detailed above, we found that Prosapip1 neuronal knockout mice have deficits in LTP in the dHP, and LTP is the hallmark of learning and memory (<xref ref-type="bibr" rid="bib8">Bliss and Collingridge, 1993</xref>; <xref ref-type="bibr" rid="bib30">Frey and Morris, 1998</xref>; <xref ref-type="bibr" rid="bib19">Collingridge et al., 2004</xref>). We also found that global neuronal knockout and dHP-specific knockout of Prosapip1 results in deficits in spatial learning and memory. Specifically, we showed that Prosapip1 in the dHP is required for normal performance in the novel object recognition, novelty T-maze, 3-chamber social interaction, and Barnes maze tests, which all require a unique form of learning and memory (<xref ref-type="bibr" rid="bib24">Davis et al., 1992</xref>; <xref ref-type="bibr" rid="bib13">Broadbent et al., 2010</xref>; <xref ref-type="bibr" rid="bib5">Barker and Warburton, 2011</xref>; <xref ref-type="bibr" rid="bib64">Rosenfeld and Ferguson, 2014</xref>; <xref ref-type="bibr" rid="bib48">Lueptow, 2017</xref>; <xref ref-type="bibr" rid="bib59">Pitts, 2018</xref>; <xref ref-type="bibr" rid="bib65">Sánchez-Rodríguez et al., 2022</xref>). The novel object recognition test is primarily examining recognition memory, and with an inter-trial interval of 24 hr, specifically long-term memory (<xref ref-type="bibr" rid="bib13">Broadbent et al., 2010</xref>; <xref ref-type="bibr" rid="bib5">Barker and Warburton, 2011</xref>; <xref ref-type="bibr" rid="bib2">Antunes and Biala, 2012</xref>; <xref ref-type="bibr" rid="bib48">Lueptow, 2017</xref>; <xref ref-type="bibr" rid="bib17">Cinalli et al., 2020</xref>). The novelty T-maze focuses on both spatial learning and memory, and with its short, 1 min inter-trial interval, this procedure is examining spatial working memory (<xref ref-type="bibr" rid="bib67">Sharma et al., 2010</xref>; d'<xref ref-type="bibr" rid="bib25">d’Isa et al., 2021</xref>). The 3-chamber social interaction test is assessing baseline sociability and also social recognition memory (<xref ref-type="bibr" rid="bib53">Meira et al., 2018</xref>; <xref ref-type="bibr" rid="bib75">Tzakis and Holahan, 2019</xref>; <xref ref-type="bibr" rid="bib78">Wang and Zhan, 2022</xref>; <xref ref-type="bibr" rid="bib22">Cope et al., 2023</xref>; <xref ref-type="bibr" rid="bib79">Wei et al., 2024</xref>). Finally, the Barnes maze tests both spatial learning and working memory in intra-day trials, while simultaneously testing long-term contextual and spatial memory in inter-day trials and the probe test (<xref ref-type="bibr" rid="bib4">Bach et al., 1995</xref>; <xref ref-type="bibr" rid="bib67">Sharma et al., 2010</xref>; <xref ref-type="bibr" rid="bib64">Rosenfeld and Ferguson, 2014</xref>; <xref ref-type="bibr" rid="bib59">Pitts, 2018</xref>). Interestingly, loss of hippocampal LTP has been shown to impair spatial, but not contextual memory in the Barnes maze (<xref ref-type="bibr" rid="bib4">Bach et al., 1995</xref>). As presented here, Prosapip1 knockout mice significantly reduced distance traveled to exit but did not switch to spatial searching. In this example, Prosapip1 knockout mice are retaining the contextual understanding of escaping the platform but do not recall the spatial location of the exit. Additionally, the link between NMDAR function and learning and memory is well established (<xref ref-type="bibr" rid="bib56">Newcomer et al., 2000</xref>; <xref ref-type="bibr" rid="bib45">Li and Tsien, 2009</xref>). For example, blockage of hippocampal NMDA receptors impairs spatial learning in rats (<xref ref-type="bibr" rid="bib24">Davis et al., 1992</xref>; <xref ref-type="bibr" rid="bib15">Bye and McDonald, 2019</xref>). Prosapip1 is therefore likely controlling the reinforcement of learning and memory by PSD scaffolding, stabilization, and GluN2B synaptic localization, leading to LTP.</p><p>We observed that Prosapip1 knockout specifically in the dHP replicated the recognition, social, and spatial learning and memory deficits exhibited by the global neuronal knockout mice, suggesting that Prosapip1 is controlling these learning and memory processes specifically in the dHP. The dHP primarily controls memory formation and recall (<xref ref-type="bibr" rid="bib28">Eichenbaum, 1997</xref>; <xref ref-type="bibr" rid="bib12">Broadbent et al., 2004</xref>; <xref ref-type="bibr" rid="bib69">Squire et al., 2004</xref>; <xref ref-type="bibr" rid="bib58">Pilly and Grossberg, 2012</xref>). We found that LTP in the CA1 subregion of the dHP was reliant on Prosapip1. The CA1 subregion is critically involved in contextual memory, object recognition memory, and spatial memory (<xref ref-type="bibr" rid="bib73">Tsien et al., 1996</xref>; <xref ref-type="bibr" rid="bib43">Lee and Kesner, 2004</xref>; <xref ref-type="bibr" rid="bib23">Daumas et al., 2005</xref>; <xref ref-type="bibr" rid="bib66">Sanderson et al., 2009</xref>; <xref ref-type="bibr" rid="bib67">Sharma et al., 2010</xref>; <xref ref-type="bibr" rid="bib71">Stevenson et al., 2018</xref>; <xref ref-type="bibr" rid="bib15">Bye and McDonald, 2019</xref>; <xref ref-type="bibr" rid="bib17">Cinalli et al., 2020</xref>; <xref ref-type="bibr" rid="bib37">Jeong and Singer, 2022</xref>). Loss of Prosapip1 in CA1 is likely leading to decreased performance in the novel object recognition, novelty T-maze, and Barnes maze tests. The lack of social recognition displayed by <italic>Prosapip1</italic>(fl/fl);Syn1-Cre(+) mice and AAV-Cre-infected mice is likely attributed to the loss of Prosapip1 in the CA2 subregion of the dHP, which is the primary subregion controlling social recognition memory (<xref ref-type="bibr" rid="bib53">Meira et al., 2018</xref>; <xref ref-type="bibr" rid="bib75">Tzakis and Holahan, 2019</xref>; <xref ref-type="bibr" rid="bib78">Wang and Zhan, 2022</xref>; <xref ref-type="bibr" rid="bib22">Cope et al., 2023</xref>; <xref ref-type="bibr" rid="bib79">Wei et al., 2024</xref>). Specifically, silencing the CA2 subregion of the dHP impairs social memory formation and consolidation (<xref ref-type="bibr" rid="bib53">Meira et al., 2018</xref>). However, the CA3 and DG subregions of the dHP are also involved in spatial and contextual memory (<xref ref-type="bibr" rid="bib12">Broadbent et al., 2004</xref>; <xref ref-type="bibr" rid="bib43">Lee and Kesner, 2004</xref>; <xref ref-type="bibr" rid="bib23">Daumas et al., 2005</xref>). As our conditional knockout strategy resulted in Prosapip1 deletion from the whole dHP, further studies are required to dissect the subregion specificity of the contribution of Prosapip1 to recognition, social, and spatial learning and memory processes.</p><p>Memory consists of three primary processes: encoding, consolidation, and retrieval (<xref ref-type="bibr" rid="bib72">Straube, 2012</xref>). In this study, the defect in memory function is likely due to a failure to encode new information (<xref ref-type="bibr" rid="bib15">Bye and McDonald, 2019</xref>) or consolidate this ‘short-term’ into ‘long-term’ memory (<xref ref-type="bibr" rid="bib82">Yang et al., 2022</xref>). The spatial T-maze experiment utilized a short inter-trial interval of 1 min, which requires working spatial memory (<xref ref-type="bibr" rid="bib67">Sharma et al., 2010</xref>), and Prosapip1 knockout mice exhibited a failure to encode new information. Similarly, the Barnes maze training trials were separated by an inter-trial interval of 30 min, but Prosapip1 knockout mice did not acquire spatial memory between training trials, nor during the longer consolidation periods between days, again implying a failure to encode spatial information or consolidate this information. The lack of synaptic localization of GluN2B is likely underlying the loss of memory encoding or consolidation (<xref ref-type="bibr" rid="bib54">Nachtigall et al., 2024</xref>). It is unlikely that NMDAR dysfunction is affecting the retrieval of memory, as studies have exhibited rats’ ability to use previously acquired spatial information during NMDAR blockage (<xref ref-type="bibr" rid="bib6">Bast et al., 2005</xref>; <xref ref-type="bibr" rid="bib50">Mackes and Willner, 2006</xref>; <xref ref-type="bibr" rid="bib15">Bye and McDonald, 2019</xref>).</p><p>Prosapip1 belongs to the Fezzin family of proteins (<xref ref-type="bibr" rid="bib80">Wendholt et al., 2006</xref>). It is important to note that other Fezzins do not compensate for the loss of Prosapip1 in the dHP. Knockout of other Fezzins, like PSD-Zip70, also leads to cognitive deficits (<xref ref-type="bibr" rid="bib52">Mayanagi et al., 2015</xref>). However, these deficits were attributed to the action of PSD-Zip70 in the PFC. Therefore, one could hypothesize that proteins in this family enact their function in specific brain subregions.</p><p>In summary, Prosapip1 in the dorsal hippocampus is integral to the synaptic localization of SPAR, PSD-95, and GluN2B, which are required for the formation of LTP and subsequent spatial learning and memory behavior. Abnormalities with PSD proteins are associated with neuropsychiatric disorders (<xref ref-type="bibr" rid="bib38">Kaizuka and Takumi, 2018</xref>), and further unraveling of the physiological role of Prosapip1 may unlock insights into normal and abnormal mechanisms of learning and memory.</p></sec></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Biological Sample (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom">Single cell C57BL/6 J embryos</td><td align="left" valign="bottom">Jackson Laboratory</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Electroporated with gRNA to create new mouse strain</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>Mus musculus</italic>, female)</td><td align="left" valign="bottom">CD-1 IGS Mouse</td><td align="left" valign="bottom">Charles River</td><td align="left" valign="bottom">Strain Code 022</td><td align="left" valign="bottom">Pseudopregnant recipient female</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>Mus musculus</italic>, female)</td><td align="left" valign="bottom">C57BL/6 J</td><td align="left" valign="bottom">Jackson Laboratory</td><td align="left" valign="bottom">000664<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:IMSR_JAX:000664">IMSR_JAX:000664</ext-link></td><td align="left" valign="bottom">Mating with first <italic>Lzts3</italic><sup>fl/fl</sup> offspring</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>Mus musculus</italic>, male and female)</td><td align="left" valign="bottom">B6.Cg-Tg(Syn1-cre)671Jxm/J</td><td align="left" valign="bottom">Jackson Laboratory</td><td align="left" valign="bottom">003966<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:IMSR_JAX:003966">IMSR_JAX:003966</ext-link></td><td align="left" valign="bottom">Mouse line</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>Mus musculus</italic>, male and female)</td><td align="left" valign="bottom"><italic>Lzts3</italic><sup>fl/fl</sup></td><td align="left" valign="bottom">First described in this paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Mouse line.<break/>Available upon request to Dorit Ron</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>Mus musculus</italic>, male and female)</td><td align="left" valign="bottom"><italic>Lzts3</italic><sup>fl/fl</sup>;Syn1-Cre</td><td align="left" valign="bottom">First described in this paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Mouse line.<break/>Syn1-Cre available at Jackson Laboratory</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Alt-R CRISPR-Cas9 crRNAs</td><td align="left" valign="bottom">IDT DNA</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">Generated by Gregg E. Homanics and available upon request.</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">long PAGE-purified Ultramer single-stranded DNA oligos</td><td align="left" valign="bottom">IDT DNA</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">140 nt, target loci in intron 2 and exon 5<break/>Generated by Gregg E. Homanics and available upon request.</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Intron 2 lox insertion F</td><td align="left" valign="bottom">This paper (materials and methods section)</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom"><named-content content-type="sequence">AGAGAAGTCTACGCTGTAGTCAG</named-content><break/>Generated by Gregg E. Homanics and available upon request.</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Intron 2 lox insertion R</td><td align="left" valign="bottom">This paper<break/>(materials and methods section)</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom"><named-content content-type="sequence">AAGCGGGAAGGTAGAGAGGT</named-content><break/>Generated by Gregg E. Homanics and available upon request.</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Exon 5 lox insertion F</td><td align="left" valign="bottom">This paper<break/>(materials and methods section)</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom"><named-content content-type="sequence">TGCACAACCTTCTGACACGT</named-content><break/>Generated by Gregg E. Homanics and available upon request.</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Exon 5 lox insertion R</td><td align="left" valign="bottom">This paper<break/>(materials and methods section)</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom"><named-content content-type="sequence">AGGGCACAGACAGTAGCACT</named-content><break/>Generated by Gregg E. Homanics and available upon request.</td></tr><tr><td align="left" valign="bottom">Transfected construct (<italic>M. musculus</italic>)</td><td align="left" valign="bottom">AAV8-Ef1a-mCherry-IRES-Cre</td><td align="left" valign="bottom">Addgene</td><td align="char" char="hyphen" valign="bottom">55632-AAV8</td><td align="left" valign="bottom">1×10<sup>13</sup> vg/ml. AAV to infect mouse brain.</td></tr><tr><td align="left" valign="bottom">Transfected construct (<italic>M. musculus</italic>)</td><td align="left" valign="bottom">AAV2-CMV-EGFP</td><td align="left" valign="bottom">Addgene</td><td align="char" char="hyphen" valign="bottom">105530-AAV2</td><td align="left" valign="bottom">1×10<sup>13</sup> vg/ml, AAV to infect mouse brain</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-SPAR (SIPA1L1) (Rabbit, polyclonal)<break/><break/></td><td align="left" valign="bottom">ProteinTech</td><td align="left" valign="bottom">25086–1-AP<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_2714023">AB_2714023</ext-link><break/></td><td align="left" valign="bottom">WB (1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-Prosapip1 (Rabbit, polyclonal)</td><td align="left" valign="bottom">ProteinTech</td><td align="left" valign="bottom">24936-1-AP<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_2714022">AB_2714022</ext-link></td><td align="left" valign="bottom">WB (1:2000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-Shank3 (Mouse, monoclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">Ab93607<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_10563849">AB_10563849</ext-link></td><td align="left" valign="bottom">WB (1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-GluN2B (Rabbit, monoclonal)</td><td align="left" valign="bottom">Cell Signaling</td><td align="left" valign="bottom">4212 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_2112463">AB_2112463</ext-link><break/></td><td align="left" valign="bottom">WB (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-GluA1 (Rabbit, monoclonal)</td><td align="left" valign="bottom">Cell Signaling</td><td align="char" char="." valign="bottom">13185 S<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_2732897">AB_2732897</ext-link></td><td align="left" valign="bottom">WB (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-CREB (Rabbit, monoclonal)</td><td align="left" valign="bottom">Cell Signaling</td><td align="left" valign="bottom">9197 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_2800317">AB_2800317</ext-link></td><td align="left" valign="bottom">WB (1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-GluN2A (Goat, polyclonal)</td><td align="left" valign="bottom">Santa Cruz</td><td align="left" valign="bottom">SC-1468<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_2630886">AB_2630886</ext-link></td><td align="left" valign="bottom">WB (1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-GAPDH (Mouse, monoclonal)</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">G8795 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_1078991">AB_1078991</ext-link><break/></td><td align="left" valign="bottom">WB (1:10,000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-PSD-95 (Mouse)</td><td align="left" valign="bottom">Millipore</td><td align="left" valign="bottom">05–494 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_2315219">AB_2315219</ext-link><break/></td><td align="left" valign="bottom">WB (1:100,000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-rabbit horseradish peroxidase (Donkey, polyclonal)</td><td align="left" valign="bottom">Jackson ImmunoResearch</td><td align="left" valign="bottom">711-035-152 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_10015282">AB_10015282</ext-link><break/></td><td align="left" valign="bottom">WB (1:5,000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-goat HRP (Donkey, polyclonal)</td><td align="left" valign="bottom">Jackson ImmunoResearch</td><td align="left" valign="bottom">705-035-003 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_2340390">AB_2340390</ext-link></td><td align="left" valign="bottom">WB (1:5,000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-mouse HRP (Donkey, polyclonal)</td><td align="left" valign="bottom">Jackson ImmunoResearch</td><td align="left" valign="bottom">715-035-150 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_2340770">AB_2340770</ext-link><break/></td><td align="left" valign="bottom">WB (1:5,000)</td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Pierce bicinchoninic acid (BCA) protein assay kit</td><td align="left" valign="bottom">Thermo Scientific</td><td align="char" char="." valign="bottom">23225</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">NuPAGE Bis-Tris precast gels</td><td align="left" valign="bottom">Life Technologies</td><td align="left" valign="bottom">NP00321BOX</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Enhance Chemiluminescence reagent (ECL)</td><td align="left" valign="bottom">Millipore</td><td align="left" valign="bottom">WBAVDCH01</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">cOmplete, Mini, EDTA-free Protease Inhibitor Cocktail</td><td align="left" valign="bottom">Roche</td><td align="char" char="." valign="bottom">11836170001</td><td align="left" valign="bottom"/></tr></tbody></table></table-wrap><sec id="s4-1"><title>Ethics statement</title><p>All animal procedures were approved by UCSF Institutional Animal Care and Use Committee (IACUC) (animal protocol AN206967) and were conducted in agreement with the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC).</p></sec><sec id="s4-2"><title>Methods of Euthanasia</title><p>Mice were euthanized by carbon dioxide inhalation followed by cervical dislocation, or deep anesthetization with pentobarbital (150 mg/kg) followed by transcranial perfusion with 4% paraformaldehyde. These procedures are in accordance with the Panel on Euthanasia of the American Veterinary Medical Association guidelines and with the standard operating procedures of the UCSF IACUC.</p></sec><sec id="s4-3"><title>Animals</title><p><italic>Lzts3</italic><sup>fl/fl</sup> mice were generated as described below. Syn1-Cre(+) mice were purchased from Jackson Laboratory (Stock #003966, Bar Harbor, Maine). <italic>Lzts3</italic><sup>fl/fl</sup> and <italic>Lzts3</italic><sup>fl/fl</sup>; Syn1-Cre mice were bred and group housed in a 12 hr light-dark cycle room that was temperature- and humidity-controlled. Unrestricted amounts of food and water were provided.</p></sec><sec id="s4-4"><title>Generation of <italic>Prosapip1</italic> floxed mice</title><p>Guide RNA binding sites in intron 2 and in the 3’UTR located in Exon 5 of <italic>Lzts3</italic> (<xref ref-type="fig" rid="fig1">Figure 1A</xref>) were identified using the CRISPRator tool (<xref ref-type="bibr" rid="bib41">Labuhn et al., 2018</xref>) within the CCTop (<xref ref-type="bibr" rid="bib70">Stemmer et al., 2015</xref>) online platform (<ext-link ext-link-type="uri" xlink:href="http://crispr.cos.uni-heidelberg.de/">http://crispr.cos.uni-heidelberg.de/</ext-link>). The gRNA binding sites are located ~3.3 kb from each other. These gRNA target sites were used to produce two Alt-R CRISPR-Cas9 crRNAs (IDT DNA, Coralville, IA) which were individually hybridized to a universal 67-mer Alt-R CRISPR-Cas9 tracrRNA (IDT DNA) to produce two gRNAs. Two 140 nt long PAGE-purified Ultramer single-stranded DNA oligos (IDT DNA) with three phosphorothioate modifications on each end (<xref ref-type="bibr" rid="bib62">Renaud et al., 2016</xref>) that were homologous to the target loci in intron 2 and exon 5 (<xref ref-type="fig" rid="fig1">Figure 1B</xref>) were used as a repair templates.</p><p>We introduced each loxP site into 1 cell and 2 cell stages of embryonic development (<xref ref-type="bibr" rid="bib35">Horii et al., 2017</xref>). Single cell C57BL/6 J embryos were electroporated with gRNA#6 (200ng/µl), IDT Alt-R HiFi Cas9 Nuclease V3 protein (75 ng/µl), and Exon 5 repair template (200 ng/µl) using a BioRad Gene-Pulser Xcell electroporator in a 1 mm-gap slide electrode (Protech International, #501P1-10) using square-wave pulses (five repeats of 3 ms 25 V pulses with 100 ms interpulse intervals). Following this first electroporation, embryos were cultured overnight. Surviving two-cell embryos were electroporated with gRNA#7 (200ng/µl), IDT Alt-R HiFi Cas9 Nuclease V3 protein (75 ng/µl), and intron 2 repair template (200 ng/µl) under conditions described above. Surviving embryos were transferred to the oviducts of CD1 (Charles River) pseudopregnant recipient females. Offspring were genotyped for the intron 2 lox insertion using PCR (forward primer 5’ <named-content content-type="sequence">AGAGAAGTCTACGCTGTAGTCAG</named-content> 3’ and reverse primer 5’ <named-content content-type="sequence">AAGCGGGAAGGTAGAGAGGT</named-content> 3’; wild-type product = 449 bp, floxed product = 489 bp) followed by Sanger sequencing. Offspring were genotyped for the Exon 5 lox insertion using PCR (forward primer 5’ <named-content content-type="sequence">TGCACAACCTTCTGACACGT</named-content> 3’ and reverse primer 5’ <named-content content-type="sequence">AGGGCACAGACAGTAGCACT</named-content> 3’; wild-type product = 408 bp, floxed product = 448 bp) followed by Sanger sequencing. Two founder animals were found that harbored loxP insertions at both the intron 2 and exon 5 sites. When mated to C57BL/6 J females, the loxP sites segregated, indicating that they were on different chromosomes. Therefore, F1 offspring that harbored only the loxP insertion at the intron 2 site were used as 1 cell embryo donors for insertion of the Exon 5 loxP site using electroporation conditions described above. One male offspring was produced that harbored both the intron 2 and exon 5 loxP insertions on the same chromosome. This male was mated to C57BL/6 J females to establish the floxed mouse line used here.</p><p>Guide RNA off-target sites were predicted and ranked using CRISPOR (<xref ref-type="bibr" rid="bib20">Concordet and Haeussler, 2018</xref>). The top 11 and 10 sites for gRNA#6 and gRNA#7, respectively, based on CFD score were amplified from this founder mouse DNA and Sanger sequenced. All predicted off-target sites analyzed were wild-type (data not shown).</p></sec><sec id="s4-5"><title>Reagents</title><p>Antibodies: Rabbit anti-Prosapip1 (1:2000) (24936-1-AP) and Rabbit anti-SPAR (SIPA1L1) (1:500) (25086–1-AP) antibodies were purchased from ProteinTech. Mouse anti-Shank3 antibodies (1:500) (#ab93607) were purchased from Abcam. Rabbit anti-GluN2B (1:1000) (#4212), Rabbit anti-GluA1 (1:1000) (#13185 S), and Rabbit anti-CREB (1:500) (#9197) antibodies were purchased from Cell Signaling. Goat anti-GluN2A antibodies (1:500) (#SC-1468) were purchased from Santa Cruz. Mouse anti-GAPDH antibodies (1:10,000) (#G8795) were purchased from Sigma. Mouse anti-PSD-95 antibodies (1:100,000) (#05–494) were purchased from Millipore (Upstate). Donkey anti-rabbit horseradish peroxidase (HRP), donkey anti-goat HRP, and donkey anti-mouse HRP conjugated secondary antibodies (1:5000) were purchased from Jackson ImmunoResearch (West Grove, PA). Enhance Chemiluminescence reagent (ECL) was purchased from Millipore (Burlington, MA). EDTA-free complete mini–Protease Inhibitor Cocktails was from Roche (Indianapolis, IN). Pierce bicinchoninic acid (BCA) protein assay kit was purchased from Thermo Scientific (Rockford, IL). NuPAGE Bis-Tris precast gels were purchased from Life Technologies (Carlsbad, CA).</p><p>Viruses: AAV8-Ef1a-mCherry-IRES-Cre (1×10<sup>13</sup> vg/ml #55632) and AAV2-CMV-EGFP (110<sup>13</sup> vg/ml, #105530) were purchased from Addgene.</p></sec><sec id="s4-6"><title>Crude synaptosomal fractionation</title><p>Tissue was first homogenized at 4 °C in 500 μl of Krebs buffer including 125 mM NaCl, 1.2 mM KCl, 1.2 mM MgSO<sub>4</sub>, 1.2 mM CaCl<sub>2</sub>, 22 mM Na<sub>2</sub>CO<sub>3</sub>, 1 mM NaH<sub>2</sub>PO<sub>4</sub>, 10 mM Glucose, 0.32 M sucrose, and protease/phosphatase inhibitors. A portion of the homogenate (100 μl) was saved as total homogenate (H), while the remaining homogenate was diluted by adding 500 μl of Krebs buffer to the remaining 400 μl. The total homogenate was transferred to a 1.5 ml Eppendorf tube. The glass homogenizer was washed with 500 μl of Krebs buffer, and the wash solution was added to the remaining homogenate. The sample was then centrifuged at 1,000 g at 4 °C for 10 min. The supernatant (S1) was collected. The process was repeated, and then the S1 supernatant was centrifuged at 16,000 g at 4 °C for 20 min. The supernatant (S2) was saved, and the pellet was kept on ice. The resulting pellet contained the synaptosomal fraction. The pellet was then resuspended in 500 μl of Krebs buffer and centrifuged at 16,000 g, 4 °C for 20 min and resuspended in radio immunoprecipitation assay (RIPA) buffer (containing 50 mM Tris-HCL, 5 mM EDTA, 120 mM NaCl, 1% NP-40, 0.1% deoxycholate, 0.5% SDS, and protease and phosphatase inhibitors) for analysis.</p></sec><sec id="s4-7"><title>Western blot analysis</title><p>Tissue collected from mice was homogenized in ice-cold RIPA buffer using a sonic dismembrator. Protein concentration was determined using the BCA protein assay kit. 30 µg of each tissue lysate was loaded for separation by SDS-PAGE (4–12%), followed by transfer onto a nitrocellulose membrane at 300 mA for 2 hr. The membranes were then blocked with 5% milk-PBS containing 0.1% Tween 20 at room temperature for 30 min before being probed with the appropriate primary antibodies overnight at 4 °C. Following washing, the membranes were incubated with HRP-conjugated secondary antibodies for 1 hr at room temperature and then visualized using ECL. Band intensities were quantified using ImageJ software (NIH, <ext-link ext-link-type="uri" xlink:href="https://imagej.net/ij/">https://imagej.net/ij/</ext-link>).</p></sec><sec id="s4-8"><title>Electrophysiology</title><p>Preparation of slices is outlined in <xref ref-type="bibr" rid="bib31">Gangal et al., 2023</xref>. In brief, coronal sections of the hippocampus (250 µm) were cut in an ice-cold solution containing the following: 40 mM NaCl, 148.5 mM sucrose, 4.5 mM KCl, 1.25 mM NaH<sub>2</sub>PO<sub>4</sub>, 25 mM NaHCO<sub>3</sub>, 0.5 mM CaCl<sub>2</sub>, 7 mM MgSO<sub>4</sub>, 10 mM dextrose, 1 mM sodium ascorbate, 3 mM myo-inositol, 3 mM sodium pyruvate, and saturated with a 95% O<sub>2</sub> and 5% CO<sub>2</sub>. After cutting, the slices were incubated for 45 min in an external solution containing the following: 125 mM NaCl, 4.5 mM KCl, 2.5 mM CaCl<sub>2</sub>, 1.3 mM MgSO<sub>4</sub>, 1.25 mM NaH<sub>2</sub>PO<sub>4</sub>, 25 mM NaHCO<sub>3</sub>, 15 mM sucrose, 15 mM glucose, and saturated with 95% O<sub>2</sub> and 5% CO<sub>2</sub>.</p><p>Field potential recordings were conducted as detailed in previous studies (<xref ref-type="bibr" rid="bib77">Wang et al., 2012</xref>)<bold>.</bold> Specifically, the procedure involved the use of stimulation electrodes filled with artificial cerebrospinal fluid (aCSF) and placed in the CA1 region of the dHP. The recording electrode, filled with 1 M NaCl, was positioned in the CA1 region, approximately 100–150 µm away from the stimulating electrodes. The optimal location for the recording electrode was determined based on the site where a stable fiber volley and field potential response could be consistently observed following the delivery of a single electrical stimulation pulse (2 ms). The stimulation intensity was carefully adjusted to elicit 50% of the maximum possible response. Baseline field potentials were meticulously recorded over 10 min at 10 s intervals. The HFS protocol for LTP included a regimen of 100 Hz, with 100 pulses every 20 s, repeated four times. Following the HFS protocol, field potential recordings were extended for 30 min. LTP was quantified based on the averaged fEPSP as a percentage of the baseline, comparing the measurements at 20–30 min post-HFS between the Prosapip1 cKO and control groups. To inhibit GABAergic transmission, picrotoxin (100 µM) was applied to the bath. The measurement of fEPSP was performed using a MultiClamp 700B amplifier integrated with Clampex 10.4 software provided by Molecular Devices.</p><p>Whole-cell recordings were executed following the protocols previously established (<xref ref-type="bibr" rid="bib77">Wang et al., 2012</xref>; <xref ref-type="bibr" rid="bib49">Ma et al., 2018</xref>). For these recordings, a cesium-based intracellular solution was employed. This solution comprised of the following components: 119 mM CsMeSO<sub>4</sub>, 8 mM Tetraethylammonium chloride (TEA-Cl), 15 mM HEPES, 0.6 mM ethylene glycol tetraacetic acid (EGTA), 0.3 mM Na<sub>3</sub>GTP, 4 mM MgATP, 5 mM QX-314-Cl, and 7 mM phosphocreatine. The pH of this solution was adjusted to 7.3 using CsOH. The temperature of the recording bath was maintained at a constant 32 °C, and the perfusion speed was set between 2–3 ml/min. For the recordings, CA1 neurons were voltage-clamped at a holding potential of –70 mV. In order to measure NMDAR-mediated transmission, a low external concentration of Mg<sup>2+</sup> (0.05 mM) was used. This was coupled with NBQX (10 µM) and picrotoxin (100 µM) to block AMPA receptor (AMPAR)-mediated synaptic transmission and inhibitory synaptic currents. NMDA-induced currents were measured by bath-applying NMDA (20 µM) for 30 s, with holding currents recorded every 5 s.</p><p>Input-output curves for NMDAR-mediated EPSC were created by electrical stimulation of varying intensities which were delivered through electrodes strategically placed within the CA1 region. The paired-pulse ratio (PPR) was calculated by dividing the amplitude of the second electrically-evoked EPSC by that of the first, with an interval of 100ms between the two pulses. Additionally, gap-free recordings of spontaneous excitatory postsynaptic currents were conducted over a duration of 2 min.</p></sec><sec id="s4-9"><title>Behavior</title><p>All behavioral paradigms were completed between the hours of 9:00 and 18:00. Mice were tested between 8 and 20 weeks of age and were age-matched based on the experiment. The mice were moved from their housing room, currently in the ‘light cycle,’ to the dimly lit behavior room (10–15 lux) 30 min before the experiment and allowed to acclimate. The light/dark box, elevated plus maze, and Barnes maze experiments were done in full room light. During experiments, white noise was played through a speaker in the room at 50 dB to reduce influence from noise outside of the room. The researcher remained in the room during the trial, but a wall was placed between the arena and the experimenter to prohibit mice from seeing the researcher. Mice were handled for 3 days for 1–2 min per day before experimentation began to reduce handling anxiety. All behavioral analyses were recorded and analyzed using Noldus Ethovision XT software.</p></sec><sec id="s4-10"><title>Locomotion</title><p>Mice were placed in a 43 cm × 43 cm open field and allowed to explore for 30 min. The center point of the mouse was tracked, and the primarily dependent variable was total locomotion during the trial. Other tracked variables were average and maximum velocity, center entrances, time spent in center, and locomotion binned into 1 min periods to examine evolution of exploration of the space.</p></sec><sec id="s4-11"><title>Novel object recognition</title><p>Mice were placed in a 43 cm × 43 cm chamber with two similar objects and allowed 20 s of total familiarization time (nose point within 2 cm radius of object), or 5 total min in the chamber, whichever came first, before being returned to home cage. After 24 hr, mice were allowed to explore the test space containing one object from the familiarization trial (familiar object) and one novel object until total object interaction time of 20 s was reached. If 20 s of total interaction time was not reached before the 5 min time limit, the trial was excluded (three trials). Mice that were climbing on objects were gently but quickly moved back to the starting position.</p></sec><sec id="s4-12"><title>Novelty T-Maze</title><p>The protocol was adapted from <xref ref-type="bibr" rid="bib66">Sanderson et al., 2009</xref>. Mice were placed in the ‘start’ arm of a T-shaped maze. The dimensions of each transparent arm were 30 cm×10 cm×20 cm (L × W × H). During training, the entrance to one arm (‘novel arm,’ assignment counterbalanced across groups) was blocked with clear plastic. Training consisted of five, 2 min trials in which each subject was allowed to explore the ‘start’ and ‘familiar’ arms. The training trials were separated by a 1 min inter-trial interval. After the training sessions, the plastic blocking the ‘novel’ arm was removed and mice were allowed to explore all arms of the maze. The test session began when the center point of the mouse left the start arm and ended when 2 min of total time was spent in the novel or familiar arm. Mice that showed anxiety-related behavior and an aversion to either arm during the test (no arm entrances, &lt;250 cm total movement) were excluded (2 mice).</p></sec><sec id="s4-13"><title>3-chamber social interaction</title><p>Mice were placed in the center chamber of a transparent 3-chamber arena and allowed 3 min to habituate to the space. The mouse was then placed into the closed center chamber and the trial was started by removing the doors and allowing 15 min to explore the ‘social’ or ‘empty’ chamber (Part I). The social chamber had a sex-matched, naïve mouse (4–5 weeks of age) in a cylindrical interaction cage, while the empty chamber had only the interaction cage. The chamber time and interaction time was recorded, with interaction time being defined as experimental mouse nose point being within interaction zone (5 cm from interaction cage). Immediately after Part I, a novel mouse, also sex-matched and naïve, was introduced in the empty cage and mice were allowed 15 min to explore ‘Novel’ or ‘Familiar’ chamber (Part II). The familiar mouse is the social mouse from Part I. The locations of the novel and familiar mice were switched to reduce side preference for this interaction partner.</p></sec><sec id="s4-14"><title>Barnes maze</title><p>The protocol was adapted from <xref ref-type="bibr" rid="bib59">Pitts, 2018</xref>. The Barnes maze apparatus is a 122 cm-diameter, white-acrylic circle with 40 evenly spaced, 5 cm holes drilled 2.5 cm from the edge of the circle. This experiment was done in light room conditions to increase the motivation to escape. The volume of the white noise was also increased (90 dB). Four visual cues were placed on each side of the platform, which consisted of brightly colored shapes (purple diamond, yellow star, green cube, red triangle).</p><p>The mouse was first habituated to the escape tunnel, a small box filled with Alphadry bedding, in its home cage for 1 min. It was then habituated to the experimental conditions. The mouse was placed in the center of the apparatus and allowed to explore until it entered the escape tunnel or 5 min elapsed. If the mouse did not organically reach the escape tunnel within the time limit, it was led to the exit. There was at least 1 hr between habituation and the onset of acquisition training. The escape tunnel was moved between habituation and training trials.</p><p> There were four training trials per day for four consecutive days. There was an inter-trial interval of 30 min. During training trials, the position of the escape tunnel remained at a fixed location relative to the spatial cues. The mouse was placed in the center of the platform and tracked until it fully entered the escape tunnel or 5 min elapsed. If the mouse failed to reach the escape tunnel in the allotted time, it was led to the escape by the researcher. Following each trial, the platform was cleaned with 70% alcohol and the bedding inside the escape chamber was replaced.</p><p> For each trial, several variables were tracked to assess performance. These include distance traveled, latency to exit, incorrect hole visits (primary errors), and incorrect hole revisits (secondary errors). Errors are defined as a nose point entering a hole that does not contain the exit. Finally, based on these errors, the search strategy was characterized. Mice searched the maze serially, spatially, or randomly. Serial searching mice spent most of the time on the periphery performing a systematic search of the holes in a clockwise or counterclockwise manner, with 2 or less direction changes. Spatial search strategy was defined as &lt;10 primary errors and a significantly reduced path and latency to exit. These mice use the surroundings to determine the shortest path to the exit and often are within 1–2 holes of the destination. All other results were defined as random search strategy. Random search strategy was usually characterized by multiple direction changes and skipping between holes, with many primary and secondary errors.</p><p> 24 hr after the last training trial, mice were tested with a probe trial. The escape tunnel was removed before the mouse was placed on the platform for 5 min. Total time spent in each quartile was recorded, along with visits to former correct and incorrect escapes.</p></sec><sec id="s4-15"><title>Light/dark box</title><p>Mice were placed in the light side of a light/dark box apparatus and movement within the apparatus was recorded from above for 10 min. The ‘light’ side of the box had translucent walls and no ceiling, illuminated by the overhead room light. The ‘dark’ side had opaque walls and a visible-light-filtering ceiling, allowing the mouse to experience a dark environment but the infrared camera to continue recording. We recorded the latency to enter the dark, transitions between zones, and time spent in zones.</p></sec><sec id="s4-16"><title>Elevated plus maze</title><p>The elevated plus maze apparatus is a white ‘+’-shaped platform elevated 50 cm above the floor with oppositely positioned ‘open’ arms and ‘closed’ arms. The closed arms are enclosed by 30 cm high opaque walls, while the open arms have no railing. Each mouse was tested for 5 min after being placed onto the center platform facing an open arm. The number of open and closed arm entries and the time spent on the various sections of the EPM was recorded. The amount of exploration into the open arm is calculated to measure anxiety-like behavior.</p></sec><sec id="s4-17"><title>Stereotaxic surgery</title><p>Mice underwent stereotaxic surgery as described in <xref ref-type="bibr" rid="bib27">Ehinger et al., 2021</xref>. Specifically, mice were anesthetized by vaporized isoflurane and were then head-fixed in a stereotaxic frame (David Kopf Instruments). The mice were between 5 and 6 weeks old. The experimental virus, or relevant control, was infused into the dorsal hippocampus (anteroposterior (AP) –2.3, mediolateral (ML)±1.7, dorsoventral (DV) –1.7 mm measured from bregma) using stainless steel injectors (33 gauge; Small Parts Incorporated) connected to Hamilton syringes (10 µl, 1701). Animals received 1 μl of virus bilaterally at a rate of 0.1 μl/min controlled by an automatic pump (Harvard Apparatus). After the infusion was complete, the injectors remained at the site for 10 min to allow diffusion of the virus. Mice were allowed to recover in their home cages for at least 3 weeks before testing to allow for maximal viral expression.</p></sec><sec id="s4-18"><title>Confirmation of viral expression</title><p>At the end of the experimental timeline, animals were euthanized via cervical dislocation and the brains were removed. The brains were placed on ice and dissected into 1 mm coronal sections. The fluorescent protein expressed by the virus (either GFP or mCherry) was visualized using an EVOS FL tabletop fluorescent microscope (Thermo Fisher Scientific). Images were taken for future reference. Animals that failed to exhibit fluorescence associated with viral overexpression were excluded from the study (4 mice).</p></sec><sec id="s4-19"><title>Statistical analysis</title><sec id="s4-19-1"><title>Biochemical analysis</title><p>Parametric tests were performed on data deemed by the D'Agostino-Pearson omnibus (K2) test to be derived from a normally distributed population. Data were analyzed using a two-tailed t-test with Welch’s correction for normal populations. Mann-Whitney tests were performed on data derived from non-normal populations. The results were determined to be statistically significant if the p-value was less than 0.05.</p></sec><sec id="s4-19-2"><title>Electrophysiology analysis</title><p>Parametric tests were performed on data deemed to be derived from a normally distributed population. Unpaired t-tests were performed on the average measurement over the experimental period. When multiple intensities were used, a two-way repeated measures ANOVA was performed. <italic>Post hoc</italic> pairwise comparisons (Tukey’s) were performed after a significant result in the ANOVA. The results were determined to be statistically significant if the p-value was less than 0.05.</p></sec><sec id="s4-19-3"><title>Behavioral analysis</title><p>Parametric tests were performed on data deemed to be derived from a normally distributed population. Behavioral experiments were first assessed using a three-way ANOVA with primary variables being genotype, sex, and experimental variable where appropriate. Where there was no significant difference between sexes, the data was consolidated by genotype. A two-way ANOVA was then performed on the consolidated data (genotype × experimental variable). <italic>Post hoc</italic> Šidák’s multiple comparison’s test was performed to measure experimental differences directly. When there was only one experimental variable, an unpaired t-test was performed. If the variance was unequal, Welch’s correction was applied. The results were determined to be statistically significant if the p-value was less than 0.05.</p></sec></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Data curation, Formal analysis, Investigation, Visualization, Methodology, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Formal analysis, Investigation</p></fn><fn fn-type="con" id="con3"><p>Data curation, Formal analysis</p></fn><fn fn-type="con" id="con4"><p>Data curation</p></fn><fn fn-type="con" id="con5"><p>Investigation</p></fn><fn fn-type="con" id="con6"><p>Data curation</p></fn><fn fn-type="con" id="con7"><p>Conceptualization, Methodology</p></fn><fn fn-type="con" id="con8"><p>Conceptualization, Formal analysis, Supervision, Validation, Investigation, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con9"><p>Conceptualization, Supervision, Validation, Investigation, Methodology, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con10"><p>Conceptualization, Supervision, Funding acquisition, Validation, Investigation, Methodology, Writing – original draft, Project administration, Writing – review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>All animal procedures were approved by UCSF Institutional Animal Care and Use Committee (IACUC) (animal protocol AN206967) and were conducted in agreement with the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC). Mice were euthanized by carbon dioxide inhalation followed by cervical dislocation, or deep anesthetization with pentobarbital (150 mg/kg) followed by transcranial perfusion with 4% paraformaldehyde. These procedures are in accordance with the Panel on Euthanasia of the American Veterinary Medical Association guidelines and with the standard operating procedures of the UCSF IACUC.</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-100653-mdarchecklist1-v1.pdf" mimetype="application" mime-subtype="pdf"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>The authors declare that all relevant data supporting the findings of this study are included in this published article, supplementary information files and source data files. Source data are provided in this paper.</p></sec><ack id="ack"><title>Acknowledgements</title><p>We thank Carolyn Ferguson for expert technical assistance. Supported by NIH grants AA027474, AA027682 (DR) and AA020889 (GH). ZWH was partially funded by GM007175. None of the authors have a conflict of interest.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abraham</surname><given-names>WC</given-names></name><name><surname>Logan</surname><given-names>B</given-names></name><name><surname>Greenwood</surname><given-names>JM</given-names></name><name><surname>Dragunow</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Induction and experience-dependent consolidation of stable long-term potentiation lasting months in the hippocampus</article-title><source>The Journal of Neuroscience</source><volume>22</volume><fpage>9626</fpage><lpage>9634</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.22-21-09626.2002</pub-id><pub-id pub-id-type="pmid">12417688</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Antunes</surname><given-names>M</given-names></name><name><surname>Biala</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The novel object recognition memory: neurobiology, test procedure, and its modifications</article-title><source>Cognitive Processing</source><volume>13</volume><fpage>93</fpage><lpage>110</lpage><pub-id pub-id-type="doi">10.1007/s10339-011-0430-z</pub-id><pub-id pub-id-type="pmid">22160349</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arons</surname><given-names>MH</given-names></name><name><surname>Thynne</surname><given-names>CJ</given-names></name><name><surname>Grabrucker</surname><given-names>AM</given-names></name><name><surname>Li</surname><given-names>D</given-names></name><name><surname>Schoen</surname><given-names>M</given-names></name><name><surname>Cheyne</surname><given-names>JE</given-names></name><name><surname>Boeckers</surname><given-names>TM</given-names></name><name><surname>Montgomery</surname><given-names>JM</given-names></name><name><surname>Garner</surname><given-names>CC</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Autism-associated mutations in ProSAP2/Shank3 impair synaptic transmission and neurexin-neuroligin-mediated transsynaptic signaling</article-title><source>The Journal of Neuroscience</source><volume>32</volume><fpage>14966</fpage><lpage>14978</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2215-12.2012</pub-id><pub-id pub-id-type="pmid">23100419</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bach</surname><given-names>ME</given-names></name><name><surname>Hawkins</surname><given-names>RD</given-names></name><name><surname>Osman</surname><given-names>M</given-names></name><name><surname>Kandel</surname><given-names>ER</given-names></name><name><surname>Mayford</surname><given-names>M</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Impairment of spatial but not contextual memory in CaMKII mutant mice with a selective loss of hippocampal LTP in the range of the theta frequency</article-title><source>Cell</source><volume>81</volume><fpage>905</fpage><lpage>915</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(95)90010-1</pub-id><pub-id pub-id-type="pmid">7781067</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barker</surname><given-names>GRI</given-names></name><name><surname>Warburton</surname><given-names>EC</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>When is the hippocampus involved in recognition memory?</article-title><source>The Journal of Neuroscience</source><volume>31</volume><fpage>10721</fpage><lpage>10731</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.6413-10.2011</pub-id><pub-id pub-id-type="pmid">21775615</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bast</surname><given-names>T</given-names></name><name><surname>da Silva</surname><given-names>BM</given-names></name><name><surname>Morris</surname><given-names>RGM</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Distinct contributions of hippocampal NMDA and AMPA receptors to encoding and retrieval of one-trial place memory</article-title><source>The Journal of Neuroscience</source><volume>25</volume><fpage>5845</fpage><lpage>5856</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0698-05.2005</pub-id><pub-id pub-id-type="pmid">15976073</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beckley</surname><given-names>JT</given-names></name><name><surname>Laguesse</surname><given-names>S</given-names></name><name><surname>Phamluong</surname><given-names>K</given-names></name><name><surname>Morisot</surname><given-names>N</given-names></name><name><surname>Wegner</surname><given-names>SA</given-names></name><name><surname>Ron</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The first alcohol drink triggers mTORC1-dependent synaptic plasticity in nucleus accumbens dopamine D1 receptor neurons</article-title><source>The Journal of Neuroscience</source><volume>36</volume><fpage>701</fpage><lpage>713</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2254-15.2016</pub-id><pub-id pub-id-type="pmid">26791202</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bliss</surname><given-names>TVP</given-names></name><name><surname>Collingridge</surname><given-names>GL</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>A synaptic model of memory: long-term potentiation in the hippocampus</article-title><source>Nature</source><volume>361</volume><fpage>31</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1038/361031a0</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boeckers</surname><given-names>TM</given-names></name><name><surname>Winter</surname><given-names>C</given-names></name><name><surname>Smalla</surname><given-names>KH</given-names></name><name><surname>Kreutz</surname><given-names>MR</given-names></name><name><surname>Bockmann</surname><given-names>J</given-names></name><name><surname>Seidenbecher</surname><given-names>C</given-names></name><name><surname>Garner</surname><given-names>CC</given-names></name><name><surname>Gundelfinger</surname><given-names>ED</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Proline-rich synapse-associated proteins ProSAP1 and ProSAP2 interact with synaptic proteins of the SAPAP/GKAP family</article-title><source>Biochemical and Biophysical Research Communications</source><volume>264</volume><fpage>247</fpage><lpage>252</lpage><pub-id pub-id-type="doi">10.1006/bbrc.1999.1489</pub-id><pub-id pub-id-type="pmid">10527873</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boeckers</surname><given-names>TM</given-names></name><name><surname>Bockmann</surname><given-names>J</given-names></name><name><surname>Kreutz</surname><given-names>MR</given-names></name><name><surname>Gundelfinger</surname><given-names>ED</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>ProSAP/Shank proteins - a family of higher order organizing molecules of the postsynaptic density with an emerging role in human neurological disease</article-title><source>Journal of Neurochemistry</source><volume>81</volume><fpage>903</fpage><lpage>910</lpage><pub-id pub-id-type="doi">10.1046/j.1471-4159.2002.00931.x</pub-id><pub-id pub-id-type="pmid">12065602</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bourin</surname><given-names>M</given-names></name><name><surname>Hascoët</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>The mouse light/dark box test</article-title><source>European Journal of Pharmacology</source><volume>463</volume><fpage>55</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1016/s0014-2999(03)01274-3</pub-id><pub-id pub-id-type="pmid">12600702</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Broadbent</surname><given-names>NJ</given-names></name><name><surname>Squire</surname><given-names>LR</given-names></name><name><surname>Clark</surname><given-names>RE</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Spatial memory, recognition memory, and the hippocampus</article-title><source>PNAS</source><volume>101</volume><fpage>14515</fpage><lpage>14520</lpage><pub-id pub-id-type="doi">10.1073/pnas.0406344101</pub-id><pub-id pub-id-type="pmid">15452348</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Broadbent</surname><given-names>NJ</given-names></name><name><surname>Gaskin</surname><given-names>S</given-names></name><name><surname>Squire</surname><given-names>LR</given-names></name><name><surname>Clark</surname><given-names>RE</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Object recognition memory and the rodent hippocampus</article-title><source>Learning &amp; Memory</source><volume>17</volume><fpage>5</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1101/lm.1650110</pub-id><pub-id pub-id-type="pmid">20028732</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buffington</surname><given-names>SA</given-names></name><name><surname>Huang</surname><given-names>W</given-names></name><name><surname>Costa-Mattioli</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Translational control in synaptic plasticity and cognitive dysfunction</article-title><source>Annual Review of Neuroscience</source><volume>37</volume><fpage>17</fpage><lpage>38</lpage><pub-id pub-id-type="doi">10.1146/annurev-neuro-071013-014100</pub-id><pub-id pub-id-type="pmid">25032491</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bye</surname><given-names>CM</given-names></name><name><surname>McDonald</surname><given-names>RJ</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>A specific role of hippocampal NMDA receptors and arc protein in rapid encoding of novel environmental representations and a more general long-term consolidation function</article-title><source>Frontiers in Behavioral Neuroscience</source><volume>13</volume><elocation-id>8</elocation-id><pub-id pub-id-type="doi">10.3389/fnbeh.2019.00008</pub-id><pub-id pub-id-type="pmid">30863289</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Levy</surname><given-names>JM</given-names></name><name><surname>Hou</surname><given-names>A</given-names></name><name><surname>Winters</surname><given-names>C</given-names></name><name><surname>Azzam</surname><given-names>R</given-names></name><name><surname>Sousa</surname><given-names>AA</given-names></name><name><surname>Leapman</surname><given-names>RD</given-names></name><name><surname>Nicoll</surname><given-names>RA</given-names></name><name><surname>Reese</surname><given-names>TS</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>PSD-95 family MAGUKs are essential for anchoring AMPA and NMDA receptor complexes at the postsynaptic density</article-title><source>PNAS</source><volume>112</volume><fpage>E6983</fpage><lpage>E6992</lpage><pub-id pub-id-type="doi">10.1073/pnas.1517045112</pub-id><pub-id pub-id-type="pmid">26604311</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cinalli</surname><given-names>DA</given-names></name><name><surname>Cohen</surname><given-names>SJ</given-names></name><name><surname>Guthrie</surname><given-names>K</given-names></name><name><surname>Stackman</surname><given-names>RW</given-names><suffix>Jr</suffix></name></person-group><year iso-8601-date="2020">2020</year><article-title>Object recognition memory: distinct yet complementary roles of the mouse CA1 and perirhinal cortex</article-title><source>Frontiers in Molecular Neuroscience</source><volume>13</volume><elocation-id>527543</elocation-id><pub-id pub-id-type="doi">10.3389/fnmol.2020.527543</pub-id><pub-id pub-id-type="pmid">33192287</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coley</surname><given-names>AA</given-names></name><name><surname>Gao</surname><given-names>WJ</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>PSD-95 deficiency disrupts PFC-associated function and behavior during neurodevelopment</article-title><source>Scientific Reports</source><volume>9</volume><elocation-id>9486</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-019-45971-w</pub-id><pub-id pub-id-type="pmid">31263190</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collingridge</surname><given-names>GL</given-names></name><name><surname>Isaac</surname><given-names>JTR</given-names></name><name><surname>Wang</surname><given-names>YT</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Receptor trafficking and synaptic plasticity</article-title><source>Nature Reviews. Neuroscience</source><volume>5</volume><fpage>952</fpage><lpage>962</lpage><pub-id pub-id-type="doi">10.1038/nrn1556</pub-id><pub-id pub-id-type="pmid">15550950</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Concordet</surname><given-names>JP</given-names></name><name><surname>Haeussler</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>CRISPOR: intuitive guide selection for CRISPR/Cas9 genome editing experiments and screens</article-title><source>Nucleic Acids Research</source><volume>46</volume><fpage>W242</fpage><lpage>W245</lpage><pub-id pub-id-type="doi">10.1093/nar/gky354</pub-id><pub-id pub-id-type="pmid">29762716</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cooke</surname><given-names>SF</given-names></name><name><surname>Bliss</surname><given-names>TVP</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Plasticity in the human central nervous system</article-title><source>Brain</source><volume>129</volume><fpage>1659</fpage><lpage>1673</lpage><pub-id pub-id-type="doi">10.1093/brain/awl082</pub-id><pub-id pub-id-type="pmid">16672292</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cope</surname><given-names>EC</given-names></name><name><surname>Wang</surname><given-names>SH</given-names></name><name><surname>Waters</surname><given-names>RC</given-names></name><name><surname>Gore</surname><given-names>IR</given-names></name><name><surname>Vasquez</surname><given-names>B</given-names></name><name><surname>Laham</surname><given-names>BJ</given-names></name><name><surname>Gould</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Activation of the CA2-ventral CA1 pathway reverses social discrimination dysfunction in Shank3B knockout mice</article-title><source>Nature Communications</source><volume>14</volume><elocation-id>1750</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-023-37248-8</pub-id><pub-id pub-id-type="pmid">36991001</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daumas</surname><given-names>S</given-names></name><name><surname>Halley</surname><given-names>H</given-names></name><name><surname>Francés</surname><given-names>B</given-names></name><name><surname>Lassalle</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Encoding, consolidation, and retrieval of contextual memory: differential involvement of dorsal CA3 and CA1 hippocampal subregions</article-title><source>Learning &amp; Memory</source><volume>12</volume><fpage>375</fpage><lpage>382</lpage><pub-id pub-id-type="doi">10.1101/lm.81905</pub-id><pub-id pub-id-type="pmid">16027176</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname><given-names>S</given-names></name><name><surname>Butcher</surname><given-names>SP</given-names></name><name><surname>Morris</surname><given-names>RG</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>The NMDA receptor antagonist D-2-amino-5-phosphonopentanoate (D-AP5) impairs spatial learning and LTP in vivo at intracerebral concentrations comparable to those that block LTP in vitro</article-title><source>The Journal of Neuroscience</source><volume>12</volume><fpage>21</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.12-01-00021.1992</pub-id><pub-id pub-id-type="pmid">1345945</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>d’Isa</surname><given-names>R</given-names></name><name><surname>Comi</surname><given-names>G</given-names></name><name><surname>Leocani</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Apparatus design and behavioural testing protocol for the evaluation of spatial working memory in mice through the spontaneous alternation T-maze</article-title><source>Scientific Reports</source><volume>11</volume><elocation-id>21177</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-021-00402-7</pub-id><pub-id pub-id-type="pmid">34707108</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dolnik</surname><given-names>A</given-names></name><name><surname>Kanwal</surname><given-names>N</given-names></name><name><surname>Mackert</surname><given-names>S</given-names></name><name><surname>Halbedl</surname><given-names>S</given-names></name><name><surname>Proepper</surname><given-names>C</given-names></name><name><surname>Bockmann</surname><given-names>J</given-names></name><name><surname>Schoen</surname><given-names>M</given-names></name><name><surname>Boeckers</surname><given-names>TM</given-names></name><name><surname>Kühl</surname><given-names>SJ</given-names></name><name><surname>Schmeisser</surname><given-names>MJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Sipa1l3/SPAR3 is targeted to postsynaptic specializations and interacts with the Fezzin ProSAPiP1/Lzts3</article-title><source>Journal of Neurochemistry</source><volume>136</volume><fpage>28</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1111/jnc.13353</pub-id><pub-id pub-id-type="pmid">26364583</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ehinger</surname><given-names>Y</given-names></name><name><surname>Morisot</surname><given-names>N</given-names></name><name><surname>Phamluong</surname><given-names>K</given-names></name><name><surname>Sakhai</surname><given-names>SA</given-names></name><name><surname>Soneja</surname><given-names>D</given-names></name><name><surname>Adrover</surname><given-names>MF</given-names></name><name><surname>Alvarez</surname><given-names>VA</given-names></name><name><surname>Ron</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>cAMP-Fyn signaling in the dorsomedial striatum direct pathway drives excessive alcohol use</article-title><source>Neuropsychopharmacology</source><volume>46</volume><fpage>334</fpage><lpage>342</lpage><pub-id pub-id-type="doi">10.1038/s41386-020-0712-1</pub-id><pub-id pub-id-type="pmid">32417851</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eichenbaum</surname><given-names>H</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Declarative memory: insights from cognitive neurobiology</article-title><source>Annual Review of Psychology</source><volume>48</volume><fpage>547</fpage><lpage>572</lpage><pub-id pub-id-type="doi">10.1146/annurev.psych.48.1.547</pub-id><pub-id pub-id-type="pmid">9046568</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elias</surname><given-names>GM</given-names></name><name><surname>Funke</surname><given-names>L</given-names></name><name><surname>Stein</surname><given-names>V</given-names></name><name><surname>Grant</surname><given-names>SG</given-names></name><name><surname>Bredt</surname><given-names>DS</given-names></name><name><surname>Nicoll</surname><given-names>RA</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Synapse-specific and developmentally regulated targeting of AMPA receptors by a family of MAGUK scaffolding proteins</article-title><source>Neuron</source><volume>52</volume><fpage>307</fpage><lpage>320</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2006.09.012</pub-id><pub-id pub-id-type="pmid">17046693</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frey</surname><given-names>U</given-names></name><name><surname>Morris</surname><given-names>RG</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Synaptic tagging: implications for late maintenance of hippocampal long-term potentiation</article-title><source>Trends in Neurosciences</source><volume>21</volume><fpage>181</fpage><lpage>188</lpage><pub-id pub-id-type="doi">10.1016/s0166-2236(97)01189-2</pub-id><pub-id pub-id-type="pmid">9610879</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gangal</surname><given-names>H</given-names></name><name><surname>Xie</surname><given-names>X</given-names></name><name><surname>Huang</surname><given-names>Z</given-names></name><name><surname>Cheng</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Lu</surname><given-names>J</given-names></name><name><surname>Zhuang</surname><given-names>X</given-names></name><name><surname>Essoh</surname><given-names>A</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>R</given-names></name><name><surname>Smith</surname><given-names>LN</given-names></name><name><surname>Smith</surname><given-names>RJ</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Drug reinforcement impairs cognitive flexibility by inhibiting striatal cholinergic neurons</article-title><source>Nature Communications</source><volume>14</volume><elocation-id>3886</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-023-39623-x</pub-id><pub-id pub-id-type="pmid">37391566</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Graber</surname><given-names>TE</given-names></name><name><surname>McCamphill</surname><given-names>PK</given-names></name><name><surname>Sossin</surname><given-names>WS</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>A recollection of mTOR signaling in learning and memory</article-title><source>Learning &amp; Memory</source><volume>20</volume><fpage>518</fpage><lpage>530</lpage><pub-id pub-id-type="doi">10.1101/lm.027664.112</pub-id><pub-id pub-id-type="pmid">24042848</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herring</surname><given-names>BE</given-names></name><name><surname>Nicoll</surname><given-names>RA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Long-term potentiation: from CaMKII to AMPA receptor trafficking</article-title><source>Annual Review of Physiology</source><volume>78</volume><fpage>351</fpage><lpage>365</lpage><pub-id pub-id-type="doi">10.1146/annurev-physiol-021014-071753</pub-id><pub-id pub-id-type="pmid">26863325</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoeffer</surname><given-names>CA</given-names></name><name><surname>Klann</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>mTOR signaling: at the crossroads of plasticity, memory and disease</article-title><source>Trends in Neurosciences</source><volume>33</volume><fpage>67</fpage><lpage>75</lpage><pub-id pub-id-type="doi">10.1016/j.tins.2009.11.003</pub-id><pub-id pub-id-type="pmid">19963289</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horii</surname><given-names>T</given-names></name><name><surname>Morita</surname><given-names>S</given-names></name><name><surname>Kimura</surname><given-names>M</given-names></name><name><surname>Terawaki</surname><given-names>N</given-names></name><name><surname>Shibutani</surname><given-names>M</given-names></name><name><surname>Hatada</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Efficient generation of conditional knockout mice via sequential introduction of lox sites</article-title><source>Scientific Reports</source><volume>7</volume><elocation-id>7891</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-017-08496-8</pub-id><pub-id pub-id-type="pmid">28801621</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huganir</surname><given-names>RL</given-names></name><name><surname>Nicoll</surname><given-names>RA</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>AMPARs and synaptic plasticity: the last 25 years</article-title><source>Neuron</source><volume>80</volume><fpage>704</fpage><lpage>717</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2013.10.025</pub-id><pub-id pub-id-type="pmid">24183021</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeong</surname><given-names>N</given-names></name><name><surname>Singer</surname><given-names>AC</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Learning from inhibition: Functional roles of hippocampal CA1 inhibition in spatial learning and memory</article-title><source>Current Opinion in Neurobiology</source><volume>76</volume><elocation-id>102604</elocation-id><pub-id pub-id-type="doi">10.1016/j.conb.2022.102604</pub-id><pub-id pub-id-type="pmid">35810533</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaizuka</surname><given-names>T</given-names></name><name><surname>Takumi</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Postsynaptic density proteins and their involvement in neurodevelopmental disorders</article-title><source>Journal of Biochemistry</source><volume>163</volume><fpage>447</fpage><lpage>455</lpage><pub-id pub-id-type="doi">10.1093/jb/mvy022</pub-id><pub-id pub-id-type="pmid">29415158</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kennedy</surname><given-names>MB</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The protein biochemistry of the postsynaptic density in glutamatergic synapses mediates learning in neural networks</article-title><source>Biochemistry</source><volume>57</volume><fpage>4005</fpage><lpage>4009</lpage><pub-id pub-id-type="doi">10.1021/acs.biochem.8b00496</pub-id><pub-id pub-id-type="pmid">29913061</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuriu</surname><given-names>T</given-names></name><name><surname>Inoue</surname><given-names>A</given-names></name><name><surname>Bito</surname><given-names>H</given-names></name><name><surname>Sobue</surname><given-names>K</given-names></name><name><surname>Okabe</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Differential control of postsynaptic density scaffolds via actin-dependent and -independent mechanisms</article-title><source>The Journal of Neuroscience</source><volume>26</volume><fpage>7693</fpage><lpage>7706</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0522-06.2006</pub-id><pub-id pub-id-type="pmid">16855097</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Labuhn</surname><given-names>M</given-names></name><name><surname>Adams</surname><given-names>FF</given-names></name><name><surname>Ng</surname><given-names>M</given-names></name><name><surname>Knoess</surname><given-names>S</given-names></name><name><surname>Schambach</surname><given-names>A</given-names></name><name><surname>Charpentier</surname><given-names>EM</given-names></name><name><surname>Schwarzer</surname><given-names>A</given-names></name><name><surname>Mateo</surname><given-names>JL</given-names></name><name><surname>Klusmann</surname><given-names>JH</given-names></name><name><surname>Heckl</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Refined sgRNA efficacy prediction improves large- and small-scale CRISPR-Cas9 applications</article-title><source>Nucleic Acids Research</source><volume>46</volume><fpage>1375</fpage><lpage>1385</lpage><pub-id pub-id-type="doi">10.1093/nar/gkx1268</pub-id><pub-id pub-id-type="pmid">29267886</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laguesse</surname><given-names>S</given-names></name><name><surname>Morisot</surname><given-names>N</given-names></name><name><surname>Shin</surname><given-names>JH</given-names></name><name><surname>Liu</surname><given-names>F</given-names></name><name><surname>Adrover</surname><given-names>MF</given-names></name><name><surname>Sakhai</surname><given-names>SA</given-names></name><name><surname>Lopez</surname><given-names>MF</given-names></name><name><surname>Phamluong</surname><given-names>K</given-names></name><name><surname>Griffin</surname><given-names>WC</given-names><suffix>III</suffix></name><name><surname>Becker</surname><given-names>HC</given-names></name><name><surname>Bender</surname><given-names>KJ</given-names></name><name><surname>Alvarez</surname><given-names>VA</given-names></name><name><surname>Ron</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Prosapip1-dependent synaptic adaptations in the nucleus accumbens drive alcohol intake, seeking, and reward</article-title><source>Neuron</source><volume>96</volume><fpage>145</fpage><lpage>159</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2017.08.037</pub-id><pub-id pub-id-type="pmid">28890345</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>I</given-names></name><name><surname>Kesner</surname><given-names>RP</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Differential contributions of dorsal hippocampal subregions to memory acquisition and retrieval in contextual fear-conditioning</article-title><source>Hippocampus</source><volume>14</volume><fpage>301</fpage><lpage>310</lpage><pub-id pub-id-type="doi">10.1002/hipo.10177</pub-id><pub-id pub-id-type="pmid">15132429</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leger</surname><given-names>M</given-names></name><name><surname>Quiedeville</surname><given-names>A</given-names></name><name><surname>Bouet</surname><given-names>V</given-names></name><name><surname>Haelewyn</surname><given-names>B</given-names></name><name><surname>Boulouard</surname><given-names>M</given-names></name><name><surname>Schumann-Bard</surname><given-names>P</given-names></name><name><surname>Freret</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Object recognition test in mice</article-title><source>Nature Protocols</source><volume>8</volume><fpage>2531</fpage><lpage>2537</lpage><pub-id pub-id-type="doi">10.1038/nprot.2013.155</pub-id><pub-id pub-id-type="pmid">24263092</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>F</given-names></name><name><surname>Tsien</surname><given-names>JZ</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Memory and the NMDA receptors</article-title><source>The New England Journal of Medicine</source><volume>361</volume><fpage>302</fpage><lpage>303</lpage><pub-id pub-id-type="doi">10.1056/NEJMcibr0902052</pub-id><pub-id pub-id-type="pmid">19605837</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>Y</given-names></name><name><surname>Skeberdis</surname><given-names>VA</given-names></name><name><surname>Francesconi</surname><given-names>A</given-names></name><name><surname>Bennett</surname><given-names>MVL</given-names></name><name><surname>Zukin</surname><given-names>RS</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Postsynaptic density protein-95 regulates NMDA channel gating and surface expression</article-title><source>The Journal of Neuroscience</source><volume>24</volume><fpage>10138</fpage><lpage>10148</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.3159-04.2004</pub-id><pub-id pub-id-type="pmid">15537884</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>F</given-names></name><name><surname>Laguesse</surname><given-names>S</given-names></name><name><surname>Legastelois</surname><given-names>R</given-names></name><name><surname>Morisot</surname><given-names>N</given-names></name><name><surname>Ben Hamida</surname><given-names>S</given-names></name><name><surname>Ron</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>mTORC1-dependent translation of collapsin response mediator protein-2 drives neuroadaptations underlying excessive alcohol-drinking behaviors</article-title><source>Molecular Psychiatry</source><volume>22</volume><fpage>89</fpage><lpage>101</lpage><pub-id pub-id-type="doi">10.1038/mp.2016.12</pub-id><pub-id pub-id-type="pmid">26952865</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lueptow</surname><given-names>LM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Novel object recognition test for the investigation of learning and memory in mice</article-title><source>Journal of Visualized Experiments</source><volume>1</volume><elocation-id>55718</elocation-id><pub-id pub-id-type="doi">10.3791/55718-v</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>T</given-names></name><name><surname>Cheng</surname><given-names>Y</given-names></name><name><surname>Roltsch Hellard</surname><given-names>E</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Lu</surname><given-names>J</given-names></name><name><surname>Gao</surname><given-names>X</given-names></name><name><surname>Huang</surname><given-names>CCY</given-names></name><name><surname>Wei</surname><given-names>XY</given-names></name><name><surname>Ji</surname><given-names>JY</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Bidirectional and long-lasting control of alcohol-seeking behavior by corticostriatal LTP and LTD</article-title><source>Nature Neuroscience</source><volume>21</volume><fpage>373</fpage><lpage>383</lpage><pub-id pub-id-type="doi">10.1038/s41593-018-0081-9</pub-id><pub-id pub-id-type="pmid">29434375</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mackes</surname><given-names>JL</given-names></name><name><surname>Willner</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>NMDA antagonist MK-801 impairs acquisition of place strategies, but not their use</article-title><source>Behavioural Brain Research</source><volume>175</volume><fpage>112</fpage><lpage>118</lpage><pub-id pub-id-type="doi">10.1016/j.bbr.2006.08.011</pub-id><pub-id pub-id-type="pmid">16970996</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsuura</surname><given-names>K</given-names></name><name><surname>Kobayashi</surname><given-names>S</given-names></name><name><surname>Konno</surname><given-names>K</given-names></name><name><surname>Yamasaki</surname><given-names>M</given-names></name><name><surname>Horiuchi</surname><given-names>T</given-names></name><name><surname>Senda</surname><given-names>T</given-names></name><name><surname>Hayashi</surname><given-names>T</given-names></name><name><surname>Satoh</surname><given-names>K</given-names></name><name><surname>Arima-Yoshida</surname><given-names>F</given-names></name><name><surname>Iwasaki</surname><given-names>K</given-names></name><name><surname>Negishi</surname><given-names>L</given-names></name><name><surname>Yasui-Shimizu</surname><given-names>N</given-names></name><name><surname>Kohu</surname><given-names>K</given-names></name><name><surname>Kawahara</surname><given-names>S</given-names></name><name><surname>Kirino</surname><given-names>Y</given-names></name><name><surname>Nakamura</surname><given-names>T</given-names></name><name><surname>Watanabe</surname><given-names>M</given-names></name><name><surname>Yamamoto</surname><given-names>T</given-names></name><name><surname>Manabe</surname><given-names>T</given-names></name><name><surname>Akiyama</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>SIPA1L1/SPAR1 interacts with the neurabin family of proteins and is involved in GPCR signaling</article-title><source>The Journal of Neuroscience</source><volume>42</volume><fpage>2448</fpage><lpage>2473</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0569-21.2022</pub-id><pub-id pub-id-type="pmid">35121636</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayanagi</surname><given-names>T</given-names></name><name><surname>Yasuda</surname><given-names>H</given-names></name><name><surname>Sobue</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>PSD-Zip70 deficiency causes prefrontal hypofunction associated with glutamatergic synapse maturation defects by dysregulation of Rap2 activity</article-title><source>The Journal of Neuroscience</source><volume>35</volume><fpage>14327</fpage><lpage>14340</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2349-15.2015</pub-id><pub-id pub-id-type="pmid">26490870</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meira</surname><given-names>T</given-names></name><name><surname>Leroy</surname><given-names>F</given-names></name><name><surname>Buss</surname><given-names>EW</given-names></name><name><surname>Oliva</surname><given-names>A</given-names></name><name><surname>Park</surname><given-names>J</given-names></name><name><surname>Siegelbaum</surname><given-names>SA</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>A hippocampal circuit linking dorsal CA2 to ventral CA1 critical for social memory dynamics</article-title><source>Nature Communications</source><volume>9</volume><elocation-id>4163</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-018-06501-w</pub-id><pub-id pub-id-type="pmid">30301899</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nachtigall</surname><given-names>EG</given-names></name><name><surname>de C Myskiw</surname><given-names>J</given-names></name><name><surname>Izquierdo</surname><given-names>I</given-names></name><name><surname>Furini</surname><given-names>CRG</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>Cellular mechanisms of contextual fear memory reconsolidation: Role of hippocampal SFKs, TrkB receptors and GluN2B-containing NMDA receptors</article-title><source>Psychopharmacology</source><volume>241</volume><fpage>61</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.1007/s00213-023-06463-y</pub-id><pub-id pub-id-type="pmid">37700085</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naisbitt</surname><given-names>S</given-names></name><name><surname>Kim</surname><given-names>E</given-names></name><name><surname>Tu</surname><given-names>JC</given-names></name><name><surname>Xiao</surname><given-names>B</given-names></name><name><surname>Sala</surname><given-names>C</given-names></name><name><surname>Valtschanoff</surname><given-names>J</given-names></name><name><surname>Weinberg</surname><given-names>RJ</given-names></name><name><surname>Worley</surname><given-names>PF</given-names></name><name><surname>Sheng</surname><given-names>M</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Shank, a novel family of postsynaptic density proteins that binds to the NMDA receptor/PSD-95/GKAP complex and cortactin</article-title><source>Neuron</source><volume>23</volume><fpage>569</fpage><lpage>582</lpage><pub-id pub-id-type="doi">10.1016/s0896-6273(00)80809-0</pub-id><pub-id pub-id-type="pmid">10433268</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newcomer</surname><given-names>JW</given-names></name><name><surname>Farber</surname><given-names>NB</given-names></name><name><surname>Olney</surname><given-names>JW</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>NMDA receptor function, memory, and brain aging</article-title><source>Dialogues in Clinical Neuroscience</source><volume>2</volume><fpage>219</fpage><lpage>232</lpage><pub-id pub-id-type="doi">10.31887/DCNS.2000.2.3/jnewcomer</pub-id><pub-id pub-id-type="pmid">22034391</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pak</surname><given-names>DT</given-names></name><name><surname>Yang</surname><given-names>S</given-names></name><name><surname>Rudolph-Correia</surname><given-names>S</given-names></name><name><surname>Kim</surname><given-names>E</given-names></name><name><surname>Sheng</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Regulation of dendritic spine morphology by SPAR, a PSD-95-associated RapGAP</article-title><source>Neuron</source><volume>31</volume><fpage>289</fpage><lpage>303</lpage><pub-id pub-id-type="doi">10.1016/s0896-6273(01)00355-5</pub-id><pub-id pub-id-type="pmid">11502259</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pilly</surname><given-names>PK</given-names></name><name><surname>Grossberg</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>How do spatial learning and memory occur in the brain? Coordinated learning of entorhinal grid cells and hippocampal place cells</article-title><source>Journal of Cognitive Neuroscience</source><volume>24</volume><fpage>1031</fpage><lpage>1054</lpage><pub-id pub-id-type="doi">10.1162/jocn_a_00200</pub-id><pub-id pub-id-type="pmid">22288394</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pitts</surname><given-names>MW</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Barnes maze procedure for spatial learning and memory in mice</article-title><source>Bio-Protocol</source><volume>8</volume><elocation-id>e2744</elocation-id><pub-id pub-id-type="doi">10.21769/bioprotoc.2744</pub-id><pub-id pub-id-type="pmid">29651452</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qualmann</surname><given-names>B</given-names></name><name><surname>Boeckers</surname><given-names>TM</given-names></name><name><surname>Jeromin</surname><given-names>M</given-names></name><name><surname>Gundelfinger</surname><given-names>ED</given-names></name><name><surname>Kessels</surname><given-names>MM</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Linkage of the actin cytoskeleton to the postsynaptic density via direct interactions of Abp1 with the ProSAP/Shank family</article-title><source>The Journal of Neuroscience</source><volume>24</volume><fpage>2481</fpage><lpage>2495</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.5479-03.2004</pub-id><pub-id pub-id-type="pmid">15014124</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reim</surname><given-names>D</given-names></name><name><surname>Weis</surname><given-names>TM</given-names></name><name><surname>Halbedl</surname><given-names>S</given-names></name><name><surname>Delling</surname><given-names>JP</given-names></name><name><surname>Grabrucker</surname><given-names>AM</given-names></name><name><surname>Boeckers</surname><given-names>TM</given-names></name><name><surname>Schmeisser</surname><given-names>MJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The Shank3 interaction partner ProSAPiP1 regulates postsynaptic SPAR levels and the maturation of dendritic spines in hippocampal neurons</article-title><source>Frontiers in Synaptic Neuroscience</source><volume>8</volume><elocation-id>13</elocation-id><pub-id pub-id-type="doi">10.3389/fnsyn.2016.00013</pub-id><pub-id pub-id-type="pmid">27252646</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Renaud</surname><given-names>JB</given-names></name><name><surname>Boix</surname><given-names>C</given-names></name><name><surname>Charpentier</surname><given-names>M</given-names></name><name><surname>De Cian</surname><given-names>A</given-names></name><name><surname>Cochennec</surname><given-names>J</given-names></name><name><surname>Duvernois-Berthet</surname><given-names>E</given-names></name><name><surname>Perrouault</surname><given-names>L</given-names></name><name><surname>Tesson</surname><given-names>L</given-names></name><name><surname>Edouard</surname><given-names>J</given-names></name><name><surname>Thinard</surname><given-names>R</given-names></name><name><surname>Cherifi</surname><given-names>Y</given-names></name><name><surname>Menoret</surname><given-names>S</given-names></name><name><surname>Fontanière</surname><given-names>S</given-names></name><name><surname>de Crozé</surname><given-names>N</given-names></name><name><surname>Fraichard</surname><given-names>A</given-names></name><name><surname>Sohm</surname><given-names>F</given-names></name><name><surname>Anegon</surname><given-names>I</given-names></name><name><surname>Concordet</surname><given-names>JP</given-names></name><name><surname>Giovannangeli</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Improved genome editing efficiency and flexibility using modified oligonucleotides with TALEN and CRISPR-Cas9 nucleases</article-title><source>Cell Reports</source><volume>14</volume><fpage>2263</fpage><lpage>2272</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2016.02.018</pub-id><pub-id pub-id-type="pmid">26923600</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richter</surname><given-names>M</given-names></name><name><surname>Murai</surname><given-names>KK</given-names></name><name><surname>Bourgin</surname><given-names>C</given-names></name><name><surname>Pak</surname><given-names>DT</given-names></name><name><surname>Pasquale</surname><given-names>EB</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>The EphA4 receptor regulates neuronal morphology through SPAR-mediated inactivation of Rap GTPases</article-title><source>The Journal of Neuroscience</source><volume>27</volume><fpage>14205</fpage><lpage>14215</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2746-07.2007</pub-id><pub-id pub-id-type="pmid">18094260</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosenfeld</surname><given-names>CS</given-names></name><name><surname>Ferguson</surname><given-names>SA</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Barnes maze testing strategies with small and large rodent models</article-title><source>Journal of Visualized Experiments</source><volume>1</volume><elocation-id>e51194</elocation-id><pub-id pub-id-type="doi">10.3791/51194</pub-id><pub-id pub-id-type="pmid">24637673</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sánchez-Rodríguez</surname><given-names>I</given-names></name><name><surname>Temprano-Carazo</surname><given-names>S</given-names></name><name><surname>Jeremic</surname><given-names>D</given-names></name><name><surname>Delgado-Garcia</surname><given-names>JM</given-names></name><name><surname>Gruart</surname><given-names>A</given-names></name><name><surname>Navarro-López</surname><given-names>JD</given-names></name><name><surname>Jiménez-Díaz</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Recognition memory induces natural LTP-like hippocampal synaptic excitation and inhibition</article-title><source>International Journal of Molecular Sciences</source><volume>23</volume><elocation-id>10806</elocation-id><pub-id pub-id-type="doi">10.3390/ijms231810806</pub-id><pub-id pub-id-type="pmid">36142727</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanderson</surname><given-names>DJ</given-names></name><name><surname>Good</surname><given-names>MA</given-names></name><name><surname>Skelton</surname><given-names>K</given-names></name><name><surname>Sprengel</surname><given-names>R</given-names></name><name><surname>Seeburg</surname><given-names>PH</given-names></name><name><surname>Rawlins</surname><given-names>JNP</given-names></name><name><surname>Bannerman</surname><given-names>DM</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Enhanced long-term and impaired short-term spatial memory in GluA1 AMPA receptor subunit knockout mice: evidence for a dual-process memory model</article-title><source>Learning &amp; Memory</source><volume>16</volume><fpage>379</fpage><lpage>386</lpage><pub-id pub-id-type="doi">10.1101/lm.1339109</pub-id><pub-id pub-id-type="pmid">19470654</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>S</given-names></name><name><surname>Rakoczy</surname><given-names>S</given-names></name><name><surname>Brown-Borg</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Assessment of spatial memory in mice</article-title><source>Life Sciences</source><volume>87</volume><fpage>521</fpage><lpage>536</lpage><pub-id pub-id-type="doi">10.1016/j.lfs.2010.09.004</pub-id><pub-id pub-id-type="pmid">20837032</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheng</surname><given-names>M</given-names></name><name><surname>Kim</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>The Shank family of scaffold proteins</article-title><source>Journal of Cell Science</source><volume>113 (Pt 11)</volume><fpage>1851</fpage><lpage>1856</lpage><pub-id pub-id-type="doi">10.1242/jcs.113.11.1851</pub-id><pub-id pub-id-type="pmid">10806096</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Squire</surname><given-names>LR</given-names></name><name><surname>Stark</surname><given-names>CEL</given-names></name><name><surname>Clark</surname><given-names>RE</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>The medial temporal lobe</article-title><source>Annual Review of Neuroscience</source><volume>27</volume><fpage>279</fpage><lpage>306</lpage><pub-id pub-id-type="doi">10.1146/annurev.neuro.27.070203.144130</pub-id><pub-id pub-id-type="pmid">15217334</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stemmer</surname><given-names>M</given-names></name><name><surname>Thumberger</surname><given-names>T</given-names></name><name><surname>Del Sol Keyer</surname><given-names>M</given-names></name><name><surname>Wittbrodt</surname><given-names>J</given-names></name><name><surname>Mateo</surname><given-names>JL</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>CCTop: an intuitive, flexible and reliable CRISPR/Cas9 Target prediction tool</article-title><source>PLOS ONE</source><volume>10</volume><elocation-id>e0124633</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0124633</pub-id><pub-id pub-id-type="pmid">25909470</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stevenson</surname><given-names>RF</given-names></name><name><surname>Zheng</surname><given-names>J</given-names></name><name><surname>Mnatsakanyan</surname><given-names>L</given-names></name><name><surname>Vadera</surname><given-names>S</given-names></name><name><surname>Knight</surname><given-names>RT</given-names></name><name><surname>Lin</surname><given-names>JJ</given-names></name><name><surname>Yassa</surname><given-names>MA</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Hippocampal CA1 gamma power predicts the precision of spatial memory judgments</article-title><source>PNAS</source><volume>115</volume><fpage>10148</fpage><lpage>10153</lpage><pub-id pub-id-type="doi">10.1073/pnas.1805724115</pub-id><pub-id pub-id-type="pmid">30224452</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Straube</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>An overview of the neuro-cognitive processes involved in the encoding, consolidation, and retrieval of true and false memories</article-title><source>Behavioral and Brain Functions</source><volume>8</volume><elocation-id>35</elocation-id><pub-id pub-id-type="doi">10.1186/1744-9081-8-35</pub-id><pub-id pub-id-type="pmid">22827854</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsien</surname><given-names>JZ</given-names></name><name><surname>Huerta</surname><given-names>PT</given-names></name><name><surname>Tonegawa</surname><given-names>S</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>The essential role of hippocampal CA1 NMDA receptor-dependent synaptic plasticity in spatial memory</article-title><source>Cell</source><volume>87</volume><fpage>1327</fpage><lpage>1338</lpage><pub-id pub-id-type="doi">10.1016/s0092-8674(00)81827-9</pub-id><pub-id pub-id-type="pmid">8980238</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tu</surname><given-names>JC</given-names></name><name><surname>Xiao</surname><given-names>B</given-names></name><name><surname>Naisbitt</surname><given-names>S</given-names></name><name><surname>Yuan</surname><given-names>JP</given-names></name><name><surname>Petralia</surname><given-names>RS</given-names></name><name><surname>Brakeman</surname><given-names>P</given-names></name><name><surname>Doan</surname><given-names>A</given-names></name><name><surname>Aakalu</surname><given-names>VK</given-names></name><name><surname>Lanahan</surname><given-names>AA</given-names></name><name><surname>Sheng</surname><given-names>M</given-names></name><name><surname>Worley</surname><given-names>PF</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Coupling of mGluR/Homer and PSD-95 complexes by the Shank family of postsynaptic density proteins</article-title><source>Neuron</source><volume>23</volume><fpage>583</fpage><lpage>592</lpage><pub-id pub-id-type="doi">10.1016/s0896-6273(00)80810-7</pub-id><pub-id pub-id-type="pmid">10433269</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tzakis</surname><given-names>N</given-names></name><name><surname>Holahan</surname><given-names>MR</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Social memory and the role of the hippocampal CA2 region</article-title><source>Frontiers in Behavioral Neuroscience</source><volume>13</volume><elocation-id>233</elocation-id><pub-id pub-id-type="doi">10.3389/fnbeh.2019.00233</pub-id><pub-id pub-id-type="pmid">31632251</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walf</surname><given-names>AA</given-names></name><name><surname>Frye</surname><given-names>CA</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>The use of the elevated plus maze as an assay of anxiety-related behavior in rodents</article-title><source>Nature Protocols</source><volume>2</volume><fpage>322</fpage><lpage>328</lpage><pub-id pub-id-type="doi">10.1038/nprot.2007.44</pub-id><pub-id pub-id-type="pmid">17406592</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Ben Hamida</surname><given-names>S</given-names></name><name><surname>Darcq</surname><given-names>E</given-names></name><name><surname>Zhu</surname><given-names>W</given-names></name><name><surname>Gibb</surname><given-names>SL</given-names></name><name><surname>Lanfranco</surname><given-names>MF</given-names></name><name><surname>Carnicella</surname><given-names>S</given-names></name><name><surname>Ron</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Ethanol-mediated facilitation of AMPA receptor function in the dorsomedial striatum: implications for alcohol drinking behavior</article-title><source>The Journal of Neuroscience</source><volume>32</volume><fpage>15124</fpage><lpage>15132</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2783-12.2012</pub-id><pub-id pub-id-type="pmid">23100433</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Zhan</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Regulation of social recognition memory in the hippocampal circuits</article-title><source>Frontiers in Neural Circuits</source><volume>16</volume><elocation-id>839931</elocation-id><pub-id pub-id-type="doi">10.3389/fncir.2022.839931</pub-id><pub-id pub-id-type="pmid">35431817</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>E</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Qian</surname><given-names>Q</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Huang</surname><given-names>F</given-names></name><name><surname>Sun</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>Efr3b is essential for social recognition by modulating the excitability of CA2 pyramidal neurons</article-title><source>PNAS</source><volume>121</volume><elocation-id>e2314557121</elocation-id><pub-id pub-id-type="doi">10.1073/pnas.2314557121</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wendholt</surname><given-names>D</given-names></name><name><surname>Spilker</surname><given-names>C</given-names></name><name><surname>Schmitt</surname><given-names>A</given-names></name><name><surname>Dolnik</surname><given-names>A</given-names></name><name><surname>Smalla</surname><given-names>KH</given-names></name><name><surname>Proepper</surname><given-names>C</given-names></name><name><surname>Bockmann</surname><given-names>J</given-names></name><name><surname>Sobue</surname><given-names>K</given-names></name><name><surname>Gundelfinger</surname><given-names>ED</given-names></name><name><surname>Kreutz</surname><given-names>MR</given-names></name><name><surname>Boeckers</surname><given-names>TM</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>ProSAP-interacting protein 1 (ProSAPiP1), a novel protein of the postsynaptic density that links the spine-associated Rap-Gap (SPAR) to the scaffolding protein ProSAP2/Shank3</article-title><source>The Journal of Biological Chemistry</source><volume>281</volume><fpage>13805</fpage><lpage>13816</lpage><pub-id pub-id-type="doi">10.1074/jbc.M601101200</pub-id><pub-id pub-id-type="pmid">16522626</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Won</surname><given-names>S</given-names></name><name><surname>Incontro</surname><given-names>S</given-names></name><name><surname>Nicoll</surname><given-names>RA</given-names></name><name><surname>Roche</surname><given-names>KW</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>PSD-95 stabilizes NMDA receptors by inducing the degradation of STEP <sub>61</sub></article-title><source>PNAS</source><volume>113</volume><fpage>E4736</fpage><lpage>E4744</lpage><pub-id pub-id-type="doi">10.1073/pnas.1609702113</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>X</given-names></name><name><surname>Gong</surname><given-names>R</given-names></name><name><surname>Qin</surname><given-names>L</given-names></name><name><surname>Bao</surname><given-names>Y</given-names></name><name><surname>Fu</surname><given-names>Y</given-names></name><name><surname>Gao</surname><given-names>S</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>Ni</surname><given-names>J</given-names></name><name><surname>Yuan</surname><given-names>TF</given-names></name><name><surname>Lu</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Trafficking of NMDA receptors is essential for hippocampal synaptic plasticity and memory consolidation</article-title><source>Cell Reports</source><volume>40</volume><elocation-id>111217</elocation-id><pub-id pub-id-type="doi">10.1016/j.celrep.2022.111217</pub-id><pub-id pub-id-type="pmid">35977502</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Etherington</surname><given-names>LA</given-names></name><name><surname>Hafner</surname><given-names>AS</given-names></name><name><surname>Belelli</surname><given-names>D</given-names></name><name><surname>Coussen</surname><given-names>F</given-names></name><name><surname>Delagrange</surname><given-names>P</given-names></name><name><surname>Chaouloff</surname><given-names>F</given-names></name><name><surname>Spedding</surname><given-names>M</given-names></name><name><surname>Lambert</surname><given-names>JJ</given-names></name><name><surname>Choquet</surname><given-names>D</given-names></name><name><surname>Groc</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Regulation of AMPA receptor surface trafficking and synaptic plasticity by a cognitive enhancer and antidepressant molecule</article-title><source>Molecular Psychiatry</source><volume>18</volume><fpage>471</fpage><lpage>484</lpage><pub-id pub-id-type="doi">10.1038/mp.2012.80</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zucker</surname><given-names>RS</given-names></name><name><surname>Regehr</surname><given-names>WG</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Short-term synaptic plasticity</article-title><source>Annual Review of Physiology</source><volume>64</volume><fpage>355</fpage><lpage>405</lpage><pub-id pub-id-type="doi">10.1146/annurev.physiol.64.092501.114547</pub-id><pub-id pub-id-type="pmid">11826273</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.100653.3.sa0</article-id><title-group><article-title>eLife Assessment</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>McElligott</surname><given-names>Zoe A</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution>University of North Carolina at Chapel Hill</institution><country>United States</country></aff></contrib></contrib-group><kwd-group kwd-group-type="evidence-strength"><kwd>Convincing</kwd></kwd-group><kwd-group kwd-group-type="claim-importance"><kwd>Important</kwd></kwd-group></front-stub><body><p>This <bold>important</bold> study aims to understand the function of ProSAP-interacting protein 1 (Prosapip1) in the brain. Using a conditional Prosapip1 KO mouse (floxed prosapip1 crossed with Syn1-Cre line), the authors performed analysis including protein biochemistry, synaptic physiology, and behavioral learning. <bold>Convincing</bold> evidence from this study supports a role of Prosapip 1 in synaptic protein composition, synaptic NMDA responses, LTP, and spatial memory.</p></body></sub-article><sub-article article-type="referee-report" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.100653.3.sa1</article-id><title-group><article-title>Reviewer #1 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>Summary of what author's were trying to achieve: In the manuscript by Hoisington et al., the authors utilized a novel conditional neuronal prosap2-interacting protein 1 (Prosapip1) knockout mouse to delineate the effects of both neuronal and dorsal hippocampal (dHP)-specific knockout of Prosapip1 impacts biochemical and electrophysiological neuroadaptations within the dHP that may mediate behaviors associated with this brain region.</p><p>Strengths:</p><p>(1) Methodological Strengths</p><p>a) The generation and use of a conditional neuronal knockout of Prosapip1 is a strength. These mice will be useful for anyone interested in studying or comparing and contrasting the effects of loss of Prosapip1 in different brain regions or in non-neuronal tissues.</p><p>b) The use of biochemical, electrophysiological, and behavioral approaches are a strength. By providing data across multiple domains, a picture begins to emerge about the mechanistic role for Prosapip1. While questions still remain, the use of the 3 domains is a strength.</p><p>c) The use of both global, constitutive neuronal loss of Prosapip1 and postnatal dHP-specific knockout of Prosapip1 help support and validate the behavioral conclusions.</p><p>(2) Strengths of the results</p><p>a) It is interesting that loss of Prosapip1 leads to specific alterations in the expression of GluN2B and PSD95 but not GluA1 or GluN2A in a post homogenization fraction that the author's term a &quot;synaptic&quot; fraction. Therefore, these results suggest protein-specific modulation of glutamatergic receptors within a &quot;synaptic&quot; fraction.</p><p>b) The electrophysiological data demonstrate an NMDAR-dependent alteration in measures of hippocampal synaptic plasticity, including long-term potentiation (LTP) and NMDAR input/output. These data correspond with the biochemical data demonstrating a biochemical effect on GluN2B localization. Therefore, the conclusion that loss of Prosapip1 influences NMDAR function is well supported.</p><p>c) The behavioral data suggest deficits in memory in particular novel object recognition and spatial memory, in the Prosapip1 knockout mice. These data are strongly bolstered by both the pan neuronal knockout and the dHP Cre transduction.</p><p>The authors highlight potential future studies to further the understanding of Prosapip1.</p></body></sub-article><sub-article article-type="referee-report" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.100653.3.sa2</article-id><title-group><article-title>Reviewer #2 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>The authors provide valuable findings characterizing a Prosapip1 conditional knockout mouse and the effects of knockout on hippocampal excitatory transmission, NMDAR transmission, and several learning behaviors. Furthermore, the authors selectively and conditionally knockout Prosapip1 in the dorsal hippocampus and show that it is required for the same spatial learning and memory assessed in the conditional knockout mice. The study uncovers how Prosapip1 is involved PSD organization and is a functional and critical player in dorsal Hippocampal LTP via its interaction with GluN2B subunits. The study is well controlled, detailed, and data in the paper match the conclusions.</p><p>Comments on revisions:</p><p>The authors have addressed all concerns.</p></body></sub-article><sub-article article-type="author-comment" id="sa3"><front-stub><article-id pub-id-type="doi">10.7554/eLife.100653.3.sa3</article-id><title-group><article-title>Author response</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Hoisington</surname><given-names>Zachary W</given-names></name><role specific-use="author">Author</role><aff><institution>University of California, San Francisco</institution><addr-line><named-content content-type="city">San Francisco</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Gangal</surname><given-names>Himanshu</given-names></name><role specific-use="author">Author</role><aff><institution>Texas A&amp;M University</institution><addr-line><named-content content-type="city">College Station, TX</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Phamluong</surname><given-names>Khanhky</given-names></name><role specific-use="author">Author</role><aff><institution>University of California, San Francisco</institution><addr-line><named-content content-type="city">San Francisco</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Shukla</surname><given-names>Chhavi</given-names></name><role specific-use="author">Author</role><aff><institution>University of California, San Francisco</institution><addr-line><named-content content-type="city">San Francisco</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Moffat</surname><given-names>Jeffrey J</given-names></name><role specific-use="author">Author</role><aff><institution>University of California, San Francisco</institution><addr-line><named-content content-type="city">San Francisco</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Salvi</surname><given-names>Alexandra</given-names></name><role specific-use="author">Author</role><aff><institution>University of California, San Francisco</institution><addr-line><named-content content-type="city">San Francisco</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Homanics</surname><given-names>Gregg</given-names></name><role specific-use="author">Author</role><aff><institution>University of Pittsburgh</institution><addr-line><named-content content-type="city">Pittsburgh</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Jun</given-names></name><role specific-use="author">Author</role><aff><institution>Texas A&amp;M University</institution><addr-line><named-content content-type="city">College Station, TX</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Ehinger</surname><given-names>Yann</given-names></name><role specific-use="author">Author</role><aff><institution>University of California, San Francisco</institution><addr-line><named-content content-type="city">San Francisco</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Ron</surname><given-names>Dorit</given-names></name><role specific-use="author">Author</role><aff><institution>University of California, San Francisco</institution><addr-line><named-content content-type="city">San Francisco</named-content></addr-line><country>United States</country></aff></contrib></contrib-group></front-stub><body><p>The following is the authors’ response to the original reviews.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #1 (Recommendations for the authors):</bold></p><p>The biochemical fractionation and use of the term &quot;synaptic&quot; were my biggest issues. I would recommend using a more targeted approach to measure the PSD or compare and contrast synaptic from extrasynaptic. For instance, PMID 16797717 does a PSD purification, whereas other papers have fractionated extrasynaptic from synaptic. Moreover, a PSD95 immunoprecipitation may be of interest as one question that could arise is since you see decreases in PSD95 GluN2B, but not 2A or GluA1, could the association of PSD95 with the different proteins be altered? To evaluate this, proteomics or some other unbiased methodology could enhance an understanding of the full panoply of changes induced by Prosapip1 within the dHP.</p></disp-quote><p>The reviewer makes value points; however, this is a large endeavor, which we will address in future experiments.</p><disp-quote content-type="editor-comment"><p>There seems to be a missed opportunity to really determine how Prosapip1 is influencing protein expression and/or phosphorylation at the PSD.</p></disp-quote><p>There is no indication that Prosapip1 is linked to transcription or translation machinery; therefore, we don’t see the value of examining protein expression in this context. Phosphorylation is a broad term, and although this can be answered through phosphoproteomics, this is outside the scope of this study.</p><disp-quote content-type="editor-comment"><p>At the very least, additional discussion within this realm would help the reader contextualize the biochemical data.</p></disp-quote><p>Further studies are needed to determine the mechanism by which Prosapip1 controls the localization of PSD95, GlunN2B, and potentially others. It is plausible that posttranslational modifications are responsible for Prosapip1 function. For example, the Prosapip1 sequence contains a potential glycosylation site (Ser622), and several potential phosphorylation sites (<ext-link ext-link-type="uri" xlink:href="https://glygen.org/protein/O60299#Glycosylation">https://glygen.org/protein/O60299#Glycosylation</ext-link>, <ext-link ext-link-type="uri" xlink:href="https://www.phosphosite.org/proteinAction.action?id=18395&amp;showAllSites=true#appletMsg">https://www.phosphosite.org/proteinAction.action?id=18395&amp;showAllSites=true#appletMsg</ext-link>). These posttranslational modifications can contribute to the stabilization of the synaptic localization of GluN2B and PSD95.</p><p>We added to the discussion the paragraph above as well as the caveat that proteomic studies are needed for a comprehensive study of the role of Prosapip1 in the PSD.</p><disp-quote content-type="editor-comment"><p>Weaknesses:</p><p>(1) Methodological Weaknesses</p><p>a. The synapsin-Cre mice may more broadly express Cre-recombinase than just in neuronal tissues. Specifically, according to Jackson Laboratories, there is a concern with these mice expressing Cre-recombinase germline. As the human protein atlas suggests that Prosapip1 protein is expressed extraneuronally, validation of neuron or at least brain-specific knockout would be helpful in interpreting the data. Having said that, the data demonstrating that the brain region-specific knockout has similar behavioral impacts helps alleviate this concern somewhat; however, there are no biochemical or electrophysiological readouts from these animals, and therefore an alternative mechanism in this adult knockout cannot be excluded.</p></disp-quote><p>This is a valuable insight from the reviewer, especially considering the information from Jackson Laboratories. As mentioned in the paper, we exclusively used female Syn1-Cre carrying breeders to avoid germline recombination. Furthermore, we consistently assessed the prevalence of the Prosapip1 flox sites alongside the presence of Syn1-Cre with our regular litter genotyping, confirming the presence of Prosapip1. Additionally, Prosapip1 protein expression was directly examined in rats in Wendholdt et al., 2006, where this group reported that Prosapip1 is a brain-specific protein, minimizing the potential consequences of a peripheral loss of Prosapip1. In addition, to confirm that Prosapip1 is a brain-specific protein in mice, we performed a western blot analysis on the dorsal hippocampus, liver, and kidney of a C57BL/6 mouse (Author response image 1), and found that Prosapip1 protein is not found in these peripheral organs, aligning with the findings in rats reported by Wendholdt et al.</p><fig id="sa3fig1" position="float"><label>Author response image 1.</label><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100653-sa3-fig1-v1.tif"/></fig><disp-quote content-type="editor-comment"><p>b. The use of the word synaptic and the crude fractionation make some of the data difficult to interpret/contextualize. It is unclear how a single centrifugation that eliminates the staining of a nuclear protein can be considered a &quot;synaptic&quot; fraction. This is highlighted by the presence of GAPDH in this fraction which is a cytosolically-enriched protein. While GAPDH may be associated with some membranes it is not a synaptic protein. There is no quantification of GAPDH against total protein to validate that it is not enriched in this fraction over control. Moreover, it should not be used as a loading control in the synaptic fraction. There are multiple different ways to enrich membranes, extrasynaptic fractions, and PSDs and a better discussion on the caveats of the biochemical fractionation is a minimum to help contextualize the changes in PSD95 and GluN2B.</p></disp-quote><p>We apologize for the confusion. As we described in the methods section, the crude synaptosome was isolated by several centrifugations as depicted in the figure which we are now including in the manuscript. As shown in Extended Figure 2, the P2 fraction does contain PSD-95 and synapsin, as well as GluN2B, GluN2A, and GluA1; however, it does not contain the transcription factor CREB, indicating the isolation of the crude synaptosomal fraction. As shown in the figure, a small amount of GAPDH is present in the crude synaptosomal fraction. The presence of GAPDH in the crude synaptosomal fraction has been previously reported in (Atsushi et al., 2003; Lee et al. 2016; Wang et al. 2012). As we have added to the discussion, there remains a caveat that we cannot differentiate the pre- and post-synaptic fraction, and as a result we do not know if Prosapip1 plays a role in the assembly of axonal proteins.</p><disp-quote content-type="editor-comment"><p>c. Also, the word synaptosomal on page 7 is not correct. One issue is this is more than synaptosomes and another issue is synaptosomes are exclusively presynaptic terminals. The correct term to use is synaptoneurosome, which includes both pre and postsynaptic components. Moreover, as stated above, this may contain these components but is most likely not a pure or even enriched fraction.</p></disp-quote><p>Since we cannot exclude the possibility that Prosapip1 is also expressed in glia, we do not believe that the term synaptoneurosome is accurate.</p><disp-quote content-type="editor-comment"><p>d. The age at which the mice underwent injection of the Cre virus was not mentioned.</p></disp-quote><p>We apologize for the oversight. As now noted in the methods, the mice used for experiments underwent surgery to infect neurons with the AAV-GFP or AAV-Cre viruses between 5 and 6 weeks of age to ensure full viral expression by the experimental window beginning at 8 weeks old.</p><disp-quote content-type="editor-comment"><p>(2) Weaknesses of Results</p><p>a. There were no measures of GluN1 or GluA2 in the biochemical assays. As GluN1 is the obligate subunit, how it is impacted by the loss of Prosapip1 may help contextualize the fact that GluN2B, but not GluN2A, is altered. Moreover, as GluA2 has different calcium permeance, alterations in it may be informative.</p></disp-quote><p>Since we detect NMDAR current, which requires the obligatory subunit GluN1 and at least one GluN2 subunit (GluN2A, GluN2B, GluN2C, GluN2D), we did not see the rationale behind examining the level of GluN1 in the Prosapip1 knockout mice.</p><disp-quote content-type="editor-comment"><p>b. While there was no difference in GluA1 expression in the &quot;synaptic&quot; fraction, it does not mean that AMPAR function is not impacted by the loss of Prosapip1. This is particularly important as Prosapip1 may interact with kinases or phosphatases or their targeting proteins. Therefore, measuring AMPAR function electrophysiologically or synaptic protein phosphorylation would be informative.</p></disp-quote><p>We agree with the reviewer that the loss of Prosapip1 could potentially impact AMPAR function. To address this, we measured spontaneous excitatory postsynaptic currents (sEPSCs) in hippocampal pyramidal neurons from both Prosapip1(flx/flx);Syn1-Cre(-) and Prosapip1(flx/flx);Syn1-Cre(+) mice. Given that neurons were voltage-clamped at -70 mV and extracellular Mg<sup>2+</sup> was maintained at 1.3 mM, the sEPSCs we recorded were primarily mediated by AMPARs.</p><p>We found no significant differences in either the frequency or amplitude of these AMPA-mediated sEPSCs between Prosapip1(flx/flx);Syn1-Cre(-) and Prosapip1(flx/flx);Syn1-Cre(+) mice, suggesting that AMPAR function in hippocampal pyramidal neurons is not noticeably affected by the loss of Prosapip1 (see Author response image 2 below).</p><fig id="sa3fig2" position="float"><label>Author response image 2.</label><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100653-sa3-fig2-v1.tif"/></fig><disp-quote content-type="editor-comment"><p>c. There is a lack of mechanistic data on what specifically and how GluN2B and PSD95 expression is altered. This is due to some of the challenges with interpreting the biochemical fractionation and a lack of results regarding changes in protein posttranslational modifications.</p></disp-quote><p>See response above.</p><disp-quote content-type="editor-comment"><p>d. The loss of social novelty measures in both the global and dHP-specific Prosapip1 knockout mice were not very robust. As they were consistently lost in both approaches and as there were other consistent memory deficits, this does not impact the conclusions, but may be important to temper discussion to match these smaller deficits within this domain.</p></disp-quote><p>There is a clear difference between the Prosapip1(flx/flx);Syn1-Cre(-) and Prosapip1(flx/flx);Syn1-Cre(+) mice as well as the AAV-GFP and AAV-Cre mice in the loss of social novelty metric. We have emphasized that the Prosapip1(flx/flx);Syn1-Cre(+) mice and AAV-Cre mice do not recognize social novelty, which is supported by the statistics.</p><p>4E: Two-way ANOVA: Effect of Social Novelty F<sub>(1,20)</sub> = 17.60, p = 0.0002; <italic>Post hoc Familiar vs. Novel (Cre(-)) p = 0.0008, Familiar vs. Novel (Cre(+)) p = 0.1451.</italic></p><p>5I: Two-way ANOVA: Effect of Social Novelty F<sub>(1,31)</sub> = 9.777, p = 0.0038; <italic>Post hoc Familiar vs. Novel (AAV-GFP) p = 0.0303, Familiar vs. Novel (AAV-Cre) p = 0.1319.</italic></p><disp-quote content-type="editor-comment"><p>e. Alterations in presynaptic paired-pulse ratio measures are intriguing and may point to a role for Prosapip1 in synapse development, as discussed in the manuscript. It would be interesting to delineate if these PPR changes also occur in the adult knockout to help detail the specific Prosapip1-induced neuroadaptations that link to the alterations in novelty-induced behaviors.</p></disp-quote><p>This interesting question will be addressed in future studies.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #2 (Recommendations for the authors):</bold></p><p>(1) The test statistics are required for each experiment for completeness. Currently, only p-values, tests used, and N are included.</p></disp-quote><p>The entirety of the statistical information can be found in TYable 1, including test statistics and degrees of freedom (see Column 7, ‘Result’).</p><disp-quote content-type="editor-comment"><p>(2) The authors claim that the function of Prosapip1 is not known in vivo, yet detail a study in the NAc where they investigated its function in vivo. The wording or discussion around what is and is not known should be altered to reflect this.</p></disp-quote><p>The reviewer is correct to point to our previous manuscript (Laguesse et al. Neuron. 2017.) in which we found that Prosapip1 is important in mechanisms underlying alcohol-associated molecular, cellular and behavioral adaptations. However, these findings are specific to alcohol-related paradigms. Since the normal physiological role of Prosapip1 has never been delineated, this study was aimed to start addressing this gap in knowledge.</p><p>References</p><p>Wang, M., Li, S., Zhang, H. et al. Direct interaction between GluR2 and GAPDH regulates AMPAR-mediated excitotoxicity. Mol Brain 5, 13 (2012). <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/1756-6606-5-13">https://doi.org/10.1186/1756-6606-5-13</ext-link></p><p>Atsushi Ikemoto, David G. Bole, Tetsufumi Ueda, Glycolysis and Glutamate Accumulation into Synaptic Vesicles: Role of Glyceraldehyde Phosphate Dehydrogenase and 3-Phosphoglycerate Kinase, Journal of Biological Chemistry, 8, 278 (2003). <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1074/jbc.M211617200">https://doi.org/10.1074/jbc.M211617200</ext-link>.</p><p>Lee, F., Su, P., Xie, YF. et al. Disrupting GluA2-GAPDH Interaction Affects Axon and Dendrite Development. Sci Rep 6, 30458 (2016). <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/srep30458">https://doi.org/10.1038/srep30458</ext-link></p></body></sub-article></article>